≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Eating disorder

DOID Endpoint Browser

KRA_PSY_EATING

eating disorder: A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F50
  • Hospital discharge: ICD-9 — 3071|3075[ABE]
  • Hospital discharge: ICD-8 — 30650
  • Cause of death: ICD-10 — F50
  • Cause of death: ICD-9 — 3071|3075[ABE]
  • Cause of death: ICD-8 — 30650

2 out of 7 registries used, show all original rules.

4292

4. Check minimum number of events

None

4292

5. Include endpoints

None

4292

6. Filter based on genotype QC (FinnGen only)

4106

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF12
Parent code in ICD-10
F50-F59
Name in latin
Perturbationes edendi

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4106 3771 335
Unadjusted period prevalence (%) 1.24 1.34 0.15
Median age at first event (years) 22.38 21.65 30.58

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4292
Matched controls
42832
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.6
315.1
546
920
P86
ICPC
Anorexia nervosa/bulimia
53.9
307.7
402
82
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.8
307.7
1811
5656
F50.2
ICD-10 Finland
Bulimia nervosa
409.2
307.7
1099
36
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.4
307.7
782
1448
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.2
307.7
651
1194
F50.9
ICD-10 Finland
Eating disorder, unspecified
343.3
307.7
1912
100
F50.1
ICD-10 Finland
Atypical anorexia nervosa
687.1
307.7
962
18
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.4
307.7
809
1489
N03AX09
ATC
lamotrigine; oral
5.4
307.7
781
1708
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.4
307.7
776
1692
N05AX12
ATC
aripiprazole; systemic
6.2
307.7
775
1474
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.4
307.7
1143
2313
N05AH04
ATC
quetiapine; oral
5.5
307.7
2031
6056
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
6.9
307.7
843
1472
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.9
307.7
500
699
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.5
307.7
594
1038
N06AB03
ATC
fluoxetine; oral
10.2
307.7
1864
3000
F50.3
ICD-10 Finland
Atypical bulimia nervosa
320.6
307.7
766
29
F50.0
ICD-10 Finland
Anorexia nervosa
1980.5
307.7
1263
9
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.4
307.7
1276
3738
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.2
307.7
1477
4720
N05BA04
ATC
oxazepam; oral
3.5
307.7
1817
7398
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.9
307.7
690
1348
N05AH03
ATC
olanzapine; systemic
5.9
307.7
805
1619
N06AX16
ATC
venlafaxine; oral
4.3
307.7
1453
4565
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.4
307.7
959
2175
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.9
307.7
464
520
F50.8
ICD-10 Finland
Other eating disorders
201.9
307.7
710
42
N06AB06
ATC
sertraline; oral
4.1
307.7
1333
4265
ZY010
NOMESCO Finland
Hospital outpatient
5.6
307.7
874
1884
N05AX08
ATC
risperidone; systemic
5.4
300.7
658
1382
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.8
298.9
782
1910
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.5
297.4
527
907
IER01
NOMESCO Finland
Psychoeducation, group
11.9
271.8
282
251
N06AX12
ATC
bupropion; oral
3.8
263.0
967
3022
R4190
NOMESCO Finland
Nutritional therapy
5.8
257.9
511
976
N91.1
ICD-10 Finland
Secondary amenorrhoea
5.8
257.2
512
982
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.1
256.9
1532
6460
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.3
255.4
559
1168
Z2445
NOMESCO Finland
Psychologist
5.0
252.6
608
1378
F50
ICD-10 Finland
Eating disorders
58.2
250.9
141
25
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.6
249.2
512
1010
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.9
247.1
607
1398
T05
ICPC
Feeding problem of adult
9.6
245.8
297
328
F60.9
ICD-10 Finland
Personality disorder, unspecified
10.2
245.6
283
293
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.0
243.3
585
1323
N06AB04
ATC
citalopram; systemic
3.2
239.2
1220
4669
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.8
238.2
345
476
N06AX11
ATC
mirtazapine; oral
2.8
236.4
1937
9622
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.9
233.9
452
841
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.2
232.3
364
548
Z2446
NOMESCO Finland
Social worker
4.4
226.0
646
1673
N05AA02
ATC
levomepromazine; systemic
7.2
219.9
340
504
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.1
217.8
497
1072
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.7
215.9
429
818
Z3226
NOMESCO Finland
Physiotherapist
3.3
213.3
1009
3664
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
210.0
502
1125
IBZ05
NOMESCO Finland
Evaluation of patient with eating disorder
248.4
208.6
213
9
N06AB10
ATC
escitalopram; oral
2.7
207.2
1767
8821
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.9
206.9
392
714
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.7
202.3
514
1210
Z3231
NOMESCO Finland
Registered nurse
2.8
199.6
1449
6645
F61.0
ICD-10 Finland
Mixed personality disorders
8.0
199.2
280
372
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.7
198.2
389
732
N05AF03
ATC
chlorprothixene; systemic
7.7
194.6
283
391
N03AG01
ATC
valproic acid; systemic, rectal
4.6
194.1
498
1180
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.0
188.6
430
924
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.5
185.0
498
1224
R63.0
ICD-10 Finland
Anorexia
26.6
184.1
127
49
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
7.5
183.4
273
387
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
178.9
1098
4575
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.3
177.9
504
1287
N05AN01
ATC
lithium; oral
6.3
177.9
310
519
F34.1
ICD-10 Finland
Dysthymia
4.7
175.5
438
1013
N05BA06
ATC
lorazepam; systemic, sublingual
6.1
170.7
307
530
N06AX05
ATC
trazodone; oral
6.6
166.7
279
448
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.8
163.7
313
573
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.6
162.8
1317
6269
N06AX26
ATC
vortioxetine; oral
3.1
162.2
812
3007
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.6
162.0
325
622
N05CF01
ATC
zopiclone; oral
2.6
161.6
1248
5807
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
6.3
160.6
282
475
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.9
159.0
300
542
E66.8
ICD-10 Finland
Other obesity
3.8
158.9
547
1602
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
157.8
435
1085
P76
ICPC
Depressive disorder
3.0
156.3
821
3120
P29
ICPC
Psychological sympt/compl other
2.8
155.2
999
4233
N05BA01
ATC
diazepam; systemic, rectal
3.3
154.9
652
2174
ZYC01
NOMESCO Finland
Remote contact by phone
3.7
151.4
535
1593
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.3
148.8
412
1030
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.5
148.7
218
303
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.5
147.8
299
576
N05BE01
ATC
buspirone; oral
6.0
147.3
268
467
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.9
147.0
272
482
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
9.1
146.6
182
207
N05AB03
ATC
perphenazine; systemic, rectal
5.9
146.0
274
492
3071A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Anorexia nervosa
+∞
145.5
139
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.9
145.5
800
3108
N06AB05
ATC
paroxetine; oral
4.0
144.7
444
1197
N06AX03
ATC
mianserin; oral
5.5
143.3
288
551
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.4
143.2
384
936
AA400
NOMESCO Finland
Electroconvulsive therapy
12.1
141.8
144
123
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.7
141.1
348
794
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
7.2
140.2
214
311
N05CD07
ATC
temazepam; oral
4.8
137.0
327
726
C07AA05
ATC
propranolol; systemic
2.4
134.9
1331
6841
RD210, ,
NOMESCO Finland
6.1
134.4
239
407
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
12.1
132.3
134
114
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.1
130.7
388
1019
N03AX16
ATC
[U] pregabalin
2.6
127.2
878
3815
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.5
124.4
464
1425
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.5
123.8
207
331
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
3.0
123.4
640
2393
F50.4
ICD-10 Finland
Overeating associated with other psychological disturbances
257.0
122.5
125
5
N06AX21
ATC
duloxetine; oral
2.8
121.1
725
2926
Z2221
NOMESCO Finland
Medical doctor
2.2
119.7
1439
7960
T08
ICPC
Weight loss
6.5
119.5
200
320
P99
ICPC
Psychological disorders other
3.8
118.4
386
1082
F93.89
ICD-10 Finland
Other childhood emotional disorders
5.5
118.4
237
451
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.8
117.1
278
613
ZY000
NOMESCO Finland
Hospital inpatient
6.1
115.4
207
355
P01
ICPC
Feeling anxious/nervous/tense
2.1
114.2
1641
9692
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
7.4
114.2
169
237
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
5.7
113.9
220
405
P03
ICPC
Feeling depressed
2.3
113.8
1176
6096
N05AH02
ATC
clozapine; systemic
6.1
110.8
197
335
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.7
110.6
213
391
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.4
110.5
441
1410
P74
ICPC
Anxiety disorder/anxiety state
2.8
107.9
632
2513
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
107.5
815
3677
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
24.1
106.4
76
32
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
104.6
1016
5108
R4140
NOMESCO Finland
Psychotherapy
8.5
103.5
135
163
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.3
103.0
281
691
N06AX22
ATC
agomelatine; oral
4.2
102.5
283
702
IEY01
NOMESCO Finland
Psychoeducation, individual
6.2
100.9
175
290
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
6.2
100.9
175
290
R63.4
ICD-10 Finland
Abnormal weight loss
4.9
100.4
228
484
X78
ICD-10 Finland
Intentional self-harm by sharp object
7.6
98.6
142
193
ZXY60
NOMESCO Finland
2-person team, nurses
8.7
98.2
126
149
E87.6
ICD-10 Finland
Hypokalaemia
6.2
97.0
168
278
F32.1
ICD-10 Finland
Moderate depressive episode
2.5
95.9
674
2922
IGV01
NOMESCO Finland
Psychiatric network contact
5.3
95.5
196
381
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.3
94.2
256
627
G03DB01
ATC
dydrogesterone; oral
2.3
93.5
816
3900
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
8.0
93.4
128
164
F50.5
ICD-10 Finland
Vomiting associated with other psychological disturbances
322.7
93.2
94
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.9
93.0
212
451
N06AB08
ATC
fluvoxamine; oral
6.3
92.8
158
257
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
92.6
380
1232
F40.1
ICD-10 Finland
Social phobias
3.3
92.4
376
1213
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
8.9
92.1
116
134
N07BB01
ATC
disulfiram; oral
4.4
92.0
238
561
SPAT1240
SPAT
Therapeutic discussion
2.2
91.2
1010
5319
N03AE01
ATC
clonazepam; systemic
4.0
91.1
276
732
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.4
89.7
182
350
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
5.4
88.5
179
343
F60.5
ICD-10 Finland
Anankastic personality disorder
5.8
88.0
165
295
N05CF02
ATC
zolpidem; oral
2.3
87.6
781
3758
F33.8
ICD-10 Finland
Other recurrent depressive disorders
5.9
86.6
158
275
P11
ICPC
Eating problem in child
15.5
86.1
75
49
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.8
84.9
276
769
30650
ICD-8 Finland
Special symptoms not elsewhere classified, Feeding disturbance
+∞
84.6
81
*
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
6.8
83.3
131
196
RF220, ,
NOMESCO Finland
8.4
81.6
107
130
N03AX11
ATC
topiramate; oral
3.8
80.4
261
726
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
6.0
80.0
143
244
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.9
79.9
395
1424
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
6.3
79.8
135
218
N06AG02
ATC
moclobemide; oral
4.5
79.0
200
463
SPAT1139
SPAT
Nutrition survey
4.1
78.2
224
570
N05AD01
ATC
haloperidol; systemic
5.7
78.0
147
264
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.0
77.3
119
174
ICB06, ,
NOMESCO Finland
5.4
76.6
155
297
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
76.2
349
1204
IDR02
NOMESCO Finland
Systematic group therapy, cognitive
21.8
75.3
56
26
SPAT1307
SPAT
Psychosocial counselling and guidance
2.2
75.2
802
4127
T82
ICPC
Obesity
3.0
75.2
359
1268
N05AE04
ATC
ziprasidone; systemic
7.2
74.3
111
157
R4110
NOMESCO Finland
Physiotherapy
2.0
73.3
1023
5810
F33
ICD-10 Finland
Recurrent depressive disorder
3.2
73.2
308
1011
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
72.7
696
3428
N05BA12
ATC
alprazolam; oral
2.7
72.3
419
1641
IEV99
NOMESCO Finland
Other psychiatric network intervention
5.9
72.0
130
224
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.6
71.9
244
699
E66.9
ICD-10 Finland
Obesity, unspecified
3.1
71.6
311
1040
F31
ICD-10 Finland
Bipolar affective disorder
5.1
70.1
151
306
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
8.9
69.9
87
99
N06AA12
ATC
doxepin; systemic
4.5
69.8
175
402
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.3
69.6
118
191
X84
ICD-10 Finland
Intentional self-harm by unspecified means
9.8
68.8
80
83
F32
ICD-10 Finland
Depressive episode
2.4
67.2
499
2199
N04AA02
ATC
biperiden; systemic
5.8
66.3
122
214
F60.8
ICD-10 Finland
Other specific personality disorders
7.2
64.6
97
138
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
5.3
64.3
130
249
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
5.2
64.0
133
261
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
8.5
63.3
82
98
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
62.9
2004
14484
E66.00
ICD-10 Finland
Metabolic syndrome
3.3
62.8
243
757
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
11.5
62.8
65
57
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.7
62.7
117
208
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.3
62.3
127
245
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
62.1
470
2086
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
8.5
62.1
80
95
RT230, ,
NOMESCO Finland
24.6
62.0
44
18
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
7.9
62.0
85
109
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.9
61.7
112
194
IBA03
NOMESCO Finland
Psychotherapy evaluation
4.1
61.2
172
431
IDY04
NOMESCO Finland
Systematic individual therapy, dialectical behaviour therapy (DBT)
10.8
60.9
66
62
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.2
60.8
548
2621
G03FB06
ATC
medroxyprogesterone and estrogen; systemic
4.1
60.7
170
425
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
7.2
60.4
90
127
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
60.3
1356
8869
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
6.3
59.8
102
166
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
59.8
873
4992
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
5.5
59.5
116
215
G47.3
ICD-10 Finland
Sleep apnoea
2.1
59.3
653
3377
R5599
NOMESCO Finland
Other rehabilitation service
4.0
58.8
174
453
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
6.5
58.6
96
150
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.8
58.5
134
286
N06BA04
ATC
methylphenidate; oral
2.3
58.4
488
2259
A06AD11
ATC
lactulose; oral
2.5
57.6
397
1687
A04
ICPC
Weakness/tiredness general
1.8
57.5
1033
6304
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.6
57.5
194
553
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
7.5
57.1
82
111
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
8.0
57.0
77
97
N06AA06
ATC
trimipramine; systemic
5.3
56.4
115
222
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
5.8
56.2
103
180
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
6.4
55.7
92
145
K59.09
ICD-10 Finland
Constipation, unspecified
3.0
55.6
262
916
IGP01
NOMESCO Finland
Psychiatric family contact
4.1
54.1
149
368
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.7
53.8
307
1189
N06AX18
ATC
reboxetine; oral
7.5
53.7
77
104
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
6.8
53.3
84
126
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
5.2
53.2
110
215
ZXY49
NOMESCO Finland
Other health care provider
6.6
52.6
85
131
A02BC02
ATC
pantoprazole; systemic
1.6
52.5
2359
18308
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
51.8
284
1077
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.9
51.8
116
243
Z71.8
ICD-10 Finland
Other specified counselling
1.6
51.6
1917
14176
H03AA01
ATC
levothyroxine sodium; systemic
1.8
51.5
952
5833
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.0
51.5
231
785
N05AX15
ATC
cariprazine; oral
6.7
51.2
81
122
N05AE05
ATC
lurasidone; oral
6.8
51.1
80
119
R53
ICD-10 Finland
Malaise and fatigue
1.7
51.0
1334
9013
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.6
51.0
123
274
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
7.9
50.9
70
90
AA1AD
NOMESCO Finland
CT of head and brain
1.9
50.9
711
3986
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.4
50.6
101
191
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
49.9
480
2347
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
6.9
49.8
77
113
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
49.4
1394
9589
F41.00
ICD-10 Finland
Moderate panic disorder
3.4
49.4
183
554
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
49.2
335
1413
R11
ICD-10 Finland
Nausea and vomiting
2.1
48.8
553
2877
C03CA01
ATC
furosemide; systemic
2.3
48.2
410
1907
F60.0
ICD-10 Finland
Paranoid personality disorder
9.9
47.9
55
56
S51.7
ICD-10 Finland
Multiple open wounds of forearm
7.9
47.9
66
85
N02AX02
ATC
tramadol; systemic, rectal
1.7
47.9
1285
8711
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
6.5
47.1
77
120
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
11.8
47.1
48
41
F32.8
ICD-10 Finland
Other depressive episodes
3.4
47.0
170
507
L17
ICPC
Foot/toe symptom/complaint
1.7
46.9
1323
9073
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.0
46.9
71
102
P80
ICPC
Personality disorder
6.4
46.8
78
124
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
46.5
377
1717
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
5.8
46.2
85
149
N06AA09
ATC
amitriptyline; systemic
2.7
46.1
255
971
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
45.6
414
1975
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
9.3
45.6
55
60
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
45.4
392
1833
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
10.1
45.0
51
51
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
44.6
348
1559
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
44.5
492
2533
A28
ICPC
Limited function/disability NOS
2.4
44.4
314
1346
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
44.2
686
3963
N05AF01
ATC
flupentixol; systemic
6.8
44.0
69
103
P06
ICPC
Sleep disturbance
1.8
43.9
770
4620
IBZ99
NOMESCO Finland
Other behavioural observation
118.6
43.8
47
*
P15
ICPC
Chronic alcohol abuse
3.5
43.6
150
433
N05AX16
ATC
brexpiprazole; oral
7.5
43.6
62
83
E66
ICD-10 Finland
Obesity
2.3
43.5
365
1685
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.3
43.4
360
1654
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.8
43.4
133
355
OAB74, ,
SPAT
4.8
43.3
99
211
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.7
43.0
141
394
IFA37
NOMESCO Finland
Ketamine treatment
10.3
43.0
48
47
R02
ICPC
Shortness of breath/dyspnoea
1.9
42.9
578
3187
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
11.7
42.8
44
38
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.7
42.8
136
372
R55
ICD-10 Finland
Syncope and collapse
2.2
42.8
370
1730
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
42.5
544
2948
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
42.0
1083
7221
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
41.6
962
6231
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
41.5
1129
7628
D01
ICPC
Abdominal pain/cramps general
1.7
41.3
886
5622
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
41.2
527
2854
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.5
41.1
270
1118
N05AA01
ATC
chlorpromazine; systemic, rectal
6.7
41.0
65
98
Z72.8
ICD-10 Finland
Other problems related to lifestyle
5.7
40.9
77
138
N06AA04
ATC
clomipramine; systemic
5.0
40.9
88
178
E66.0
ICD-10 Finland
Obesity due to excess calories
6.6
40.3
65
100
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
7.1
40.1
60
85
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.9
39.9
120
316
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
39.9
773
4763
N02BF02
ATC
pregabalin; oral
2.4
39.9
302
1334
R42
ICD-10 Finland
Dizziness and giddiness
1.7
39.7
802
4998
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
39.5
1473
10707
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
6.6
39.4
63
96
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
39.3
613
3538
M79.6
ICD-10 Finland
Pain in limb
1.5
39.3
1804
13730
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
5.6
39.2
74
133
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
39.1
718
4352
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
6.1
39.1
68
113
IEY03
NOMESCO Finland
Vocational rehabilitation
6.1
38.6
67
111
RS210, ,
NOMESCO Finland
7.9
38.6
53
68
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
7.9
38.6
53
68
3075A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[TARKEMMIN MÄÄRITTELEMÄTÖN SYÖMISHÄIRIÖ]
+∞
38.6
37
*
L28
ICPC
Limited function/disability (L)
2.0
38.5
470
2500
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
38.3
534
2971
P72
ICPC
Schizophrenia
4.1
38.3
107
267
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
38.2
228
901
F10.24
ICD-10 Finland
Alcohol depence active use
5.2
38.1
79
155
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
6.8
38.0
59
87
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.5
37.9
242
988
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
37.8
243
996
IDY99
NOMESCO Finland
Other individual psychotherapy intervention
6.6
37.7
61
94
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
37.7
269
1157
IEP99
NOMESCO Finland
Other psychiatric family intervention
5.0
37.4
81
165
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
37.1
250
1047
R06.0
ICD-10 Finland
Dyspnoea
1.7
37.1
895
5841
F84.5
ICD-10 Finland
Asperger syndrome
4.0
37.0
107
274
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
37.0
1087
7453
P18
ICPC
Medication abuse
5.8
36.9
67
116
K59.0
ICD-10 Finland
Constipation
2.4
36.9
255
1080
T90
ICPC
Diabetes non-insulin dependent
2.0
36.5
429
2251
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
13.0
36.5
35
27
F61
ICD-10 Finland
Mixed and other personality disorders
7.0
36.3
55
79
Z91.5
ICD-10 Finland
Personal history of self-harm
7.0
36.3
55
79
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.5
36.3
88
197
SPAT1389
SPAT
Visit based on need for special support
2.1
36.2
358
1763
IDY24
NOMESCO Finland
Systematic individual treatment, dialectical behaviour therapy (DBT), pre-treatment
10.1
36.2
41
41
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
5.6
36.1
68
122
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
36.1
348
1696
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.1
36.1
100
248
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
35.9
275
1220
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
12.1
35.8
36
30
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.8
35.6
108
286
3075B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]
+∞
35.4
34
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
35.4
778
4946
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
6.0
35.3
62
104
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
35.1
217
872
N91.0
ICD-10 Finland
Primary amenorrhoea
6.3
35.0
59
95
F45.8
ICD-10 Finland
Other somatoform disorders
1.8
35.0
543
3123
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.0
34.9
99
250
S18
ICPC
Laceration/cut
1.5
34.9
1549
11620
N05AL01
ATC
sulpiride; systemic
5.8
34.8
63
109
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
34.7
343
1688
A01
ICPC
Pain general/multiple sites
2.0
34.7
425
2262
A10BJ02
ATC
liraglutide; parenteral
3.5
34.5
119
344
E86
ICD-10 Finland
Volume depletion
5.0
34.2
73
147
SPAT1234
SPAT
Support of social functional capacity
2.8
34.1
172
623
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.3
34.0
68
129
F21
ICD-10 Finland
Schizotypal disorder
6.4
34.0
56
88
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
33.8
164
582
Z01.7
ICD-10 Finland
Laboratory examination
1.7
33.8
765
4897
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
33.7
239
1024
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.1
33.5
356
1799
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
3.8
33.4
101
267
C07AB07
ATC
bisoprolol; oral
1.6
33.4
939
6346
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
33.1
1543
11657
S29
ICPC
Skin symptom/complaint other
1.6
33.1
871
5790
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
32.8
211
864
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
5.8
32.7
60
105
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.8
32.6
169
622
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.0
32.5
145
491
N05BA02
ATC
chlordiazepoxide; systemic
4.9
32.4
72
150
P16
ICPC
Acute alcohol abuse
3.9
32.3
94
242
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
7.9
32.3
44
56
ZXE00
NOMESCO Finland
One hour or less
1.5
32.2
1538
11661
WX892
NOMESCO Finland
Monitored bed care
2.4
32.2
232
1001
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
5.3
32.2
64
121
N03AX12
ATC
[U] gabapentin; oral
1.8
31.7
481
2741
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
31.6
263
1207
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
31.5
766
4986
RD112, ,
NOMESCO Finland
8.9
31.5
39
44
N05AD03
ATC
melperone; systemic
7.9
31.4
43
55
R51.80
ICD-10 Finland
Headache
1.6
31.3
963
6635
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
31.3
277
1305
IER02, ,
SPAT
10.7
31.2
34
32
N17
ICPC
Vertigo/dizziness
1.8
31.1
517
3030
K03.2
ICD-10 Finland
Erosion of teeth
3.2
31.0
125
399
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
4.8
31.0
70
148
IDY02
NOMESCO Finland
Systematic individual therapy, cognitive
6.7
30.9
49
74
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
9.3
30.8
37
40
A29
ICPC
General symptom/complaint other
1.8
30.8
509
2978
ZYC02
NOMESCO Finland
Remote contact by video link
5.9
30.8
55
94
A97
ICPC
No disease
1.6
30.6
985
6853
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
30.5
370
1960
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.2
30.4
62
120
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
30.3
1725
13492
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.7
30.3
98
272
A02BC01
ATC
omeprazole; systemic
1.6
30.2
945
6527
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.0
30.2
86
218
R4120
NOMESCO Finland
Occupational therapy
2.2
30.1
251
1153
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
5.4
30.1
59
110
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
30.0
1544
11838
RS214, ,
NOMESCO Finland
7.1
30.0
45
64
160
Kela drug reimbursment
exenatide
5.4
29.8
59
111
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
29.8
202
848
A02BC05
ATC
esomeprazole; systemic
1.5
29.7
1249
9193
ZXY03
NOMESCO Finland
Occupational therapist
5.9
29.5
53
91
WX002
NOMESCO Finland
Sedation and analgesia
1.8
29.2
507
3008
A10BA02
ATC
metformin; oral
1.7
29.1
615
3854
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
6.2
29.0
49
79
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
29.0
819
5519
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
28.9
1686
13217
S51.8
ICD-10 Finland
Open wound of other parts of forearm
4.4
28.9
72
165
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
28.8
1439
10948
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
3.6
28.6
96
273
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
28.6
1197
8790
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
4.9
28.5
62
127
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.2
28.4
251
1181
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
2.6
28.3
166
650
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
6.2
28.2
48
78
S06.0
ICD-10 Finland
Concussion
1.7
28.1
518
3124
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
5.2
28.0
57
110
F28
ICD-10 Finland
Other nonorganic psychotic disorders
6.7
27.9
44
66
IGY02, ,
SPAT
2.9
27.9
132
462
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
5.6
27.9
53
96
J01FF01
ATC
clindamycin; systemic
1.5
27.6
912
6359
XF600
NOMESCO Finland
Bloodpressure measurement
2.2
27.6
237
1102
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
27.4
353
1906
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
5.0
27.3
59
120
K59.1
ICD-10 Finland
Functional diarrhoea
2.2
27.3
243
1147
RS220, ,
NOMESCO Finland
3.9
27.2
81
212
WX722
NOMESCO Finland
PEEP
3.3
27.2
105
327
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
9.5
27.0
32
34
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
4.7
27.0
62
133
D11
ICPC
Diarrhoea
1.6
26.9
747
5003
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
26.9
790
5362
UJF32
NOMESCO Finland
Coloscopy
1.7
26.9
602
3825
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
26.8
1654
13045
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
4.5
26.7
65
146
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
6.7
26.7
42
63
S97
ICPC
Chronic ulcer skin
2.9
26.6
128
453
D12
ICPC
Constipation
2.7
26.6
150
577
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.6
26.5
751
5054
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.5
26.4
93
273
RT250, ,
NOMESCO Finland
7.9
26.3
36
46
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
26.2
678
4463
M81.8
ICD-10 Finland
Other osteoporosis
7.1
26.2
39
55
ZXY61
NOMESCO Finland
2-person team, special workers
7.1
26.2
39
55
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
6.1
26.2
45
74
U04
ICPC
Incontinence urine
2.6
26.1
154
605
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
26.1
330
1770
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
9.4
26.1
31
33
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
26.1
2097
17305
N06AX17
ATC
milnacipran; oral
5.0
25.9
56
114
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.0
25.8
39
56
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
7.0
25.8
39
56
F60.7
ICD-10 Finland
Dependent personality disorder
7.2
25.8
38
53
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
5.4
25.6
50
93
SPAT1243
SPAT
Psychiatric/psychological examination
2.1
25.6
252
1237
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
10.0
25.5
29
29
A46
ICD-10 Finland
Erysipelas
2.0
25.5
294
1528
188
Kela drug reimbursment
Psychosis requiring demanding treatment
5.4
25.3
50
94
A03FA02
ATC
cisapride; oral, rectal
2.3
25.3
200
899
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
25.3
294
1533
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
7.9
25.1
34
43
Z72.2
ICD-10 Finland
Drug use
4.3
25.0
65
154
A10BJ06
ATC
semaglutide; parenteral
2.6
24.9
149
590
N05AF05
ATC
zuclopenthixol; systemic
5.8
24.8
45
78
M79.7
ICD-10 Finland
Fibromyalgia
2.3
24.8
190
842
P28
ICPC
Limited function/disability (P)
4.0
24.7
70
177
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
24.7
724
4903
T91
ICPC
Vitamin/nutritional deficiency
5.1
24.7
51
100
ZYY01
NOMESCO Finland
Contact between professionals
4.1
24.6
68
169
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
7.5
24.5
35
47
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
24.5
157
642
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
24.4
2317
19576
B03BA03
ATC
hydroxocobalamin; parenteral
2.8
24.4
124
452
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
24.4
666
4436
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
24.3
617
4036
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
24.3
718
4870
X23
ICPC
Fear sexually transm dis female
1.6
24.1
737
5034
N30.0
ICD-10 Finland
Acute cystitis
1.5
24.1
905
6463
K62.3
ICD-10 Finland
Rectal prolapse
5.3
24.1
48
91
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.3
24.1
48
91
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
24.0
244
1211
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
2.9
23.9
115
407
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
23.7
419
2491
P27
ICPC
Fear of mental disorder
2.8
23.7
122
448
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
23.6
1944
16003
R52.2
ICD-10 Finland
Other chronic pain
2.4
23.5
161
679
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
5.1
23.4
49
97
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.7
23.3
487
3033
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
5.1
23.2
48
94
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
23.2
159
671
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
6.1
23.2
40
66
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
6.2
23.1
39
63
WYA10
NOMESCO Finland
Emergency care or similar visit
1.7
22.9
410
2448
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
22.8
3451
31424
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.8
22.7
68
179
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
22.7
215
1039
R50.9
ICD-10 Finland
Fever, unspecified
1.6
22.6
657
4432
IHZ05, ,
SPAT
1.7
22.6
472
2938
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
5.4
22.5
44
82
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.4
22.5
80
237
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
8.8
22.4
28
32
P19
ICPC
Drug abuse
3.4
22.3
81
243
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
22.3
485
3051
RS140, ,
NOMESCO Finland
5.8
22.2
40
69
R33
ICD-10 Finland
Retention of urine
2.6
22.1
132
523
IAB11
NOMESCO Finland
Psychiatric mood consultation
5.6
22.0
41
73
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
7.6
22.0
31
41
K03.28
ICD-10 Finland
Other erosion of teeth
2.4
21.9
157
676
E0000UV, ,
ATC
1.4
21.8
1844
15181
G44.2
ICD-10 Finland
Tension-type headache
1.5
21.7
705
4872
K03.00
ICD-10 Finland
Approximal wear
1.8
21.7
378
2238
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.1
21.6
58
141
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.9
21.5
102
358
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.3
21.5
170
764
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
4.2
21.4
57
138
P01AB01
ATC
metronidazole; oral, rectal
1.4
21.2
1543
12380
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
21.2
1131
14392
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
4.5
21.2
51
114
G03FB08
ATC
dydrogesterone and estrogen; systemic
2.2
21.1
172
783
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.7
21.1
65
175
A91
ICPC
Abnormal result investigation NOS
2.1
21.0
198
955
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
21.0
441
2746
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.2
20.9
81
253
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
20.8
518
3365
N06BA12
ATC
lisdexamfetamine; oral
2.4
20.8
147
629
IHZ05
NOMESCO Finland
Therapeutic conversation
3.7
20.8
66
181
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
20.8
800
5722
M79.1
ICD-10 Finland
Myalgia
1.5
20.8
736
5177
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
20.7
243
1270
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
4.7
20.7
47
100
ICA04
NOMESCO Finland
Psychiatric treatment plan, psychotherapy supported by Social Insurance Institution
4.1
20.5
56
138
A08AB01
ATC
orlistat; oral
15.8
20.5
33
21
A08
ICPC
Swelling
2.4
20.5
147
634
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.0
20.4
91
309
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
20.3
1393
11050
L03
ICPC
Low back symptom/complaint
1.4
20.3
1319
10370
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.7
20.2
447
2819
R52.9
ICD-10 Finland
Pain, unspecified
1.7
20.2
412
2544
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
4.7
20.2
46
98
S21
ICPC
Skin texture symptom/complaint
1.6
20.2
591
3986
R32
ICD-10 Finland
Unspecified urinary incontinence
3.1
20.2
82
264
ZYD01
NOMESCO Finland
Emergency clinic
5.1
20.2
42
83
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
2.8
20.1
99
355
A02BA02
ATC
ranitidine; systemic
1.7
20.1
373
2246
F20.8
ICD-10 Finland
Other schizophrenia
8.4
20.1
26
31
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
8.4
20.1
26
31
A10BH01
ATC
sitagliptin; oral
2.4
20.1
137
578
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.9
20.0
44
91
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
6.6
19.9
32
49
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
6.8
19.9
31
46
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.7
19.9
375
2268
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
5.0
19.9
42
84
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
7.0
19.9
30
43
P73
ICPC
Affective psychosis
4.8
19.8
44
92
G03DA02
ATC
medroxyprogesterone; systemic
2.1
19.8
192
937
N05AB01
ATC
dixyrazine; systemic
6.1
19.8
34
56
N03AF01
ATC
carbamazepine; oral, rectal
2.5
19.8
126
515
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
19.7
889
6548
UKC02
NOMESCO Finland
Cystoscopy
1.9
19.7
263
1436
ZXA05
NOMESCO Finland
Left side
1.6
19.6
497
3241
R00.1
ICD-10 Finland
Bradycardia, unspecified
3.7
19.6
62
170
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.5
19.5
120
482
S76
ICPC
Skin infection other
2.1
19.5
188
916
R5110, ,
SPAT
2.1
19.5
188
916
RT120, ,
NOMESCO Finland
6.8
19.5
30
44
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
6.0
19.4
34
57
K07.60
ICD-10 Finland
Snapping jaw
1.7
19.4
351
2099
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.6
19.4
517
3413
SFA30
NOMESCO Finland
Three-surface restoration
1.4
19.4
1366
10867
EBA00
NOMESCO Finland
Extraction of tooth
1.3
19.4
1759
14554
OAB43, ,
SPAT
0.7
19.4
1554
18628
L13
ICPC
Hip symptom/complaint
1.6
19.4
493
3219
R96
ICPC
Asthma
1.7
19.3
377
2302
ZXD35
NOMESCO Finland
Usual procedure
2.8
19.3
98
358
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
19.2
649
4512
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
19.2
267
1476
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
19.2
125
516
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.0
19.2
214
1099
N91.4
ICD-10 Finland
Secondary oligomenorrhoea
3.3
19.2
71
216
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
19.1
770
5547
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
6.5
19.1
31
48
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
4.7
19.1
44
95
U02
ICPC
Urinary frequency/urgency
1.5
19.0
670
4698
N05AH05
ATC
asenapine; oral
7.2
19.0
28
39
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
19.0
3268
29755
D09
ICPC
Nausea
1.7
18.9
409
2565
N01
ICPC
Headache
1.4
18.9
984
7434
A10AE04
ATC
insulin glargine; parenteral
1.9
18.8
242
1306
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
18.7
395
2463
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
18.6
338
2022
N04BC05
ATC
pramipexole; oral
2.2
18.6
162
758
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
18.6
799
5825
F22.0
ICD-10 Finland
Delusional disorder
4.1
18.6
50
122
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.0
18.5
39
78
I73.0
ICD-10 Finland
Raynaud syndrome
2.6
18.4
104
401
SPAT1229
SPAT
Assessment of need for aid
2.3
18.4
144
645
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.1
18.3
78
258
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.3
18.3
134
583
IAZ99
NOMESCO Finland
Other psychiatric consultation
4.0
18.3
52
132
B82
ICPC
Anaemia other/unspecified
2.7
18.2
100
380
J01MA02
ATC
ciprofloxacin; systemic
1.4
18.2
1023
7826
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
4.4
18.2
45
103
D19
ICPC
Teeth/gum symptom/complaint
1.3
18.2
1552
12688
WZC00, ,
SPAT
1.5
18.2
749
5417
G04BD12
ATC
mirabegron; oral
2.0
18.1
193
975
R15
ICD-10 Finland
Faecal incontinence
3.4
18.1
65
194
P23
ICPC
Adolescent behaviour sympt/compl
3.1
18.0
74
240
F41
ICD-10 Finland
Other anxiety disorders
2.2
18.0
161
762
N02BF01
ATC
gabapentin; oral
1.7
18.0
319
1897
P58
ICPC
Psychological, Therapeutic counselling/listening
2.0
17.9
183
911
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
17.9
340
2061
J01MA12
ATC
levofloxacin; systemic
1.6
17.8
405
2570
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
17.8
115
473
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
17.8
414
2643
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.0
17.7
203
1052
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
17.7
812
5985
SPAT1284
SPAT
Extensive health certificate
2.1
17.7
163
780
XA820, ,
NOMESCO Finland
5.6
17.7
33
59
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.4
17.6
938
7103
Z08
ICPC
Social welfare problem
3.1
17.6
72
233
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.2
17.6
149
690
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
17.5
67
208
N05AX13
ATC
paliperidone; systemic
4.9
17.5
38
78
Z00.0
ICD-10 Finland
General medical examination
1.4
17.4
808
5968
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
17.4
339
2067
A11
ICPC
Chest pain NOS
1.9
17.4
224
1209
JGC01
NOMESCO Finland
Laparoscopic rectopexy
5.5
17.4
33
60
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.2
17.3
69
220
B81
ICPC
Anaemia vit B12/folate deficiency
2.9
17.3
80
278
R03BA02
ATC
budesonide; inhalant
1.5
17.3
704
5076
T83
ICPC
Overweight
2.2
17.2
144
664
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
17.2
186
946
A06AX04
ATC
linaclotide; oral
6.2
17.1
29
47
R03BB04
ATC
tiotropium bromide; inhalant
2.1
17.1
168
824
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.6
17.1
395
2517
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.7
17.1
88
324
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
3.7
17.0
53
144
I50.0
ICD-10 Finland
Congestive heart failure
3.3
17.0
63
192
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.1
17.0
71
233
IEZ99, ,
SPAT
5.9
16.9
30
51
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
3.4
16.9
59
173
C03DA01
ATC
spironolactone; oral
1.9
16.8
227
1243
X58
ICD-10 Finland
Exposure to other specified factors
1.5
16.8
630
4467
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.6
16.7
361
2261
L12
ICPC
Hand/finger symptom/complaint
1.4
16.7
802
5956
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
16.7
619
4378
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.1
16.7
70
230
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
5.2
16.7
34
66
IEP01
NOMESCO Finland
Psychoeducation, family
5.2
16.7
34
66
M54.5
ICD-10 Finland
Low back pain
1.3
16.7
1494
12259
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.5
16.6
480
3221
Z07
ICPC
Education problem
2.5
16.6
103
416
A99
ICPC
Disease/condition unspecnature/site
1.6
16.6
395
2534
OAB76, ,
SPAT
2.1
16.6
158
766
A10AB04
ATC
insulin lispro; parenteral
2.2
16.6
135
615
V03AA01, ,
ATC
5.8
16.6
30
52
SPAT1310
SPAT
Counselling related to known health issue
1.3
16.6
1396
11348
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
16.6
174
875
R4110, ,
SPAT
1.6
16.5
380
2418
A02BC03
ATC
lansoprazole; oral
1.5
16.5
635
4525
A10BX04
ATC
[U] exenatide
7.0
16.5
25
36
RK320, ,
NOMESCO Finland
7.0
16.5
25
36
B01AB05
ATC
enoxaparin; parenteral
1.4
16.4
773
5718
C07AB02
ATC
metoprolol; systemic
1.7
16.4
332
2044
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.1
16.4
156
756
N91.2
ICD-10 Finland
Amenorrhoea, unspecified
2.7
16.3
84
309
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
16.3
207
1111
N05AE03
ATC
sertindole; oral
5.4
16.3
32
60
F41.01
ICD-10 Finland
Severe panic disorder
3.1
16.3
68
223
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.6
16.2
424
2782
A10AB01
ATC
insulin (human); parenteral
2.2
16.2
144
680
A10BK03
ATC
empagliflozin; oral
2.0
16.2
166
828
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
3.7
16.1
51
140
N76.0
ICD-10 Finland
Acute vaginitis
1.5
16.1
622
4432
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
4.0
16.1
45
113
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
16.1
724
5309
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
2.7
16.1
88
334
F30.0
ICD-10 Finland
Hypomania
5.8
16.1
29
50
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
4.9
16.1
35
72
K03.29
ICD-10 Finland
Erosion of teeth occupational
2.6
16.1
91
352
J02AC01
ATC
fluconazole; systemic
1.3
16.0
1733
14583
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
15.9
158
778
WX290
NOMESCO Finland
Other blockage of nerve
1.3
15.9
2534
22446
S71.1
ICD-10 Finland
Open wound of thigh
3.4
15.9
57
170
SFA10
NOMESCO Finland
One-surface restoration
1.3
15.9
2571
22825
N02AA05
ATC
oxycodone; systemic
1.7
15.9
270
1586
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
15.8
411
2692
F05.9
ICD-10 Finland
Delirium, unspecified
4.7
15.8
36
77
UJH02
NOMESCO Finland
Anoscopy
2.4
15.8
107
451
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
15.8
902
6896
WX730
NOMESCO Finland
Conventional respirator
3.8
15.7
47
124
RT420, ,
NOMESCO Finland
6.6
15.7
25
38
RT130, ,
NOMESCO Finland
6.6
15.7
25
38
K80
ICPC
Cardiac arrhythmia NOS
1.8
15.7
243
1389
N03AF02
ATC
oxcarbazepine; oral
2.2
15.7
129
591
A10BX07
ATC
[U] liraglutide
5.0
15.7
33
66
E87.5
ICD-10 Finland
Hyperkalaemia
5.5
15.7
30
55
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
15.6
267
1570
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
15.6
1093
8626
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
2.1
15.6
145
697
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
15.6
918
7050
R60.0
ICD-10 Finland
Localized oedema
1.7
15.5
295
1786
RF120, ,
NOMESCO Finland
3.6
15.5
50
139
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
15.5
305
1864
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
15.5
335
2098
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
4.0
15.5
44
112
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.5
15.5
465
3146
J01DB01
ATC
cefalexin; oral
1.4
15.5
3431
31803
T06
ICPC
ANOREXIA NERVOSA W/WO BULIMIA
160.2
15.5
16
*
K04
ICPC
Palpitations/awareness of heart
1.8
15.5
225
1262
SPAT1260
SPAT
Consultation of another employee
1.4
15.4
668
4862
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
3.4
15.4
54
159
A10BB12
ATC
glimepiride; oral
3.2
15.4
61
194
P50
ICPC
Psychological, Medication/prescr/renewal
5.4
15.4
30
56
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
6.4
15.3
25
39
XG466
NOMESCO Finland
Sleep oxymetry
3.1
15.3
64
210
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
1.9
15.3
204
1113
M35.7
ICD-10 Finland
Hypermobility syndrome
2.3
15.3
120
539
RS221, ,
NOMESCO Finland
3.0
15.3
66
221
N06BA09
ATC
atomoxetine; oral
3.4
15.3
54
160
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
15.2
234
1334
J01EA01
ATC
trimethoprim; systemic
1.4
15.2
1042
8190
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.7
15.2
47
127
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
2.4
15.2
105
446
Z01.2
ICD-10 Finland
Dental examination
1.3
15.2
2326
20435
R00.2
ICD-10 Finland
Palpitations
1.6
15.2
375
2426
OAA43, ,
SPAT
2.0
15.2
163
827
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.0
15.2
42
105
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.4
15.1
37
84
J45
ICD-10 Finland
Asthma
1.5
15.1
428
2858
Z50.1
ICD-10 Finland
Other physical therapy
2.2
15.1
129
600
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.5
15.1
500
3455
EB1AA, ,
SPAT
1.7
15.0
265
1572
OAA80, ,
SPAT
0.6
15.0
209
3591
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
3.4
15.0
53
157
A10AB05
ATC
insulin aspart; parenteral
1.8
15.0
224
1267
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
4.0
15.0
42
106
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.0
15.0
64
213
R03AC03
ATC
terbutaline; inhalant
1.5
14.9
503
3485
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
4.0
14.9
41
102
Z25
ICPC
Assault/harmful event problem
2.6
14.9
83
319
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
14.9
915
7071
I95.1
ICD-10 Finland
Orthostatic hypotension
3.3
14.8
55
168
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
14.8
597
4286
L01
ICPC
Neck symptom/complaint
1.4
14.8
765
5744
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
16.5
14.7
23
14
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
14.7
154
775
XKD00
NOMESCO Finland
Uroflowmetry
2.0
14.7
168
872
A27
ICPC
Fear of other disease NOS
1.9
14.6
184
986
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
6.1
14.6
25
41
P98
ICPC
Psychosis NOS/other
3.6
14.6
47
131
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.8
14.6
226
1293
F30.9
ICD-10 Finland
Manic episode, unspecified
5.6
14.6
27
48
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.7
14.5
259
1541
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
2.5
14.5
89
358
IGV01, ,
SPAT
6.3
14.5
24
38
L15
ICPC
Knee symptom/complaint
1.4
14.5
891
6882
D06
ICPC
Abdominal pain localized other
1.5
14.5
500
3483
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.0
14.4
40
100
T89
ICPC
Diabetes insulin dependent
1.9
14.4
174
919
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
5.8
14.4
26
45
F20
ICD-10 Finland
Schizophrenia
4.6
14.4
34
75
X05
ICPC
Menstruation absent/scanty
2.0
14.4
159
815
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
14.4
640
4679
H3603, E103,
ICD-10 Finland
3.4
14.3
50
147
SPA02
NOMESCO Finland
Preparation for dental prosthetics
2.6
14.3
80
308
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.7
14.3
77
291
IDP01
NOMESCO Finland
Systematic family therapy, family therapy
10.4
14.2
27
26
ZXY13
NOMESCO Finland
Trainee psychologist, supervised
10.4
14.2
27
26
L29
ICPC
Musculoskeletal sympt/complt other
1.6
14.1
332
2124
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
3.1
14.1
58
189
SPAT1227
SPAT
Substance abuse rehabilitation
4.2
14.1
37
89
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
14.1
191
1049
U13
ICPC
Bladder symptom/complaint other
2.3
14.1
110
494
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
14.0
126
598
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
2.1
14.0
126
598
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.0
14.0
145
726
U05
ICPC
Urination problems other
2.1
14.0
125
592
N89
ICPC
Migraine
1.6
14.0
373
2456
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
14.0
294
1828
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
4.9
14.0
30
61
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
13.9
1053
8384
R07.3
ICD-10 Finland
Other chest pain
1.6
13.9
302
1893
OAB72, ,
SPAT
2.3
13.9
109
490
R06AE07
ATC
cetirizine; oral
1.3
13.9
1924
16613
W26
ICD-10 Finland
Contact with other sharp object(s)
2.5
13.9
85
342
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
15.8
13.9
22
14
M25.5
ICD-10 Finland
Pain in joint
1.3
13.9
1275
10435
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.9
307
1934
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
13.8
564
4055
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.3
13.8
106
472
SPAT1379
SPAT
Health check-up of pregnant person
0.7
13.8
728
9439
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.9
13.8
162
848
A08AA02
ATC
fenfluramine; oral
6.0
13.8
24
40
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
13.8
1088
8714
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
13.8
627
4598
T11.1
ICD-10 Finland
Open wound of upper limb, level unspecified
5.0
13.8
29
58
Z87.8
ICD-10 Finland
Personal history of other specified conditions
4.0
13.7
38
95
IBC98
NOMESCO Finland
Other child protection assessment
4.0
13.7
38
95
E16.19
ICD-10 Finland
Other specified hypoglycaemia
4.9
13.7
30
62
RF210, ,
NOMESCO Finland
2.2
13.7
110
499
WX110, ,
SPAT
1.7
13.7
269
1645
N06AA10
ATC
nortriptyline; systemic
2.6
13.7
76
292
U07
ICPC
Urine symptom/complaint other
1.7
13.6
272
1669
S04
ICPC
Lump/swelling localized
1.5
13.6
529
3770
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
13.5
425
2900
S10
ICPC
Boil/carbuncle
1.7
13.5
232
1366
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.3
13.5
34
79
IHZ04, ,
SPAT
2.0
13.5
135
668
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
5.9
13.5
24
41
OAB38, ,
SPAT
1.7
13.4
278
1722
F32.0
ICD-10 Finland
Mild depressive episode
1.8
13.4
189
1050
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
13.4
424
2898
N02BE01
ATC
paracetamol; systemic, rectal
1.4
13.4
3464
32349
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
13.3
361
2385
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
6.1
13.3
23
38
C10AA01
ATC
simvastatin; oral
1.6
13.3
355
2337
P20
ICPC
Memory disturbance
2.2
13.3
107
486
UJD02
NOMESCO Finland
Gastroscopy
2.2
13.3
115
538
W19
ICD-10 Finland
Unspecified fall
1.6
13.3
322
2073
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
4.3
13.3
34
80
J01DA01
ATC
[U] cefalexin
1.3
13.3
2180
19181
IDR19
NOMESCO Finland
Systematic group therapy, dialectical behavioral therapy (DKT), skill group
6.3
13.2
22
35
EB1SA, ,
SPAT
1.7
13.2
268
1651
T07
ICPC
Weight gain
2.1
13.2
124
599
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.0
13.2
152
791
RS310, ,
NOMESCO Finland
5.3
13.2
26
49
K30
ICD-10 Finland
Functional dyspepsia
1.5
13.2
433
2984
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
1.8
13.1
203
1160
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.8
13.1
200
1138
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
13.1
788
6051
Z71.9
ICD-10 Finland
Counselling, unspecified
1.6
13.1
338
2209
ZXA10
NOMESCO Finland
Bilateral
1.5
13.1
476
3346
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.5
13.1
83
340
SPAT1312
SPAT
General health counselling
1.3
13.1
1614
13706
S81.7
ICD-10 Finland
Multiple open wounds of lower leg
4.9
13.0
28
57
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
4.4
13.0
32
73
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.3
13.0
93
402
ZYC02, ,
SPAT
1.5
13.0
399
2710
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
13.0
467
3276
A10AE05
ATC
insulin detemir; parenteral
1.9
13.0
165
888
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.2
12.9
109
505
-58
ICPC
Therapeutic counselling/listening
3.2
12.9
49
152
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
12.9
62
221
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
5.6
12.8
24
43
F44.88
ICD-10 Finland
Other definite dissociation disorder
5.6
12.8
24
43
SPAT1254
SPAT
Administration of medicine
1.4
12.8
646
4819
ICB03, ,
SPAT
3.8
12.8
38
100
G04BD08
ATC
solifenacin; oral
2.2
12.8
105
481
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.6
12.8
41
114
A10AC01
ATC
insulin (human); parenteral
1.7
12.8
236
1419
RF430, ,
NOMESCO Finland
5.3
12.7
25
47
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
4.1
12.7
34
83
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
10.5
12.7
24
23
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
12.7
204
1180
N05AL05
ATC
amisulpride; oral
9.6
12.7
25
26
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
12.7
158
845
L02
ICPC
Back symptom/complaint
1.4
12.7
538
3895
E000003, ,
ATC
1.8
12.6
178
990
M02AA07
ATC
piroxicam; topical
1.4
12.6
721
5491
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
12.6
201
1160
K08.3
ICD-10 Finland
Retained dental root
1.9
12.6
165
897
Z2230
NOMESCO Finland
Head nurse
6.0
12.5
22
37
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
12.5
311
2014
SFA00
NOMESCO Finland
Small restoration
1.4
12.5
521
3756
T74.1
ICD-10 Finland
Physical abuse
2.1
12.5
123
605
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
11.0
12.5
23
21
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
12.5
245
1498
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
12.4
143
744
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.3
12.4
92
404
F20.10
ICD-10 Finland
Raise schizophrenia continuously
6.2
12.4
21
34
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.6
12.4
280
1773
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
12.4
138
711
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
12.3
55
188
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
4.0
12.3
34
85
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.5
12.3
381
2592
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
12.3
250
1543
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
12.2
98
445
A05
ICPC
Feeling ill
1.4
12.2
521
3772
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
12.2
285
1819
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.3
12.2
87
376
R41.0
ICD-10 Finland
Disorientation, unspecified
3.1
12.2
51
168
F60.1
ICD-10 Finland
Schizoid personality disorder
9.0
12.2
25
28
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.8
12.1
170
944
H3601, E103,
ICD-10 Finland
3.3
12.1
45
138
WZA10, ,
SPAT
1.8
12.1
179
1011
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
4.5
12.1
29
65
R03AC13
ATC
formoterol; inhalant
2.0
12.1
126
634
WX290, ,
SPAT
1.8
12.1
188
1078
K92.0
ICD-10 Finland
Haematemesis
2.8
12.0
60
218
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
12.0
75
305
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
3.3
12.0
44
134
K11.70
ICD-10 Finland
Hypoptyalism
5.2
12.0
24
46
M01AH01
ATC
celecoxib; oral
1.5
11.9
338
2256
F29
ICPC
Eye symptom/complaint other
1.5
11.9
442
3118
E03
ICD-10 Finland
Other hypothyroidism
1.7
11.9
229
1392
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
11.9
178
1008
OAA67, ,
SPAT
0.7
11.9
581
7653
R06.4
ICD-10 Finland
Hyperventilation
2.3
11.9
86
374
S28
ICPC
Limited function/disability (S)
5.7
11.9
22
39
Z73.1
ICD-10 Finland
Accentuation of personality traits
4.3
11.9
30
70
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
11.9
425
2977
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
11.9
859
6776
G04BD04
ATC
oxybutynin; oral, transdermal
2.1
11.9
116
570
P77
ICPC
Suicide/suicide attempt
4.8
11.9
26
54
WX402
NOMESCO Finland
General anaesthesia
1.3
11.8
802
6265
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.7
11.8
27
58
S22
ICPC
Nail symptom/complaint
1.6
11.8
244
1511
F34.0
ICD-10 Finland
Cyclothymia
3.6
11.8
38
106
IBA01, ,
SPAT
1.8
11.8
170
952
R13
ICD-10 Finland
Dysphagia
1.8
11.8
173
974
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
11.8
77
320
ICB01, ,
SPAT
2.6
11.8
65
249
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.8
11.8
1364
15951
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
11.7
85
370
L08
ICPC
Shoulder symptom/complaint
1.4
11.7
658
4991
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.2
11.7
98
454
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
11.6
298
1944
ICA03
NOMESCO Finland
Psychiatric treatment plan, outsourced psychotherapy
4.9
11.6
25
51
L20.0
ICD-10 Finland
Besnier prurigo
1.4
11.6
542
3987
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
11.6
137
720
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.5
11.6
379
2607
C09CA06
ATC
candesartan; oral
1.4
11.6
619
4659
IGY99, ,
SPAT
1.7
11.6
224
1365
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.6
11.5
248
1552
R25.1
ICD-10 Finland
Tremor, unspecified
2.4
11.5
80
342
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.4
11.5
80
342
XQ800
NOMESCO Finland
Prick test
1.5
11.5
391
2710
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.5
11.5
38
108
ZXA00
NOMESCO Finland
Right side
1.4
11.5
496
3598
U01
ICPC
Dysuria/painful urination
1.5
11.5
421
2962
RT310, ,
NOMESCO Finland
11.1
11.5
21
19
SPAT1167
SPAT
Insertion of urinary catheter
3.5
11.5
39
113
K04.0
ICD-10 Finland
Pulpitis
1.4
11.5
446
3174
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
3.7
11.4
36
99
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
11.4
321
2138
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.4
11.4
524
3842
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.3
11.4
29
68
D02AE01
ATC
carbamide; topical
1.7
11.4
222
1354
M01AB01
ATC
indometacin; systemic, rectal
2.4
11.4
74
307
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
11.4
375
2584
RK110, ,
NOMESCO Finland
4.5
11.4
27
60
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.4
11.4
473
3409
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.5
11.4
38
109
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.9
11.3
149
811
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
11.3
377
2602
L16
ICPC
Ankle symptom/complaint
1.4
11.3
582
4350
IEP03
NOMESCO Finland
Focused parental counselling
4.0
11.3
31
77
H04AA01
ATC
glucagon; nasal, parenteral
1.9
11.3
136
719
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
11.8
11.3
20
17
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
11.3
152
834
M05BA04
ATC
alendronic acid; oral
2.3
11.3
86
383
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
11.2
111
548
N05AC01
ATC
periciazine; systemic
10.5
11.2
21
20
F38.8
ICD-10 Finland
Other specified mood [affective] disorders
4.2
11.2
29
69
W78
ICPC
Pregnancy
0.8
11.2
1158
13754
S61.7
ICD-10 Finland
Multiple open wounds of wrist and hand
3.0
11.2
49
166
D02
ICPC
Abdominal pain epigastric
1.6
11.2
294
1930
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.2
11.2
42
130
IEP02
NOMESCO Finland
Child-centred family therapy
4.0
11.2
31
78
G04BD07
ATC
tolterodine; oral
2.5
11.1
71
292
D07AC01
ATC
betamethasone; topical
1.3
11.1
1173
9719
IBZ98
NOMESCO Finland
Other psychiatric evaluation
5.2
11.0
22
42
F95.9
ICD-10 Finland
Tic disorder, unspecified
5.2
11.0
22
42
N05AC02
ATC
thioridazine; oral
2.4
11.0
73
306
A06AC51
ATC
ispaghula, combinations; oral
1.9
11.0
133
705
M03BX01
ATC
baclofen; systemic
2.5
11.0
66
264
XLA10, ,
NOMESCO Finland
1.9
11.0
130
684
IFC99
NOMESCO Finland
Other biological psychiatric intervention
5.7
11.0
20
35
R4190, ,
SPAT
3.1
10.9
45
147
TQW40
NOMESCO Finland
Remowal of suture of skin
1.8
10.9
173
997
K02.1
ICD-10 Finland
Caries of dentine
1.3
10.9
2804
25708
H02AB06
ATC
prednisolone; systemic
1.3
10.9
1453
12382
P79
ICPC
Phobia/compulsive disorder
2.6
10.9
62
242
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
10.8
318
2140
G43.3
ICD-10 Finland
Complicated migraine
1.9
10.8
133
710
IHZ07, ,
SPAT
3.2
10.8
41
128
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
3.3
10.8
39
118
IHZ02, ,
SPAT
1.7
10.7
182
1070
F43.00
ICD-10 Finland
Acute stress reaction mild
1.8
10.7
156
877
WX882
NOMESCO Finland
High dependency care
2.2
10.7
87
398
K08.80
ICD-10 Finland
Toothache NOS
1.4
10.7
439
3155
309
Kela drug reimbursment
Nalmefene and naltrexone
4.9
10.7
23
47
SGA01
NOMESCO Finland
Emergency treatment
1.3
10.6
716
5580
NH1AD
NOMESCO Finland
Ankle and foot CT
2.2
10.6
83
374
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
60.0
10.6
12
*
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
2.5
10.6
65
263
F64.0
ICD-10 Finland
Transsexualism
3.6
10.6
34
95
S80.0
ICD-10 Finland
Contusion of knee
1.5
10.6
344
2364
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.2
10.6
90
420
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.5
3394
31885
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
3.7
10.5
32
86
P17
ICPC
Tobacco abuse
2.4
10.5
67
276
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
8.5
10.5
22
26
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
10.5
58
223
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
2.9
10.5
48
167
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.5
1423
12137
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
2.7
10.4
56
212
SPAT1197
SPAT
Extensive health check-up of expecting family
0.8
10.4
843
10350
D07AB08
ATC
desonide; topical
1.4
10.4
428
3075
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
4.8
10.4
23
48
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.0
10.4
29
73
SPAT1380
SPAT
Postpartum check-up
0.7
10.4
602
7745
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
2.3
10.4
77
339
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
10.4
1937
17101
R04.2
ICD-10 Finland
Haemoptysis
2.7
10.4
54
201
SPF40
NOMESCO Finland
Removal and reattachment of crown or small bridge
3.5
10.4
35
101
N05CD02
ATC
nitrazepam; oral
4.1
10.4
28
69
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
5.4
10.4
20
37
R35
ICD-10 Finland
Polyuria
1.9
10.4
136
741
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.5
10.3
65
266
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
3.9
10.3
30
78
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
1.9
10.3
121
635
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
10.3
489
3604
R44.0
ICD-10 Finland
Auditory hallucinations
4.2
10.3
27
65
A03CA02
ATC
clidinium and psycholeptics; oral
2.3
10.3
78
347
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.9
10.3
46
158
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.6
10.3
236
1502
SPAT1244
SPAT
Occupational therapy
3.7
10.3
31
83
RT150, ,
NOMESCO Finland
4.3
10.3
26
61
T99
ICPC
Endocr/metab/nutrit disease other
2.7
10.2
53
197
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.3
10.2
75
329
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
10.2
280
1855
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
10.2
189
1138
R44.3
ICD-10 Finland
Hallucinations, unspecified
4.4
10.2
25
57
R63.1
ICD-10 Finland
Polydipsia
4.4
10.2
25
57
R03AC02
ATC
salbutamol; inhalant
1.2
10.2
2255
20258
IBZ08
NOMESCO Finland
Gender identity assessment
3.3
10.2
38
117
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.7
10.2
52
192
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.8
10.2
788
9734
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.0
10.2
43
143
SPAT1301
SPAT
No procedures
1.3
10.2
1163
9715
WZC30
NOMESCO Finland
Teaching
1.4
10.2
395
2810
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.8
10.2
138
760
H02AB09
ATC
hydrocortisone; systemic
2.1
10.1
96
467
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
10.1
256
1666
A08AA10
ATC
sibutramine; oral
13.1
10.1
17
13
S00.0
ICD-10 Finland
Superficial injury of scalp
2.4
10.1
68
287
F40.2
ICD-10 Finland
Specific (isolated) phobias
2.4
10.1
67
281
L14
ICPC
Leg/thigh symptom/complaint
1.5
10.1
280
1860
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.2
10.0
26
62
IAA01, ,
SPAT
2.2
10.0
78
351
R40.2
ICD-10 Finland
Coma, unspecified
4.0
10.0
28
71
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
14.6
10.0
16
11
G83.4
ICD-10 Finland
Cauda equina syndrome
4.6
10.0
23
50
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
10.0
112
580
H01
ICPC
Ear pain/earache
1.3
10.0
708
5558
RT236, ,
NOMESCO Finland
40.1
9.9
12
*
L20
ICPC
Joint symptom/complaint NOS
1.7
9.9
163
950
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
3.7
9.9
31
85
U71
ICPC
Cystitis/urinary infection other
1.5
9.9
310
2113
SPA47
NOMESCO Finland
Precision impression for denture
2.8
9.9
47
167
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.5
9.9
58
230
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
9.8
391
2793
R2110
NOMESCO Finland
Giving the first information
1.5
9.8
267
1766
WW200
NOMESCO Finland
Immunization
2.1
9.8
90
433
Z00.8
ICD-10 Finland
Other general examinations
1.5
9.8
341
2375
R45.8
ICD-10 Finland
Other symptoms and signs involving emotional state
2.9
9.8
45
157
J05AB11
ATC
valaciclovir; oral
1.4
9.8
492
3662
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.7
9.8
158
917
SPAT1262
SPAT
Handing over of treatment supplies
1.5
9.8
354
2485
H53.2
ICD-10 Finland
Diplopia
2.1
9.8
89
427
M02AA10
ATC
ketoprofen; topical
1.5
9.8
338
2352
K04.00
ICD-10 Finland
Hyperemia of pulp
1.6
9.7
236
1521
D18
ICPC
Change in faeces/bowel movements
2.0
9.7
105
536
P25
ICPC
Phase of life problem adult
1.5
9.7
282
1892
D25
ICPC
Abdominal distension
2.0
9.7
107
550
X14
ICPC
Vaginal discharge
1.6
9.7
231
1482
SPAT1281
SPAT
Other administrative function
1.5
9.7
314
2156
K10.3
ICD-10 Finland
Alveolitis of jaws
1.5
9.7
257
1691
SPAT1058
SPAT
PEF monitoring instruction
1.6
9.7
251
1644
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.3
9.7
36
111
C03AA03
ATC
hydrochlorothiazide; oral
2.1
9.7
89
429
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.9
9.7
127
693
D07AA02
ATC
hydrocortisone; topical
1.3
9.6
672
5260
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
9.6
1066
8864
OAB73, ,
SPAT
7.8
9.6
21
27
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.2
9.5
36
112
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
9.5
278
1868
IFA01, ,
SPAT
3.3
9.5
35
107
K03.66
ICD-10 Finland
Tooth plaque
1.5
9.5
309
2123
M01AB05
ATC
diclofenac; systemic, rectal
1.2
9.5
2069
18501
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
9.5
95
472
L84
ICPC
Back syndrome without radiat pain
1.7
9.5
179
1084
IDR07
NOMESCO Finland
Systematic group therapy, acceptance and commitment therapy
15.0
9.5
15
10
ZXD05
NOMESCO Finland
Urgent procedure
1.3
9.5
1106
9248
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
7.1
9.5
22
31
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
9.5
156
911
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.1
9.4
85
406
D50
ICD-10 Finland
Iron deficiency anaemia
1.8
9.4
137
771
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.7
9.4
160
942
K04.08
ICD-10 Finland
Other specified pulpit
1.4
9.4
406
2943
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
9.4
250
1646
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.8
9.4
138
779
F51
ICD-10 Finland
Nonorganic sleep disorders
1.6
9.4
243
1590
K04.09
ICD-10 Finland
Pulpit UNS
1.6
9.4
222
1423
L86
ICPC
Back syndrome with radiating pain
1.6
9.3
190
1174
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.2
9.3
24
57
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
9.3
1276
10860
RS123, ,
NOMESCO Finland
5.1
9.3
19
37
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
1.6
9.3
197
1229
C05AA08
ATC
fluocortolone; rectal, topical
1.5
9.3
274
1845
-1, ,
NOMESCO Finland
1.2
9.3
1721
15126
602
Kela drug reimbursment
Children's severe malnutrition
3.1
9.3
37
119
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
6.9
9.3
22
32
V03AG01
ATC
sodium cellulose phosphate; systemic
6.9
9.3
22
32
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
4.5
9.3
22
49
P45
ICPC
Psychological, Observ/health educat/advice/diet
4.5
9.3
22
49
E66.1
ICD-10 Finland
Drug-induced obesity
4.5
9.3
22
49
RF242, ,
NOMESCO Finland
10.6
9.3
17
16
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.2
482
3608
SFA20
NOMESCO Finland
Two-surface restoration
1.2
9.2
2479
22614
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.5
9.2
54
214
Z09
ICPC
Legal problem
4.0
9.2
25
62
OAA11, ,
SPAT
0.7
9.2
454
5993
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.5
9.2
30
85
RT253, ,
NOMESCO Finland
13.7
9.2
15
11
E000002, ,
ATC
1.4
9.2
502
3788
N94.2
ICD-10 Finland
Vaginismus
3.5
9.1
31
90
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
3.0
9.1
40
136
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.6
9.1
49
186
3051, ,
Kela drug reimbursment
2.6
9.1
49
186
IFA99, ,
SPAT
3.3
9.1
33
100
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
9.1
101
521
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.0
9.1
39
131
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.1
800
6457
KMAK, ,
NOMESCO Finland
1.2
9.1
2120
19055
SPAT1252
SPAT
Overall medication plan or its review
1.9
9.1
114
613
A10BJ01
ATC
exenatide; parenteral
4.4
9.0
22
50
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
8.3
9.0
19
23
SPAT1336
SPAT
Request for examination
1.9
9.0
118
643
IEY19, ,
SPAT
3.1
9.0
36
116
Z03
ICPC
Housing/neighbourhood problem
4.0
9.0
25
63
X57
ICD-10 Finland
Unspecified privation
2.2
9.0
75
348
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
2.5
9.0
55
223
R74
ICPC
Upper respiratory infection acute
1.2
9.0
2042
18303
R05
ICPC
Cough
1.3
8.9
1066
8926
X04
ICPC
Painful intercourse female
2.3
8.9
65
285
TKC22
NOMESCO Finland
Catheterisation instruction
3.0
8.9
37
122
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.6
8.9
48
183
H36.01
ICD-10 Finland
Diabetic maculopathy
3.0
8.8
38
128
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
8.8
142
824
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.7
8.8
47
178
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
8.8
75
351
QBJ30
NOMESCO Finland
Correction of abdominal apron
2.6
8.8
48
184
H3602, E103,
ICD-10 Finland
4.7
8.8
20
43
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
2.2
8.8
70
319
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.1
8.8
36
118
RF110, ,
NOMESCO Finland
8.6
8.8
18
21
C01CA24
ATC
epinephrine; parenteral
1.5
8.8
311
2175
RS141, ,
NOMESCO Finland
9.5
8.7
17
18
F12.20
ICD-10 Finland
Dependence caused by cannabis currently independent
9.5
8.7
17
18
H02AB07
ATC
prednisone; oral
1.5
8.7
305
2126
M03BX02
ATC
tizanidine; oral
1.2
8.7
2137
19269
F43.25
ICD-10 Finland
Adaptive disorder with mixed mental disorder and behavioral disorder
3.3
8.7
32
98
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
7.2
8.7
20
28
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
4.1
8.7
23
56
N94.1
ICD-10 Finland
Dyspareunia
1.8
8.7
137
791
C09AA05
ATC
ramipril; oral
1.5
8.7
249
1668
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
8.7
361
2601
R03BB01
ATC
ipratropium bromide; inhalant
2.5
8.7
51
203
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
8.7
150
889
SPAT1324
SPAT
Screening procedure
0.7
8.6
524
6711
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.4
8.6
343
2451
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
2.0
8.6
85
421
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
8.6
806
6553
N02CC06
ATC
eletriptan; oral
1.6
8.6
213
1381
Z61.8
ICD-10 Finland
Other negative life events in childhood
3.5
8.6
29
84
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.9
8.6
108
582
R06AX27
ATC
desloratadine; oral
1.2
8.6
1424
12349
U08
ICPC
Urinary retention
3.2
8.6
32
99
SPF12
NOMESCO Finland
Fitting of the denture in the mouth during the repair of the loose prosthesis
4.6
8.6
20
44
I45.9
ICD-10 Finland
Conduction disorder, unspecified
4.6
8.6
20
44
Z63.2
ICD-10 Finland
Inadequate family support
4.8
8.6
19
40
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
8.5
142
832
78400
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Anorexia
16.3
8.5
13
8
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.3
8.5
61
266
M03AX01
ATC
botulinum toxin; parenteral
1.9
8.5
100
527
IBB04
NOMESCO Finland
Risk assessment concerning problem behaviour
10.0
8.5
16
16
R03BA05
ATC
fluticasone; inhalant
1.3
8.5
706
5653
H13
ICPC
Plugged feeling ear
1.4
8.5
453
3403
D03
ICPC
Heartburn
1.7
8.5
156
940
C08CA01
ATC
amlodipine; oral
1.4
8.5
449
3370
R3110
NOMESCO Finland
Psychosocial training
1.9
8.4
108
585
M01AH02
ATC
rofecoxib; oral
1.6
8.4
169
1041
Z11
ICPC
Compliance/being ill problem
3.2
8.4
32
100
R03DA04
ATC
theophylline; systemic, rectal
2.0
8.4
89
452
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
0.4
8.4
38
969
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
8.4
141
829
M01AE02
ATC
naproxen; oral, rectal
1.2
8.4
2429
22223
SAA04
NOMESCO Finland
Special examination of mouth
1.5
8.4
259
1763
F43.8
ICD-10 Finland
Other reactions to severe stress
1.6
8.4
195
1247
3007
Kela drug reimbursment
Erenumab and fremanezumab
1.9
8.4
99
523
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
8.3
249
1682
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
8.3
162
990
SPAT1237
SPAT
Psychotherapy
2.4
8.3
53
219
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
7.8
8.3
18
23
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.7
8.3
44
166
J01FA06
ATC
roxithromycin; oral
1.2
8.3
1126
9550
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
8.3
223
1472
S01
ICPC
Pain/tenderness of skin
1.7
8.3
158
960
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.0
8.3
84
420
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.9
8.3
107
581
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.7
8.3
25
67
CL2S4, ,
SPAT
2.4
8.3
56
238
-60
ICPC
Result test/procedure
1.6
8.3
175
1093
N28
ICPC
Limited function/disability (N)
2.8
8.3
40
144
A10BJ05
ATC
dulaglutide; parenteral
2.7
8.3
43
161
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.1
8.3
76
367
F48.9
ICD-10 Finland
Neurotic disorder, unspecified
9.4
8.3
16
17
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
1.9
8.2
103
554
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
7.0
8.2
19
27
S32.7
ICD-10 Finland
Multiple fractures of lumbar spine and pelvis
4.1
8.2
22
54
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.8
8.2
24
63
G04CA02
ATC
tamsulosin; oral
1.7
8.2
147
880
R1250, ,
SPAT
1.7
8.2
150
903
SGA05
NOMESCO Finland
Opening and preparing the root canals, extremely complicated And time consuming
1.5
8.2
265
1821
H29
ICPC
Ear symptom/complaint other
1.4
8.2
371
2714
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.3
8.2
61
271
S14
ICPC
Burn/scald
1.7
8.2
153
927
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.7
8.1
141
836
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
1.8
8.1
123
702
X80
ICD-10 Finland
Intentional self-harm by jumping from a high place
7.5
8.1
18
24
AA40B, ,
NOMESCO Finland
7.5
8.1
18
24
SPAT1235
SPAT
Mental health, emotional support
2.6
8.1
46
180
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
3.0
8.1
34
113
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
1.6
8.1
188
1201
B02AA02
ATC
tranexamic acid; systemic
1.3
8.1
578
4534
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.3
8.1
60
266
RD220, ,
NOMESCO Finland
33.3
8.1
10
*
K91.1
ICD-10 Finland
Postgastric surgery syndromes
11.7
8.1
14
12
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
4.0
8.0
22
55
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
2.6
8.0
46
181
F92.0
ICD-10 Finland
Depressive conduct disorder
2.9
8.0
37
130
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
8.9
8.0
16
18
N06
ICPC
Sensation disturbance other
2.4
8.0
51
211
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.5
8.0
48
193
ICA02
NOMESCO Finland
Psychiatric treatment plan, extended psychotherapy in specialised care
10.0
8.0
15
15
RT110, ,
NOMESCO Finland
22.0
8.0
11
5
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.3
8.0
590
4650
SPAT1265
SPAT
Breathalyser
3.0
8.0
33
109
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.7
8.0
130
759
XKC03
NOMESCO Finland
Water cystometry
2.2
7.9
63
287
X15
ICPC
Vaginal symptom/complaint other
1.4
7.9
342
2479
C08CA05
ATC
nifedipine; systemic
1.8
7.9
114
641
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
7.9
122
700
R41.3
ICD-10 Finland
Other amnesia
2.8
7.9
39
142
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
1.7
7.9
146
881
ZYC01, ,
SPAT
1.3
7.9
628
4995
W0A10
NOMESCO Finland
Mapping of psychosocial situation
4.3
7.9
20
47
M54.3
ICD-10 Finland
Sciatica
1.7
7.9
150
913
L04
ICPC
Chest symptom/complaint
1.5
7.9
236
1597
ZXY85
NOMESCO Finland
Other special worker in multidisciplinary team
13.0
7.9
13
10
IBZ14, ,
SPAT
4.6
7.8
18
39
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.6
7.8
196
1275
RS313, ,
NOMESCO Finland
6.1
7.8
20
33
O81.4
ICD-10 Finland
Vacuum extractor delivery
0.7
7.8
223
3243
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.1
7.8
66
309
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.7
7.8
40
149
RS120, ,
NOMESCO Finland
3.5
7.8
26
75
OAA12, ,
SPAT
0.7
7.8
309
4231
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
2.4
7.8
50
208
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
10.8
7.8
14
13
RS230, ,
NOMESCO Finland
4.0
7.8
21
52
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.5
7.8
207
1366
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
9.4
7.8
15
16
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.2
7.8
29
90
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.3
7.8
28
85
SDA03
NOMESCO Finland
Periodontal treatment
1.2
7.8
1708
15187
A02BA04
ATC
nizatidine; systemic
1.9
7.7
97
523
D10
ICPC
Vomiting
1.3
7.7
450
3426
IAB01, ,
SPAT
2.8
7.7
37
133
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.6
7.7
24
66
SPAT1369
SPAT
Meeting with student welfare group of educational institution
2.7
7.7
40
150
SPAT1153
SPAT
Removal of sutures
1.3
7.7
726
5904
SCA02
NOMESCO Finland
Preventive oral health care
1.3
7.7
679
5477
D07XC01
ATC
betamethasone; topical
1.5
7.7
269
1879
J01CF05
ATC
flucloxacillin; systemic
1.5
7.6
262
1821
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
7.6
140
844
T18.9
ICD-10 Finland
Foreign body in alimentary tract, part unspecified
4.5
7.6
18
40
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
7.6
99
540
SPAT1272
SPAT
Drug screening
3.0
7.6
33
112
XCK00
NOMESCO Finland
Perimetry
1.8
7.6
110
620
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.7
7.6
40
151
ZXD20
NOMESCO Finland
Day surgery
1.4
7.6
357
2627
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.7
7.6
23
62
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.5
7.6
250
1725
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.4
7.6
338
2466
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
7.6
481
3710
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
6.7
7.6
18
27
M89.0
ICD-10 Finland
Algoneurodystrophy
2.7
7.6
38
140
E44.0
ICD-10 Finland
Moderate protein-energy malnutrition
11.8
7.6
13
11
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
2.3
7.6
55
242
WX780
NOMESCO Finland
Remote monitoring CPAP
1.8
7.5
100
549
A10BD07
ATC
metformin and sitagliptin; systemic
2.4
7.5
48
199
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
2.5
7.5
46
187
H81
ICPC
Excessive ear wax
1.4
7.5
311
2239
B80
ICPC
Iron deficiency anaemia
1.7
7.5
132
787
R4120, ,
SPAT
2.6
7.5
40
152
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.9
7.5
33
113
C01AA05
ATC
digoxin; systemic
2.3
7.5
52
224
A07AA02
ATC
nystatin; oral
1.8
7.5
113
645
R25.2
ICD-10 Finland
Cramp and spasm
2.0
7.5
78
395
D16
ICPC
Rectal bleeding
1.9
7.5
92
493
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.4
7.5
384
2867
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
7.5
135
811
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.5
7.5
43
170
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
4.2
7.4
19
45
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.3
7.4
51
219
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
4.4
7.4
18
41
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.1
7.4
30
98
E000001, ,
ATC
1.3
7.4
817
6766
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
7.4
100
553
OAA68, ,
SPAT
2.0
7.4
74
370
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
3.1
7.4
29
93
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
13.3
7.4
12
9
IBA05, ,
NOMESCO Finland
7.6
7.4
16
21
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
7.4
67
323
R04
ICPC
Breathing problem other
1.7
7.4
122
716
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
3.2
7.4
28
88
D10AF01
ATC
clindamycin; topical
1.6
7.4
177
1142
SPB20
NOMESCO Finland
Temporary bridge
5.9
7.3
19
32
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
7.3
364
2702
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
2.1
7.3
68
330
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.3
7.3
51
220
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
7.3
159
1001
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.4
7.3
48
202
ZXY54
NOMESCO Finland
2-person team, doctor-occupational therapist
8.3
7.3
15
18
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
1.8
7.3
97
534
J01AA07
ATC
tetracycline; systemic
1.3
7.3
598
4778
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.6
7.2
152
949
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.1
7.2
19
46
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.2
7.2
28
89
E000006, ,
ATC
1.5
7.2
205
1372
F38.00
ICD-10 Finland
Mood syndrome of mixed type
15.7
7.2
11
7
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.4
7.2
25
74
IEY01, ,
SPAT
4.3
7.2
18
42
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
7.2
118
691
R39.1
ICD-10 Finland
Other difficulties with micturition
2.2
7.2
56
254
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
7.2
288
2063
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
7.2
113
654
SPF20
NOMESCO Finland
Temporary relining of dentures
7.3
7.2
16
22
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
2.6
7.2
39
150
F45.0
ICD-10 Finland
Somatization disorder
3.7
7.2
22
60
K03.80
ICD-10 Finland
Irradiated enamel
1.5
7.1
253
1771
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.5
7.1
41
162
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
1.7
7.1
135
822
K59.01
ICD-10 Finland
Constipation outlet obstruction type
2.7
7.1
37
139
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.6
7.1
143
884
IDR99
NOMESCO Finland
Other psychotherapeutic group intervention
6.5
7.1
17
26
TKD00
NOMESCO Finland
Dilatation of urethra
3.3
7.1
25
75
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
2.6
7.1
39
151
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.0
7.1
68
335
I95.9
ICD-10 Finland
Hypotension, unspecified
2.8
7.1
33
117
X07
ICPC
Menstruation irregular/frequent
1.6
7.0
169
1090
SGC10
NOMESCO Finland
Pulp capping
1.3
7.0
446
3440
J05AB01
ATC
aciclovir; systemic
1.3
7.0
737
6066
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
4.2
7.0
18
43
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
4.2
7.0
18
43
A10AB06
ATC
insulin glulisine; parenteral
2.7
7.0
35
129
D64.8
ICD-10 Finland
Other specified anaemias
2.6
7.0
39
152
E22.1
ICD-10 Finland
Hyperprolactinaemia
2.2
7.0
53
238
L60.0
ICD-10 Finland
Ingrowing nail
1.5
7.0
184
1213
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
2.5
7.0
43
176
R40.0
ICD-10 Finland
Somnolence
3.5
7.0
23
66
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
6.9
93
513
SPAT1216
SPAT
Assessment of functional ability
1.4
6.9
283
2033
T74.2
ICD-10 Finland
Sexual abuse
3.3
6.9
25
76
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
6.9
384
2902
Z04
ICD-10 Finland
Examination and observation for other reasons
2.3
6.9
51
226
J01AA02
ATC
doxycycline; systemic
1.2
6.9
2403
22163
A01AB04
ATC
amphotericin B; local oral
2.1
6.9
64
311
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
6.9
300
2179
Y94.8
ICD-10 Finland
Other leisure activity accident
1.8
6.9
92
507
T02
ICPC
Excessive appetite
13.8
6.9
11
8
N05BB01
ATC
hydroxyzine; systemic
1.5
6.9
224
1543
K03.1
ICD-10 Finland
Abrasion of teeth
2.1
6.9
63
305
WZB00, ,
SPAT
1.2
6.9
780
6474
A13
ICPC
Concern/fear medical treatment
2.1
6.9
58
272
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
2.0
6.9
75
387
J20
ICD-10 Finland
Acute bronchitis
1.4
6.9
358
2680
C08CA02
ATC
felodipine; oral
1.9
6.9
88
479
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
6.9
362
2715
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.1
6.9
28
92
E23.05
ICD-10 Finland
Lack of TSH
3.6
6.8
22
62
-, ,
ICD-10 Finland
2.3
6.8
50
221
OAB42, ,
SPAT
1.3
6.8
624
5050
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
6.8
196
1316
R51
ICD-10 Finland
Headache
1.4
6.8
308
2253
SPAT1051
SPAT
Guidance regarding sleep disorders
2.0
6.8
69
347
ZX120
NOMESCO Finland
Intravenous
1.5
6.8
224
1547
N92.5
ICD-10 Finland
Other specified irregular menstruation
1.4
6.8
322
2374
G03FB01
ATC
norgestrel and estrogen; systemic
4.1
6.8
18
44
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
4.1
6.8
18
44
ICB07, ,
NOMESCO Finland
3.8
6.8
20
53
RF230, ,
NOMESCO Finland
9.3
6.8
13
14
S22.3
ICD-10 Finland
Fracture of rib
1.6
6.8
137
849
WX872
NOMESCO Finland
Intensive care
2.0
6.8
68
341
3000B
ICD-9 Finland
Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]
40.0
6.7
8
*
RT210, ,
NOMESCO Finland
40.0
6.7
8
*
F55
ICD-10 Finland
Abuse of non-dependence-producing substances
16.7
6.7
10
6
RT180, ,
NOMESCO Finland
16.7
6.7
10
6
A10AE06
ATC
insulin degludec; parenteral
1.7
6.7
106
614
OAA10, ,
SPAT
0.7
6.7
320
4257
S32.5
ICD-10 Finland
Fracture of pubis
4.3
6.7
17
40
S50
ICPC
Skin, Medication/prescr/renewal
4.3
6.7
17
40
XF404
NOMESCO Finland
Ambulatory ECG
1.6
6.7
158
1015
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.8
6.7
813
9599
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.8
6.7
102
585
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.8
6.7
32
115
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.0
6.7
68
342
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
0.6
6.7
93
1596
R30.0
ICD-10 Finland
Dysuria
1.5
6.7
180
1192
IEY09, ,
SPAT
3.9
6.7
19
49
205
Kela drug reimbursment
Chronic hypertension
1.5
6.7
199
1347
N06AX27
ATC
esketamine; nasal
22.5
6.7
9
*
H57.1
ICD-10 Finland
Ocular pain
1.5
6.7
179
1185
K58
ICD-10 Finland
Irritable bowel syndrome
1.6
6.7
139
868
R03DC03
ATC
montelukast; oral
1.3
6.6
612
4956
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.6
6.6
137
853
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
6.4
6.6
16
25
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.3
6.6
46
199
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
6.6
46
199
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
6.6
177
1171
J01CA08
ATC
pivmecillinam; oral
1.2
6.6
1927
17485
L70.0
ICD-10 Finland
Acne vulgaris
1.4
6.6
311
2291
R21
ICPC
Throat symptom/complaint
1.2
6.6
1515
13469
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
3.0
6.6
27
89
2961A
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
12.2
6.6
11
9
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
3.6
6.6
21
59
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
6.5
415
3199
MAE00
NOMESCO Finland
Outlet vacuum delivery
0.7
6.5
184
2683
C10AC01
ATC
colestyramine; oral
1.9
6.5
79
422
Z29
ICPC
Social problem NOS
1.7
6.5
118
710
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
3.4
6.5
22
64
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
6.5
1677
15049
U28
ICPC
Limited function/disability (U)
4.2
6.5
17
41
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
10.0
6.5
12
12
G03DC02
ATC
norethisterone; oral
1.5
6.5
186
1248
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
6.5
594
4805
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
2.4
6.5
43
182
G03CA04
ATC
estriol; systemic, vaginal
2.3
6.5
47
207
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.8
6.5
30
106
A02BA03
ATC
famotidine; systemic
2.4
6.5
42
176
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.8
6.5
566
6934
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.5
6.5
38
152
N06BA02
ATC
dexamfetamine; oral
3.0
6.5
27
90
WVA30, ,
SPAT
1.6
6.5
145
922
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.3
6.4
18
34
IER07
NOMESCO Finland
Psychiatric sleep coaching, group
69.8
6.4
7
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
3.5
6.4
21
60
IEV99, ,
SPAT
3.5
6.4
21
60
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
6.4
819
6883
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
6.4
299
2200
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.2
6.4
24
75
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
3.4
6.4
22
65
G25.0
ICD-10 Finland
Essential tremor
2.3
6.4
45
196
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
2.6
6.3
34
130
T86
ICPC
Hypothyroidism/myxoedema
1.6
6.3
157
1021
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
1.8
6.3
93
528
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
3.7
6.3
19
51
Z06
ICPC
Unemployment problem
2.3
6.3
46
203
SPAT1255
SPAT
Intravenous administration of medicine
1.6
6.3
149
958
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.2
6.3
968
8282
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
4.1
6.3
17
42
SPF30
NOMESCO Finland
Relining of denture
4.1
6.3
17
42
G04BD09
ATC
trospium; oral
2.5
6.3
36
142
Z02
ICPC
Food/water problem
8.1
6.3
13
16
SPAT1131
SPAT
Colonoscopy
2.0
6.3
60
295
W90
ICPC
Uncompl labour/delivery livebirth
0.7
6.3
295
3935
SPE02
NOMESCO Finland
Metal-framed partial denture
3.1
6.3
25
81
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
3.1
6.3
25
81
M54
ICD-10 Finland
Dorsalgia
1.3
6.3
514
4102
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.2
6.3
51
236
G03DB02
ATC
megestrol; oral
2.4
6.3
42
179
-64
ICPC
Encounter/prob initiated by provider
2.4
6.3
42
179
R03AC12
ATC
salmeterol; inhalant
1.8
6.3
86
479
K92.1
ICD-10 Finland
Melaena
1.8
6.3
89
501
L90
ICPC
Osteoarthrosis of knee
1.9
6.3
74
393
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
18.0
6.3
9
5
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
6.2
134
843
3079X
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified special symptoms or syndromes, not elsewhere classified
+∞
6.2
6
*
3075E
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[PSYKOGEENINEN OKSENTELU]
+∞
6.2
6
*
162
Kela drug reimbursment
liraglutide
3.3
6.2
22
66
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.2
6.2
50
230
SPC10
NOMESCO Finland
Standard dental crown
2.5
6.2
38
155
A10BG03
ATC
pioglitazone; oral
2.8
6.2
29
103
E61.1
ICD-10 Finland
Iron deficiency
1.4
6.2
220
1541
N39.3
ICD-10 Finland
Stress incontinence
1.5
6.2
172
1147
RJ421, ,
NOMESCO Finland
7.0
6.2
14
20
N76
ICD-10 Finland
Other inflammation of vagina and vulva
1.8
6.2
86
481
F84.8
ICD-10 Finland
Other pervasive developmental disorders
3.7
6.2
19
52
S74
ICPC
Dermatophytosis
2.0
6.2
64
325
ZYY79, ,
SPAT
3.1
6.2
25
82
X21
ICPC
Breast sympt/compl female other
1.6
6.2
121
745
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.4
6.2
39
162
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.8
6.2
963
11100
IDY01
NOMESCO Finland
Systematic individual therapy, psychodynamic
5.3
6.1
17
32
N02CC03
ATC
zolmitriptan; nasal, oral
1.4
6.1
251
1806
R2130, ,
SPAT
1.6
6.1
149
966
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
2.2
6.1
48
219
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
6.1
310
2311
W17
ICD-10 Finland
Other fall from one level to another
1.5
6.1
169
1127
J01DA09
ATC
[U] cefadroxil
1.2
6.1
849
7193
R06AX22
ATC
ebastine; oral
1.3
6.1
613
5014
SPAT1104
SPAT
Monitoring of emergency patient
1.5
6.1
163
1079
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
6.1
162
1071
O99.80
ICD-10 Finland
The fear of childbirth
1.3
6.1
418
3259
N94.9
ICD-10 Finland
Unspecified condition associated with female genital organs and menstrual cycle
3.0
6.1
26
88
N02CD03
ATC
fremanezumab; systemic
1.9
6.1
70
369
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
6.1
1502
13416
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.5
6.0
160
1057
F20.6
ICD-10 Finland
Simple schizophrenia
8.6
6.0
12
14
-69
ICPC
Other reason for encounter NEC
1.7
6.0
114
695
X11
ICPC
Menopausal symptom/complaint
2.0
6.0
63
321
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.0
6.0
64
328
E41
ICD-10 Finland
Nutritional marasmus
10.0
6.0
11
11
ZXY12
NOMESCO Finland
Trainee nurse, supervised
6.7
6.0
14
21
V03AB30, ,
ATC
6.7
6.0
14
21
SPAT1053
SPAT
Memory test
1.9
6.0
70
370
Y34
ICD-10 Finland
Unspecified event, undetermined intent
2.9
6.0
27
94
Y96.8
ICD-10 Finland
Other type of accident
2.9
6.0
27
94
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
3.1
6.0
24
78
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
6.0
1711
15454

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
1.5e+00
2.2e+00
2.7e+00
7.1e+00
3.9e+00
3.7e+00
2.6e+00
cases:21.23%
controls:5.42%
cases:23.92%
controls:3.27%
cases:17.14%
controls:1.34%
cases:55.77%
controls:0.11%
cases:40.01%
controls:1.36%
cases:58.74%
controls:3.47%
cases:55.59%
controls:8.70%
875
2229
3246
38864
987
1343
3139
39786
707
551
3419
40578
2301
44
1825
41085
1649
559
2472
40551
2395
1414
1682
39333
2128
3327
1700
34902
fluoxetine; oral
N06AB03 [21604711]
2.0e+00
2.9e+00
3.3e+00
4.8e+00
3.8e+00
3.4e+00
2.8e+00
cases:10.51%
controls:1.51%
cases:11.27%
controls:0.72%
cases:4.90%
controls:0.18%
cases:1.82%
controls:0.01%
cases:7.60%
controls:0.18%
cases:19.25%
controls:0.75%
cases:20.43%
controls:1.60%
433
622
3688
40471
465
297
3661
40832
202
75
3924
41054
75
6
4051
41123
313
74
3808
41036
785
307
3292
40440
782
612
3046
37617
Eating disorder, unspecified
F50.9 [45547713]
3.1e+00
5.6e+00
—
1.0e+50
—
8.0e+00
6.3e+00
cases:0.73%
controls:0.03%
cases:3.10%
controls:0.01%
—
—
cases:28.57%
controls:0.00%
—
—
cases:24.99%
controls:0.01%
cases:15.78%
controls:0.03%
30
13
4091
41080
128
5
3998
41124
—
1179
0
2947
41129
—
1019
5
3058
40742
604
13
3224
38216
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
9.5e-01
1.8e+00
2.7e+00
5.9e+00
3.6e+00
3.1e+00
2.4e+00
cases:9.51%
controls:3.93%
cases:10.52%
controls:1.89%
cases:9.55%
controls:0.67%
cases:16.77%
controls:0.05%
cases:19.46%
controls:0.67%
cases:27.25%
controls:1.66%
cases:22.34%
controls:2.60%
392
1613
3729
39480
434
779
3692
40350
394
277
3732
40852
692
22
3434
41107
802
277
3319
40833
1111
677
2966
40070
855
994
2973
37235
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.5e+00
2.2e+00
2.5e+00
5.7e+00
3.2e+00
2.7e+00
1.9e+00
cases:5.56%
controls:1.34%
cases:5.14%
controls:0.60%
cases:2.52%
controls:0.22%
cases:4.07%
controls:0.01%
cases:4.44%
controls:0.19%
cases:9.66%
controls:0.71%
cases:11.91%
controls:2.07%
229
552
3892
40541
212
246
3914
40883
104
90
4022
41039
168
6
3958
41123
183
80
3938
41030
394
290
3683
40457
456
790
3372
37439
Mixed personality disorders
F61.0 [2000502024]
2.7e+00
2.9e+00
3.2e+00
1.0e+50
3.6e+00
3.2e+00
3.1e+00
cases:1.24%
controls:0.09%
cases:0.85%
controls:0.05%
cases:0.29%
controls:0.01%
cases:0.68%
controls:0.00%
cases:0.63%
controls:0.02%
cases:1.64%
controls:0.07%
cases:2.66%
controls:0.12%
51
35
4070
41058
35
20
4091
41109
12
5
4114
41124
28
0
4098
41129
26
7
4095
41103
67
28
4010
40719
102
47
3726
38182
Dietary counselling and surveillance
Z71.3 [45552101]
1.3e+00
2.3e+00
4.6e+00
1.0e+50
4.6e+00
3.4e+00
1.9e+00
cases:1.89%
controls:0.53%
cases:1.75%
controls:0.18%
cases:1.45%
controls:0.01%
cases:0.99%
controls:0.00%
cases:2.26%
controls:0.02%
cases:4.59%
controls:0.16%
cases:4.28%
controls:0.66%
78
218
4043
40875
72
75
4054
41054
60
6
4066
41123
41
0
4085
41129
93
10
4028
41100
187
65
3890
40682
164
253
3664
37976
Hospital outpatient
ZY010 [2001311599]
9.2e-01
1.3e+00
1.9e+00
5.8e+00
3.0e+00
2.8e+00
2.4e+00
cases:2.48%
controls:1.00%
cases:1.67%
controls:0.47%
cases:1.14%
controls:0.17%
cases:3.68%
controls:0.01%
cases:3.45%
controls:0.18%
cases:5.45%
controls:0.35%
cases:6.84%
controls:0.69%
102
410
4019
40683
69
192
4057
40937
47
71
4079
41058
152
5
3974
41124
142
74
3979
41036
222
142
3855
40605
262
263
3566
37966
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]
2.4e+00
2.9e+00
3.1e+00
1.0e+50
3.5e+00
3.0e+00
3.0e+00
cases:0.95%
controls:0.08%
cases:0.65%
controls:0.04%
cases:0.34%
controls:0.01%
cases:0.36%
controls:0.00%
cases:0.39%
controls:0.01%
cases:1.23%
controls:0.06%
cases:2.17%
controls:0.11%
39
34
4082
41059
27
15
4099
41114
14
6
4112
41123
15
0
4111
41129
16
5
4105
41105
50
25
4027
40722
83
43
3745
38186
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
2.1e+00
2.9e+00
3.1e+00
—
2.7e+00
3.3e+00
3.3e+00
cases:0.99%
controls:0.12%
cases:0.80%
controls:0.05%
cases:0.27%
controls:0.01%
—
—
cases:0.32%
controls:0.02%
cases:0.93%
controls:0.03%
cases:2.14%
controls:0.08%
41
49
4080
41044
33
19
4093
41110
11
5
4115
41124
—
13
9
4108
41101
38
14
4039
40733
82
32
3746
38197
Anxiety disorder, unspecified
F41.9 [45542849]
1.3e+00
1.8e+00
2.5e+00
5.3e+00
2.6e+00
2.1e+00
1.5e+00
cases:5.46%
controls:1.52%
cases:4.58%
controls:0.81%
cases:2.21%
controls:0.18%
cases:2.74%
controls:0.01%
cases:2.45%
controls:0.18%
cases:6.92%
controls:0.87%
cases:11.73%
controls:2.88%
225
626
3896
40467
189
333
3937
40796
91
74
4035
41055
113
6
4013
41123
101
75
4020
41035
282
353
3795
40394
449
1100
3379
37129
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.9e+00
2.8e+00
3.2e+00
—
3.5e+00
3.2e+00
2.5e+00
cases:5.19%
controls:0.82%
cases:5.26%
controls:0.35%
cases:2.74%
controls:0.11%
—
—
cases:3.93%
controls:0.12%
cases:9.12%
controls:0.39%
cases:11.49%
controls:1.08%
214
338
3907
40755
217
142
3909
40987
113
46
4013
41083
—
162
50
3959
41060
372
159
3705
40588
440
411
3388
37818
chlorprothixene; oral, parenteral
N05AF03 [21604533]
2.4e+00
2.8e+00
2.5e+00
—
3.3e+00
2.9e+00
2.9e+00
cases:1.55%
controls:0.14%
cases:1.16%
controls:0.07%
cases:0.15%
controls:0.01%
—
—
cases:0.34%
controls:0.01%
cases:1.55%
controls:0.09%
cases:3.21%
controls:0.18%
64
57
4057
41036
48
28
4078
41101
6
5
4120
41124
—
14
5
4107
41105
63
36
4014
40711
123
69
3705
38160
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
2.0e+00
2.6e+00
3.0e+00
—
3.3e+00
3.0e+00
2.6e+00
cases:3.32%
controls:0.45%
cases:3.22%
controls:0.24%
cases:1.55%
controls:0.08%
—
—
cases:2.33%
controls:0.09%
cases:5.08%
controls:0.25%
cases:8.41%
controls:0.70%
137
186
3984
40907
133
100
3993
41029
64
32
4062
41097
—
96
36
4025
41074
207
103
3870
40644
322
269
3506
37960
Anorexia nervosa/bulimia
P86 [2002000878]
2.8e+00
4.3e+00
—
1.0e+50
—
4.7e+00
4.7e+00
cases:0.70%
controls:0.04%
cases:1.70%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
—
—
cases:2.43%
controls:0.02%
cases:3.58%
controls:0.03%
29
17
4092
41076
70
10
4056
41119
—
7
0
4119
41129
—
99
9
3978
40738
137
13
3691
38216
quetiapine; oral
N05AH04 [21604544]
1.6e+00
2.0e+00
2.0e+00
4.0e+00
2.2e+00
2.3e+00
2.1e+00
cases:11.11%
controls:2.36%
cases:10.32%
controls:1.59%
cases:3.39%
controls:0.48%
cases:0.63%
controls:0.01%
cases:4.20%
controls:0.47%
cases:15.35%
controls:1.72%
cases:23.35%
controls:3.52%
458
970
3663
40123
426
653
3700
40476
140
197
3986
40932
26
5
4100
41124
173
194
3948
40916
626
699
3451
40048
894
1345
2934
36884
Generalized anxiety disorder
F41.1 [45571764]
1.4e+00
1.6e+00
1.8e+00
5.2e+00
2.3e+00
2.3e+00
1.6e+00
cases:2.40%
controls:0.63%
cases:2.08%
controls:0.41%
cases:0.75%
controls:0.13%
cases:2.11%
controls:0.01%
cases:1.46%
controls:0.15%
cases:4.02%
controls:0.43%
cases:6.45%
controls:1.42%
99
258
4022
40835
86
170
4040
40959
31
52
4095
41077
87
5
4039
41124
60
61
4061
41049
164
177
3913
40570
247
542
3581
37687
Other obesity
E66.8 [45533036]
2.1e+00
2.7e+00
2.9e+00
—
3.3e+00
2.7e+00
2.3e+00
cases:2.38%
controls:0.31%
cases:2.40%
controls:0.17%
cases:0.85%
controls:0.05%
—
—
cases:0.78%
controls:0.03%
cases:2.97%
controls:0.21%
cases:5.17%
controls:0.54%
98
127
4023
40966
99
70
4027
41059
35
19
4091
41110
—
32
12
4089
41098
121
86
3956
40661
198
205
3630
38024
fluvoxamine; oral
N06AB08 [21604716]
1.7e+00
2.2e+00
2.8e+00
—
3.3e+00
3.2e+00
2.4e+00
cases:0.58%
controls:0.11%
cases:0.39%
controls:0.04%
cases:0.24%
controls:0.01%
—
—
cases:0.34%
controls:0.01%
cases:0.93%
controls:0.04%
cases:1.10%
controls:0.10%
24
45
4097
41048
16
17
4110
41112
10
6
4116
41123
—
14
5
4107
41105
38
15
4039
40732
42
40
3786
38189
Psychotherapy
R4140 [2001310238]
1.9e+00
2.9e+00
—
—
4.1e+00
3.7e+00
3.1e+00
cases:0.58%
controls:0.09%
cases:0.51%
controls:0.03%
—
—
—
—
cases:0.73%
controls:0.01%
cases:1.52%
controls:0.04%
cases:1.67%
controls:0.08%
24
37
4097
41056
21
12
4105
41117
—
—
30
5
4091
41105
62
16
4015
40731
64
30
3764
38199
Personality disorder, unspecified
F60.9 [45538076]
2.1e+00
2.9e+00
3.5e+00
1.0e+50
—
3.8e+00
3.1e+00
cases:0.99%
controls:0.12%
cases:0.80%
controls:0.05%
cases:0.39%
controls:0.01%
cases:0.82%
controls:0.00%
—
—
cases:1.50%
controls:0.03%
cases:2.48%
controls:0.12%
41
49
4080
41044
33
19
4093
41110
16
5
4110
41124
34
0
4092
41129
—
61
14
4016
40733
95
44
3733
38185
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.0e+00
2.1e+00
3.2e+00
1.0e+50
3.9e+00
2.8e+00
2.3e+00
cases:1.80%
controls:0.65%
cases:2.52%
controls:0.32%
cases:1.48%
controls:0.06%
cases:0.46%
controls:0.00%
cases:2.45%
controls:0.05%
cases:4.29%
controls:0.28%
cases:5.85%
controls:0.60%
74
268
4047
40825
104
131
4022
40998
61
26
4065
41103
19
0
4107
41129
101
21
4020
41089
175
115
3902
40632
224
230
3604
37999
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.2e+00
2.4e+00
2.4e+00
—
2.7e+00
2.9e+00
2.6e+00
cases:1.89%
controls:0.21%
cases:1.26%
controls:0.11%
cases:0.70%
controls:0.06%
—
—
cases:0.90%
controls:0.06%
cases:2.58%
controls:0.14%
cases:5.07%
controls:0.41%
78
85
4043
41008
52
46
4074
41083
29
26
4097
41103
—
37
25
4084
41085
105
59
3972
40688
194
156
3634
38073
Other therapy enhancing rehabilitation
R4160 [2001310240]
7.1e-01
1.9e+00
3.2e+00
1.0e+50
3.6e+00
3.3e+00
2.4e+00
cases:0.95%
controls:0.47%
cases:0.80%
controls:0.12%
cases:0.68%
controls:0.03%
cases:0.48%
controls:0.00%
cases:1.26%
controls:0.03%
cases:3.53%
controls:0.13%
cases:3.61%
controls:0.32%
39
192
4082
40901
33
51
4093
41078
28
11
4098
41118
20
0
4106
41129
52
14
4069
41096
144
55
3933
40692
138
123
3690
38106
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
2.2e+00
2.4e+00
2.6e+00
1.0e+50
2.8e+00
2.6e+00
2.5e+00
cases:1.31%
controls:0.15%
cases:1.04%
controls:0.10%
cases:0.41%
controls:0.03%
cases:0.63%
controls:0.00%
cases:0.63%
controls:0.04%
cases:1.42%
controls:0.11%
cases:2.40%
controls:0.20%
54
63
4067
41030
43
40
4083
41089
17
13
4109
41116
26
0
4100
41129
26
16
4095
41094
58
44
4019
40703
92
76
3736
38153
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.6e+00
1.9e+00
3.6e+00
1.0e+50
2.7e+00
2.7e+00
2.4e+00
cases:2.11%
controls:0.43%
cases:1.11%
controls:0.17%
cases:0.44%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.22%
controls:0.01%
cases:2.40%
controls:0.17%
cases:4.94%
controls:0.47%
87
175
4034
40918
46
70
4080
41059
18
5
4108
41124
8
0
4118
41129
9
6
4112
41104
98
70
3979
40677
189
181
3639
38048
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
1.9e+00
2.8e+00
3.7e+00
—
—
3.6e+00
2.7e+00
cases:1.53%
controls:0.22%
cases:1.41%
controls:0.08%
cases:0.58%
controls:0.01%
—
—
—
—
cases:2.38%
controls:0.07%
cases:3.47%
controls:0.24%
63
91
4058
41002
58
34
4068
41095
24
6
4102
41123
—
—
97
28
3980
40719
133
91
3695
38138
Emotionally unstable personality disorder
F60.3 [45566852]
1.8e+00
2.4e+00
2.4e+00
—
2.8e+00
2.6e+00
2.7e+00
cases:0.80%
controls:0.14%
cases:0.75%
controls:0.07%
cases:0.39%
controls:0.03%
—
—
cases:0.36%
controls:0.02%
cases:1.10%
controls:0.08%
cases:2.51%
controls:0.18%
33
56
4088
41037
31
28
4095
41101
16
14
4110
41115
—
15
9
4106
41101
45
33
4032
40714
96
68
3732
38161
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.8e+00
2.2e+00
2.4e+00
—
3.1e+00
2.7e+00
2.2e+00
cases:3.25%
controls:0.54%
cases:2.59%
controls:0.30%
cases:1.24%
controls:0.11%
—
—
cases:1.94%
controls:0.09%
cases:5.37%
controls:0.37%
cases:8.54%
controls:1.06%
134
220
3987
40873
107
123
4019
41006
51
46
4075
41083
—
80
37
4041
41073
219
150
3858
40597
327
406
3501
37823
Nutritional therapy
R4190 [2001310243]
8.1e-01
1.5e+00
2.4e+00
1.0e+50
4.4e+00
3.0e+00
2.2e+00
cases:0.97%
controls:0.43%
cases:0.92%
controls:0.20%
cases:0.46%
controls:0.04%
cases:0.51%
controls:0.00%
cases:1.14%
controls:0.01%
cases:3.63%
controls:0.18%
cases:3.24%
controls:0.37%
40
178
4081
40915
38
81
4088
41048
19
17
4107
41112
21
0
4105
41129
47
6
4074
41104
148
75
3929
40672
124
143
3704
38086
Predominantly compulsive acts [obsessional rituals]
F42.1 [45591138]
1.4e+00
2.2e+00
2.9e+00
—
2.6e+00
2.9e+00
2.3e+00
cases:0.39%
controls:0.10%
cases:0.39%
controls:0.04%
cases:0.22%
controls:0.01%
—
—
cases:0.29%
controls:0.02%
cases:0.93%
controls:0.05%
cases:1.33%
controls:0.14%
16
40
4105
41053
16
17
4110
41112
9
5
4117
41124
—
12
9
4109
41101
38
22
4039
40725
51
52
3777
38177
venlafaxine; oral
N06AX16 [21604745]
1.6e+00
1.8e+00
1.8e+00
3.1e+00
2.0e+00
2.1e+00
1.9e+00
cases:6.58%
controls:1.46%
cases:5.43%
controls:0.97%
cases:1.79%
controls:0.30%
cases:0.27%
controls:0.01%
cases:2.21%
controls:0.32%
cases:7.90%
controls:1.02%
cases:13.45%
controls:2.24%
271
602
3850
40491
224
401
3902
40728
74
122
4052
41007
11
5
4115
41124
91
130
4030
40980
322
414
3755
40333
515
858
3313
37371
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
8.1e-01
1.7e+00
2.4e+00
3.3e+00
2.9e+00
1.7e+00
1.4e+00
cases:4.83%
controls:2.20%
cases:4.53%
controls:0.88%
cases:1.70%
controls:0.16%
cases:0.32%
controls:0.01%
cases:2.69%
controls:0.15%
cases:4.81%
controls:0.93%
cases:11.68%
controls:3.05%
199
904
3922
40189
187
363
3939
40766
70
67
4056
41062
13
5
4113
41124
111
63
4010
41047
196
377
3881
40370
447
1167
3381
37062
trazodone; oral
N06AX05 [21604734]
1.9e+00
2.5e+00
2.4e+00
—
2.8e+00
2.2e+00
2.3e+00
cases:0.99%
controls:0.16%
cases:0.85%
controls:0.07%
cases:0.22%
controls:0.02%
—
—
cases:0.29%
controls:0.02%
cases:0.98%
controls:0.11%
cases:2.59%
controls:0.27%
41
64
4080
41029
35
30
4091
41099
9
8
4117
41121
—
12
7
4109
41103
40
45
4037
40702
99
103
3729
38126
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
2.1e+00
1.9e+00
2.2e+00
—
2.6e+00
2.7e+00
2.6e+00
cases:2.09%
controls:0.27%
cases:1.43%
controls:0.21%
cases:0.80%
controls:0.09%
—
—
cases:1.19%
controls:0.09%
cases:3.38%
controls:0.24%
cases:5.72%
controls:0.47%
86
109
4035
40984
59
87
4067
41042
33
38
4093
41091
—
49
35
4072
41075
138
99
3939
40648
219
180
3609
38049
Moderate panic disorder
F41.00 [2000501994]
1.8e+00
2.0e+00
3.0e+00
1.0e+50
2.9e+00
2.5e+00
1.7e+00
cases:0.95%
controls:0.15%
cases:0.58%
controls:0.08%
cases:0.34%
controls:0.02%
cases:0.51%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.98%
controls:0.08%
cases:1.33%
controls:0.24%
39
63
4082
41030
24
34
4102
41095
14
7
4112
41122
21
0
4105
41129
13
7
4108
41103
40
32
4037
40715
51
90
3777
38139
oxazepam; oral
N05BA04 [21604569]
1.4e+00
1.8e+00
2.1e+00
3.1e+00
2.0e+00
1.9e+00
1.6e+00
cases:8.81%
controls:2.38%
cases:6.69%
controls:1.20%
cases:1.96%
controls:0.24%
cases:0.32%
controls:0.01%
cases:2.18%
controls:0.29%
cases:8.51%
controls:1.34%
cases:16.69%
controls:3.74%
363
980
3758
40113
276
493
3850
40636
81
98
4045
41031
13
6
4113
41123
90
120
4031
40990
347
545
3730
40202
639
1430
3189
36799
Secondary amenorrhoea
N91.1 [45601758]
1.3e+00
1.9e+00
2.7e+00
1.0e+50
2.6e+00
3.2e+00
2.0e+00
cases:1.65%
controls:0.45%
cases:1.60%
controls:0.23%
cases:0.41%
controls:0.03%
cases:0.53%
controls:0.00%
cases:0.44%
controls:0.03%
cases:3.70%
controls:0.16%
cases:5.36%
controls:0.72%
68
185
4053
40908
66
95
4060
41034
17
11
4109
41118
22
0
4104
41129
18
13
4103
41097
151
66
3926
40681
205
277
3623
37952
Depressive episode, unspecified
F32.9 [45571760]
1.5e+00
2.2e+00
2.7e+00
—
3.1e+00
2.5e+00
1.8e+00
cases:7.47%
controls:1.83%
cases:6.96%
controls:0.79%
cases:2.86%
controls:0.21%
—
—
cases:4.22%
controls:0.19%
cases:10.06%
controls:0.89%
cases:14.81%
controls:2.77%
308
754
3813
40339
287
326
3839
40803
118
85
4008
41044
—
174
78
3947
41032
410
361
3667
40386
567
1058
3261
37171
Social worker
Z2446 [2001311559]
8.5e-01
1.6e+00
2.8e+00
—
3.5e+00
2.8e+00
2.3e+00
cases:2.09%
controls:0.90%
cases:1.53%
controls:0.30%
cases:0.61%
controls:0.04%
—
—
cases:1.38%
controls:0.04%
cases:3.68%
controls:0.22%
cases:4.94%
controls:0.52%
86
371
4035
40722
63
125
4063
41004
25
16
4101
41113
—
57
18
4064
41092
150
91
3927
40656
189
199
3639
38030
Clinic/Center
261Q00000X [38004207]
7.2e-01
1.6e+00
2.5e+00
—
3.4e+00
3.3e+00
2.3e+00
cases:0.68%
controls:0.33%
cases:0.58%
controls:0.12%
cases:0.27%
controls:0.02%
—
—
cases:0.63%
controls:0.02%
cases:2.45%
controls:0.10%
cases:2.85%
controls:0.30%
28
136
4093
40957
24
48
4102
41081
11
9
4115
41120
—
26
9
4095
41101
100
39
3977
40708
109
113
3719
38116
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
1.7e+00
1.9e+00
2.3e+00
—
2.6e+00
2.6e+00
2.2e+00
cases:0.87%
controls:0.15%
cases:0.56%
controls:0.09%
cases:0.24%
controls:0.02%
—
—
cases:0.34%
controls:0.02%
cases:1.45%
controls:0.11%
cases:2.82%
controls:0.32%
36
63
4085
41030
23
36
4103
41093
10
10
4116
41119
—
14
10
4107
41100
59
45
4018
40702
108
123
3720
38106
Recurrent depressive disorder, unspecified
F33.9 [45581458]
1.6e+00
2.0e+00
2.4e+00
1.0e+50
2.8e+00
2.4e+00
2.2e+00
cases:1.94%
controls:0.42%
cases:1.50%
controls:0.21%
cases:0.51%
controls:0.05%
cases:1.24%
controls:0.00%
cases:0.78%
controls:0.05%
cases:2.60%
controls:0.25%
cases:6.06%
controls:0.68%
80
171
4041
40922
62
87
4064
41042
21
20
4105
41109
51
0
4075
41129
32
20
4089
41090
106
102
3971
40645
232
260
3596
37969
Psychologist
Z2445 [2001311558]
8.5e-01
1.5e+00
2.3e+00
—
3.1e+00
3.0e+00
2.5e+00
cases:2.04%
controls:0.88%
cases:1.50%
controls:0.33%
cases:0.68%
controls:0.07%
—
—
cases:1.48%
controls:0.07%
cases:3.61%
controls:0.19%
cases:5.25%
controls:0.46%
84
361
4037
40732
62
134
4064
40995
28
27
4098
41102
—
61
29
4060
41081
147
79
3930
40668
201
174
3627
38055
Other bipolar affective disorders
F31.8 [45586237]
1.9e+00
2.0e+00
2.1e+00
—
2.3e+00
2.3e+00
2.4e+00
cases:1.21%
controls:0.18%
cases:1.07%
controls:0.14%
cases:0.46%
controls:0.06%
—
—
cases:0.56%
controls:0.05%
cases:1.42%
controls:0.14%
cases:2.82%
controls:0.27%
50
75
4071
41018
44
57
4082
41072
19
24
4107
41105
—
23
22
4098
41088
58
57
4019
40690
108
103
3720
38126
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.9e+00
2.2e+00
2.0e+00
—
2.3e+00
2.3e+00
2.3e+00
cases:1.33%
controls:0.21%
cases:0.85%
controls:0.09%
cases:0.24%
controls:0.03%
—
—
cases:0.27%
controls:0.03%
cases:0.98%
controls:0.10%
cases:1.88%
controls:0.19%
55
86
4066
41007
35
39
4091
41090
10
13
4116
41116
—
11
11
4110
41099
40
41
4037
40706
72
72
3756
38157
Feeding problem of adult
T05 [2002001069]
2.6e+00
4.2e+00
—
—
—
3.5e+00
2.6e+00
cases:0.90%
controls:0.07%
cases:1.60%
controls:0.02%
—
—
—
—
—
—
cases:0.81%
controls:0.02%
cases:1.72%
controls:0.13%
37
27
4084
41066
66
10
4060
41119
—
—
—
33
10
4044
40737
66
48
3762
38181
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.3e+00
1.4e+00
2.2e+00
—
3.3e+00
2.6e+00
2.1e+00
cases:1.41%
controls:0.37%
cases:1.09%
controls:0.28%
cases:0.36%
controls:0.04%
—
—
cases:0.95%
controls:0.04%
cases:4.29%
controls:0.32%
cases:5.54%
controls:0.70%
58
153
4063
40940
45
117
4081
41012
15
16
4111
41113
—
39
15
4082
41095
175
130
3902
40617
212
268
3616
37961
Outpatient Visit
OP [9202]
2.3e-01
5.2e-01
1.2e+00
5.8e+00
2.3e+00
1.8e+00
1.0e+00
cases:66.12%
controls:60.78%
cases:54.80%
controls:41.86%
cases:29.54%
controls:10.93%
cases:60.91%
controls:0.48%
cases:54.65%
controls:10.74%
cases:82.39%
controls:42.47%
cases:87.67%
controls:71.34%
2725
24977
1396
16116
2261
17215
1865
23914
1219
4496
2907
36633
2513
199
1613
40930
2252
4414
1869
36696
3359
17306
718
23441
3356
27273
472
10956
Social phobias
F40.1 [45595907]
1.4e+00
1.8e+00
2.4e+00
—
2.9e+00
2.6e+00
1.7e+00
cases:1.50%
controls:0.39%
cases:1.21%
controls:0.21%
cases:0.78%
controls:0.07%
—
—
cases:1.19%
controls:0.06%
cases:2.89%
controls:0.23%
cases:3.58%
controls:0.64%
62
161
4059
40932
50
85
4076
41044
32
28
4094
41101
—
49
26
4072
41084
118
94
3959
40653
137
246
3691
37983
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
1.4e+00
1.1e+00
2.0e+00
1.0e+50
3.2e+00
2.7e+00
2.3e+00
cases:1.26%
controls:0.30%
cases:0.53%
controls:0.18%
cases:0.24%
controls:0.03%
cases:0.15%
controls:0.00%
cases:0.44%
controls:0.02%
cases:1.91%
controls:0.13%
cases:3.21%
controls:0.32%
52
125
4069
40968
22
76
4104
41053
10
13
4116
41116
6
0
4120
41129
18
7
4103
41103
78
55
3999
40692
123
121
3705
38108
Dysthymia
F34.1 [45586238]
1.5e+00
2.1e+00
2.2e+00
—
2.6e+00
2.3e+00
2.1e+00
cases:1.24%
controls:0.28%
cases:1.21%
controls:0.15%
cases:0.39%
controls:0.04%
—
—
cases:0.66%
controls:0.05%
cases:1.91%
controls:0.19%
cases:3.24%
controls:0.43%
51
117
4070
40976
50
63
4076
41066
16
17
4110
41112
—
27
20
4094
41090
78
78
3999
40669
124
164
3704
38065
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
9.0e-01
1.8e+00
3.1e+00
—
3.3e+00
1.9e+00
1.6e+00
cases:2.40%
controls:0.99%
cases:1.79%
controls:0.29%
cases:0.44%
controls:0.02%
—
—
cases:0.41%
controls:0.01%
cases:1.77%
controls:0.27%
cases:5.12%
controls:1.04%
99
406
4022
40687
74
119
4052
41010
18
8
4108
41121
—
17
6
4104
41104
72
108
4005
40639
196
399
3632
37830
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.3e+00
1.8e+00
3.0e+00
1.0e+50
2.6e+00
2.3e+00
1.8e+00
cases:0.97%
controls:0.26%
cases:0.92%
controls:0.16%
cases:0.48%
controls:0.02%
cases:0.22%
controls:0.00%
cases:0.44%
controls:0.03%
cases:1.47%
controls:0.16%
cases:2.01%
controls:0.35%
40
108
4081
40985
38
65
4088
41064
20
10
4106
41119
9
0
4117
41129
18
13
4103
41097
60
64
4017
40683
77
132
3751
38097
Unspecified mood [affective] disorder
F39 [45591137]
1.4e+00
2.0e+00
2.4e+00
—
3.0e+00
2.5e+00
1.4e+00
cases:0.73%
controls:0.18%
cases:0.53%
controls:0.07%
cases:0.24%
controls:0.02%
—
—
cases:0.44%
controls:0.02%
cases:0.93%
controls:0.08%
cases:1.38%
controls:0.36%
30
73
4091
41020
22
29
4104
41100
10
9
4116
41120
—
18
9
4103
41101
38
31
4039
40716
53
136
3775
38093
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.8e+00
1.9e+00
1.8e+00
—
2.5e+00
2.2e+00
2.5e+00
cases:1.48%
controls:0.25%
cases:0.92%
controls:0.14%
cases:0.29%
controls:0.05%
—
—
cases:0.51%
controls:0.04%
cases:1.72%
controls:0.19%
cases:3.74%
controls:0.32%
61
104
4060
40989
38
59
4088
41070
12
19
4114
41110
—
21
17
4100
41093
70
76
4007
40671
143
123
3685
38106
General evaluation of the need for rehabilitation
R1100 [2001310172]
7.7e-01
1.3e+00
2.8e+00
1.0e+50
4.0e+00
3.1e+00
1.5e+00
cases:0.49%
controls:0.23%
cases:0.29%
controls:0.08%
cases:0.19%
controls:0.01%
cases:0.32%
controls:0.00%
cases:0.68%
controls:0.01%
cases:1.15%
controls:0.05%
cases:0.47%
controls:0.10%
20
93
4101
41000
12
34
4114
41095
8
5
4118
41124
13
0
4113
41129
28
5
4093
41105
47
21
4030
40726
18
39
3810
38190
Other childhood emotional disorders
F93.89 [2000502046]
1.3e+00
1.8e+00
2.1e+00
—
2.3e+00
2.8e+00
2.3e+00
cases:1.33%
controls:0.35%
cases:0.99%
controls:0.16%
cases:0.56%
controls:0.07%
—
—
cases:0.70%
controls:0.07%
cases:2.55%
controls:0.17%
cases:3.06%
controls:0.32%
55
145
4066
40948
41
67
4085
41062
23
28
4103
41101
—
29
29
4092
41081
104
68
3973
40679
117
122
3711
38107
Abnormal weight loss
R63.4 [45568144]
1.9e+00
4.2e+00
—
1.0e+50
—
4.3e+00
2.2e+00
cases:0.58%
controls:0.09%
cases:1.62%
controls:0.02%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.42%
controls:0.02%
cases:0.86%
controls:0.10%
24
37
4097
41056
67
10
4059
41119
—
14
0
4112
41129
—
58
8
4019
40739
33
38
3795
38191
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.3e-01
1.7e+00
2.6e+00
—
3.4e+00
2.3e+00
1.9e+00
cases:2.09%
controls:1.13%
cases:3.20%
controls:0.62%
cases:1.79%
controls:0.14%
—
—
cases:3.76%
controls:0.12%
cases:5.47%
controls:0.55%
cases:7.34%
controls:1.21%
86
463
4035
40630
132
254
3994
40875
74
56
4052
41073
—
155
51
3966
41059
223
226
3854
40521
281
464
3547
37765
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
1.4e+00
1.6e+00
1.9e+00
—
2.9e+00
2.6e+00
2.1e+00
cases:1.50%
controls:0.37%
cases:1.60%
controls:0.33%
cases:0.75%
controls:0.11%
—
—
cases:2.04%
controls:0.11%
cases:5.25%
controls:0.41%
cases:6.14%
controls:0.82%
62
153
4059
40940
66
136
4060
40993
31
45
4095
41084
—
84
47
4037
41063
214
166
3863
40581
235
312
3593
37917
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.9e+00
1.9e+00
1.7e+00
—
2.0e+00
2.3e+00
2.5e+00
cases:1.43%
controls:0.22%
cases:0.92%
controls:0.13%
cases:0.19%
controls:0.03%
—
—
cases:0.27%
controls:0.04%
cases:1.45%
controls:0.15%
cases:3.71%
controls:0.31%
59
91
4062
41002
38
55
4088
41074
8
14
4118
41115
—
11
15
4110
41095
59
62
4018
40685
142
118
3686
38111
lithium; oral
N05AN01 [21604556]
1.9e+00
1.9e+00
1.8e+00
—
1.9e+00
2.2e+00
2.5e+00
cases:1.36%
controls:0.20%
cases:1.07%
controls:0.16%
cases:0.27%
controls:0.04%
—
—
cases:0.39%
controls:0.06%
cases:1.62%
controls:0.18%
cases:2.95%
controls:0.25%
56
82
4065
41011
44
67
4082
41062
11
18
4115
41111
—
16
23
4105
41087
66
74
4011
40673
113
97
3715
38132
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
1.5e+00
1.9e+00
2.1e+00
—
2.5e+00
2.5e+00
1.7e+00
cases:1.07%
controls:0.24%
cases:0.80%
controls:0.12%
cases:0.34%
controls:0.04%
—
—
cases:0.46%
controls:0.04%
cases:1.50%
controls:0.12%
cases:2.12%
controls:0.38%
44
100
4077
40993
33
48
4093
41081
14
18
4112
41111
—
19
16
4102
41094
61
49
4016
40698
81
144
3747
38085
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.0e+00
2.0e+00
3.3e+00
—
2.5e+00
2.0e+00
1.3e+00
cases:6.65%
controls:2.48%
cases:7.13%
controls:1.07%
cases:5.09%
controls:0.20%
—
—
cases:2.96%
controls:0.25%
cases:6.82%
controls:0.95%
cases:8.93%
controls:2.57%
274
1020
3847
40073
294
441
3832
40688
210
84
3916
41045
—
122
103
3999
41007
278
389
3799
40358
342
983
3486
37246
Moderate depressive episode
F32.1 [45552478]
1.3e+00
2.2e+00
2.8e+00
1.0e+50
2.3e+00
1.9e+00
1.5e+00
cases:2.28%
controls:0.63%
cases:2.04%
controls:0.23%
cases:0.70%
controls:0.04%
cases:0.78%
controls:0.00%
cases:0.66%
controls:0.06%
cases:1.89%
controls:0.29%
cases:4.26%
controls:1.00%
94
258
4027
40835
84
96
4042
41033
29
18
4097
41111
32
0
4094
41129
27
26
4094
41084
77
119
4000
40628
163
382
3665
37847
Nutrition survey
SPAT1139 [2001700240]
1.5e+00
2.7e+00
2.9e+00
—
—
3.0e+00
2.0e+00
cases:0.83%
controls:0.19%
cases:0.73%
controls:0.05%
cases:0.22%
controls:0.01%
—
—
—
—
cases:0.96%
controls:0.05%
cases:1.52%
controls:0.21%
34
78
4087
41015
30
21
4096
41108
9
5
4117
41124
—
—
39
20
4038
40727
58
82
3770
38147
temazepam; oral
N05CD07 [21604642]
1.6e+00
2.0e+00
2.0e+00
—
2.2e+00
2.1e+00
1.9e+00
cases:4.25%
controls:0.86%
cases:3.20%
controls:0.43%
cases:0.70%
controls:0.09%
—
—
cases:0.78%
controls:0.09%
cases:3.51%
controls:0.42%
cases:7.37%
controls:1.20%
175
352
3946
40741
132
178
3994
40951
29
38
4097
41091
—
32
35
4089
41075
143
172
3934
40575
282
459
3546
37770
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
1.5e+00
1.9e+00
2.2e+00
—
2.5e+00
2.0e+00
1.8e+00
cases:0.87%
controls:0.20%
cases:0.61%
controls:0.09%
cases:0.27%
controls:0.03%
—
—
cases:0.36%
controls:0.03%
cases:1.01%
controls:0.13%
cases:3.21%
controls:0.53%
36
84
4085
41009
25
39
4101
41090
11
12
4115
41117
—
15
12
4106
41098
41
54
4036
40693
123
201
3705
38028
Physiotherapist
Z3226 [2001311560]
6.0e-01
1.3e+00
2.3e+00
—
3.1e+00
2.6e+00
1.9e+00
cases:3.45%
controls:1.92%
cases:2.13%
controls:0.59%
cases:0.97%
controls:0.10%
—
—
cases:2.57%
controls:0.12%
cases:6.55%
controls:0.50%
cases:8.59%
controls:1.44%
142
787
3979
40306
88
241
4038
40888
40
40
4086
41089
—
106
50
4015
41060
267
205
3810
40542
329
551
3499
37678
Inpatient Hospital
21 [8717]
1.3e-01
5.7e-01
1.4e+00
5.7e+00
2.2e+00
1.1e+00
5.7e-01
cases:30.91%
controls:28.15%
cases:15.46%
controls:9.38%
cases:4.36%
controls:1.10%
cases:14.35%
controls:0.05%
cases:9.92%
controls:1.18%
cases:23.62%
controls:9.10%
cases:39.26%
controls:26.83%
1274
11568
2847
29525
638
3858
3488
37271
180
451
3946
40678
592
22
3534
41107
409
484
3712
40626
963
3710
3114
37037
1503
10256
2325
27973
Post-traumatic stress disorder
F43.1 [45595909]
1.3e+00
1.9e+00
2.2e+00
—
2.5e+00
2.2e+00
1.7e+00
cases:1.36%
controls:0.37%
cases:1.62%
controls:0.24%
cases:0.73%
controls:0.08%
—
—
cases:1.14%
controls:0.10%
cases:2.35%
controls:0.27%
cases:3.81%
controls:0.73%
56
154
4065
40939
67
98
4059
41031
30
33
4096
41096
—
47
40
4074
41070
96
112
3981
40635
146
280
3682
37949
Poisoning by systemic antibiotics
T36 [45756588]
1.7e+00
1.9e+00
3.2e+00
1.0e+50
1.7e+00
2.7e+00
2.3e+00
cases:2.74%
controls:0.51%
cases:1.36%
controls:0.21%
cases:0.65%
controls:0.03%
cases:0.29%
controls:0.00%
cases:0.17%
controls:0.03%
cases:3.04%
controls:0.22%
cases:6.06%
controls:0.64%
113
209
4008
40884
56
88
4070
41041
27
11
4099
41118
12
0
4114
41129
7
13
4114
41097
124
90
3953
40657
232
243
3596
37986
risperidone; oral, parenteral
N05AX08 [21604559]
1.8e+00
1.7e+00
2.0e+00
—
1.7e+00
2.2e+00
2.2e+00
cases:3.15%
controls:0.53%
cases:1.53%
controls:0.28%
cases:0.75%
controls:0.10%
—
—
cases:0.51%
controls:0.09%
cases:2.67%
controls:0.29%
cases:5.62%
controls:0.65%
130
218
3991
40875
63
115
4063
41014
31
41
4095
41088
—
21
37
4100
41073
109
120
3968
40627
215
249
3613
37980
escitalopram; oral
N06AB10 [21604718]
1.3e+00
1.5e+00
1.5e+00
2.8e+00
1.9e+00
1.6e+00
1.1e+00
cases:9.61%
controls:2.85%
cases:7.61%
controls:1.81%
cases:2.42%
controls:0.53%
cases:0.39%
controls:0.02%
cases:2.69%
controls:0.42%
cases:9.35%
controls:2.01%
cases:14.24%
controls:5.13%
396
1173
3725
39920
314
743
3812
40386
100
216
4026
40913
16
10
4110
41119
111
174
4010
40936
381
819
3696
39928
545
1962
3283
36267
Internal Medicine
11 [38004456]
4.4e-01
6.3e-01
1.4e+00
5.5e+00
1.8e+00
1.1e+00
7.0e-01
cases:19.15%
controls:13.26%
cases:12.72%
controls:7.20%
cases:5.21%
controls:1.38%
cases:9.86%
controls:0.04%
cases:8.27%
controls:1.41%
cases:20.87%
controls:7.73%
cases:30.59%
controls:17.94%
789
5450
3332
35643
525
2962
3601
38167
215
568
3911
40561
407
18
3719
41111
341
578
3780
40532
851
3148
3226
37599
1171
6857
2657
31372
Unspecified nonorganic psychosis
F29 [45533099]
1.4e+00
1.5e+00
2.0e+00
—
2.1e+00
2.4e+00
2.2e+00
cases:1.92%
controls:0.46%
cases:1.26%
controls:0.27%
cases:0.65%
controls:0.09%
—
—
cases:0.68%
controls:0.09%
cases:2.33%
controls:0.22%
cases:4.65%
controls:0.52%
79
189
4042
40904
52
112
4074
41017
27
38
4099
41091
—
28
36
4093
41074
95
89
3982
40658
178
199
3650
38030
Weight loss
T08 [2002001071]
1.4e+00
4.4e+00
1.0e+50
—
1.0e+50
3.1e+00
2.6e+00
cases:0.58%
controls:0.14%
cases:1.60%
controls:0.02%
cases:1.21%
controls:0.00%
—
—
cases:0.41%
controls:0.00%
cases:0.54%
controls:0.02%
cases:0.91%
controls:0.07%
24
57
4097
41036
66
8
4060
41121
50
0
4076
41129
—
17
0
4104
41110
22
10
4055
40737
35
25
3793
38204
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
1.0e+00
1.4e+00
2.2e+00
1.0e+50
3.0e+00
2.5e+00
1.4e+00
cases:1.16%
controls:0.42%
cases:0.73%
controls:0.18%
cases:0.34%
controls:0.04%
cases:0.70%
controls:0.00%
cases:0.68%
controls:0.03%
cases:1.99%
controls:0.17%
cases:2.93%
controls:0.73%
48
171
4073
40922
30
72
4096
41057
14
15
4112
41114
29
0
4097
41129
28
14
4093
41096
81
68
3996
40679
112
280
3716
37949
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.4e+00
1.5e+00
1.8e+00
—
2.7e+00
2.3e+00
1.9e+00
cases:1.80%
controls:0.44%
cases:1.36%
controls:0.32%
cases:0.44%
controls:0.07%
—
—
cases:0.66%
controls:0.05%
cases:3.38%
controls:0.36%
cases:4.23%
controls:0.63%
74
181
4047
40912
56
131
4070
40998
18
29
4108
41100
—
27
19
4094
41091
138
145
3939
40602
162
240
3666
37989
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
1.3e+00
1.3e+00
2.4e+00
—
2.8e+00
2.0e+00
1.7e+00
cases:1.31%
controls:0.34%
cases:0.56%
controls:0.15%
cases:0.24%
controls:0.02%
—
—
cases:0.36%
controls:0.02%
cases:1.18%
controls:0.16%
cases:2.72%
controls:0.52%
54
141
4067
40952
23
61
4103
41068
10
9
4116
41120
—
15
9
4106
41101
48
65
4029
40682
104
198
3724
38031
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.7e+00
1.7e+00
1.6e+00
1.0e+50
1.8e+00
2.3e+00
2.4e+00
cases:2.72%
controls:0.53%
cases:2.28%
controls:0.40%
cases:0.75%
controls:0.15%
cases:0.15%
controls:0.00%
cases:0.80%
controls:0.14%
cases:3.85%
controls:0.41%
cases:7.78%
controls:0.74%
112
218
4009
40875
94
166
4032
40963
31
60
4095
41069
6
0
4120
41129
33
56
4088
41054
157
167
3920
40580
298
282
3530
37947
Remote contact by phone
ZYC01 [2001311579]
1.1e+00
1.6e+00
2.0e+00
—
2.8e+00
2.3e+00
1.8e+00
cases:0.92%
controls:0.31%
cases:0.82%
controls:0.17%
cases:0.27%
controls:0.04%
—
—
cases:0.51%
controls:0.03%
cases:1.69%
controls:0.18%
cases:2.82%
controls:0.49%
38
128
4083
40965
34
68
4092
41061
11
15
4115
41114
—
21
13
4100
41097
69
72
4008
40675
108
187
3720
38042
Office Visit
OMOP4822458 [581477]
2.0e-01
3.9e-01
1.3e+00
5.1e+00
2.5e+00
1.3e+00
7.5e-01
cases:12.86%
controls:10.81%
cases:6.01%
controls:4.16%
cases:1.96%
controls:0.54%
cases:3.03%
controls:0.02%
cases:6.45%
controls:0.57%
cases:12.83%
controls:3.79%
cases:18.52%
controls:9.69%
530
4443
3591
36650
248
1713
3878
39416
81
221
4045
40908
125
8
4001
41121
266
236
3855
40874
523
1545
3554
39202
709
3703
3119
34526
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
9.8e-01
1.3e+00
1.8e+00
1.0e+50
3.1e+00
2.3e+00
2.0e+00
cases:1.55%
controls:0.59%
cases:0.87%
controls:0.25%
cases:0.32%
controls:0.05%
cases:0.78%
controls:0.00%
cases:0.83%
controls:0.04%
cases:1.77%
controls:0.18%
cases:3.34%
controls:0.47%
64
241
4057
40852
36
102
4090
41027
13
21
4113
41108
32
0
4094
41129
34
15
4087
41095
72
72
4005
40675
128
178
3700
38051
bupropion; oral
N06AX12 [21604741]
1.6e+00
1.9e+00
2.0e+00
—
2.3e+00
2.0e+00
1.8e+00
cases:3.23%
controls:0.67%
cases:2.59%
controls:0.41%
cases:0.80%
controls:0.11%
—
—
cases:1.04%
controls:0.11%
cases:3.36%
controls:0.48%
cases:7.50%
controls:1.30%
133
274
3988
40819
107
169
4019
40960
33
46
4093
41083
—
43
45
4078
41065
137
194
3940
40553
287
497
3541
37732
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
1.1e+00
1.3e+00
1.8e+00
—
2.6e+00
2.5e+00
2.2e+00
cases:1.65%
controls:0.55%
cases:0.99%
controls:0.28%
cases:0.36%
controls:0.06%
—
—
cases:0.95%
controls:0.07%
cases:2.58%
controls:0.21%
cases:4.02%
controls:0.46%
68
228
4053
40865
41
116
4085
41013
15
25
4111
41104
—
39
29
4082
41081
105
85
3972
40662
154
177
3674
38052
Psychotherapy, not elsewhere classified
Z50.4 [45581040]
2.4e+00
3.0e+00
—
—
—
3.6e+00
2.5e+00
cases:0.32%
controls:0.03%
cases:0.39%
controls:0.02%
—
—
—
—
—
—
cases:0.71%
controls:0.02%
cases:0.57%
controls:0.05%
13
12
4108
41081
16
8
4110
41121
—
—
—
29
8
4048
40739
22
18
3806
38211
Sleep apnoea
G47.3 [45562094]
1.5e+00
1.8e+00
2.4e+00
—
2.2e+00
1.8e+00
1.7e+00
cases:2.96%
controls:0.65%
cases:2.74%
controls:0.48%
cases:0.97%
controls:0.09%
—
—
cases:0.97%
controls:0.11%
cases:3.24%
controls:0.55%
cases:5.64%
controls:1.11%
122
267
3999
40826
113
199
4013
40930
40
35
4086
41094
—
40
44
4081
41066
132
223
3945
40524
216
423
3612
37806
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.2e+00
1.6e+00
2.4e+00
1.0e+50
2.7e+00
2.2e+00
1.2e+00
cases:1.41%
controls:0.44%
cases:0.92%
controls:0.19%
cases:0.36%
controls:0.03%
cases:0.15%
controls:0.00%
cases:0.49%
controls:0.03%
cases:1.69%
controls:0.19%
cases:2.30%
controls:0.69%
58
179
4063
40914
38
79
4088
41050
15
13
4111
41116
6
0
4120
41129
20
13
4101
41097
69
77
4008
40670
88
265
3740
37964
Depressive episode
F32 [45595904]
1.5e+00
2.0e+00
2.1e+00
—
2.5e+00
1.8e+00
1.4e+00
cases:1.80%
controls:0.42%
cases:1.26%
controls:0.17%
cases:0.27%
controls:0.03%
—
—
cases:0.27%
controls:0.02%
cases:0.91%
controls:0.16%
cases:3.06%
controls:0.74%
74
174
4047
40919
52
69
4074
41060
11
13
4115
41116
—
11
9
4110
41101
37
64
4040
40683
117
281
3711
37948
moclobemide; oral
N06AG02 [21604727]
1.9e+00
2.5e+00
2.3e+00
—
1.0e+50
2.7e+00
2.0e+00
cases:0.80%
controls:0.12%
cases:0.53%
controls:0.05%
cases:0.19%
controls:0.02%
—
—
cases:0.29%
controls:0.00%
cases:0.78%
controls:0.05%
cases:1.20%
controls:0.17%
33
50
4088
41043
22
19
4104
41110
8
8
4118
41121
—
12
0
4109
41110
32
21
4045
40726
46
66
3782
38163
Electroconvulsive therapy
AA400 [2001300694]
1.8e+00
2.6e+00
—
1.0e+50
—
3.2e+00
3.6e+00
cases:0.36%
controls:0.06%
cases:0.29%
controls:0.02%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.37%
controls:0.01%
cases:1.38%
controls:0.04%
15
24
4106
41069
12
9
4114
41120
—
5
0
4121
41129
—
15
6
4062
40741
53
14
3775
38215
citalopram; oral, parenteral
N06AB04 [21604712]
1.2e+00
1.4e+00
1.5e+00
3.0e+00
1.7e+00
1.4e+00
1.1e+00
cases:7.16%
controls:2.31%
cases:5.19%
controls:1.34%
cases:1.53%
controls:0.35%
cases:0.44%
controls:0.02%
cases:1.84%
controls:0.34%
cases:5.13%
controls:1.35%
cases:9.09%
controls:3.13%
295
948
3826
40145
214
551
3912
40578
63
144
4063
40985
18
9
4108
41120
76
138
4045
40972
209
552
3868
40195
348
1196
3480
37033
Mental disorder, not otherwise specified
F99 [45605525]
9.8e-01
3.0e+00
3.9e+00
—
—
1.8e+00
1.6e+00
cases:0.58%
controls:0.22%
cases:0.92%
controls:0.05%
cases:0.58%
controls:0.01%
—
—
—
—
cases:0.52%
controls:0.08%
cases:1.38%
controls:0.27%
24
90
4097
41003
38
20
4088
41109
24
5
4102
41124
—
—
21
34
4056
40713
53
104
3775
38125
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
9.2e-01
1.1e+00
1.9e+00
—
2.7e+00
2.5e+00
2.2e+00
cases:2.26%
controls:0.91%
cases:1.33%
controls:0.44%
cases:0.73%
controls:0.11%
—
—
cases:1.65%
controls:0.11%
cases:3.53%
controls:0.31%
cases:5.36%
controls:0.65%
93
373
4028
40720
55
182
4071
40947
30
46
4096
41083
—
68
46
4053
41064
144
128
3933
40619
205
249
3623
37980
Emergency Room Visit
ER [9203]
4.5e-01
7.9e-01
1.5e+00
5.3e+00
1.4e+00
1.0e+00
7.7e-01
cases:38.29%
controls:28.28%
cases:20.55%
controls:10.51%
cases:5.60%
controls:1.31%
cases:9.16%
controls:0.05%
cases:4.97%
controls:1.29%
cases:25.02%
controls:10.55%
cases:50.26%
controls:31.82%
1578
11620
2543
29473
848
4322
3278
36807
231
539
3895
40590
378
21
3748
41108
205
529
3916
40581
1020
4297
3057
36450
1924
12165
1904
26064
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
1.2e+00
2.0e+00
3.1e+00
—
2.2e+00
1.6e+00
1.2e+00
cases:4.34%
controls:1.38%
cases:3.25%
controls:0.47%
cases:1.21%
controls:0.05%
—
—
cases:0.80%
controls:0.09%
cases:2.26%
controls:0.47%
cases:4.70%
controls:1.52%
179
566
3942
40527
134
192
3992
40937
50
22
4076
41107
—
33
37
4088
41073
92
192
3985
40555
180
580
3648
37649
Obesity due to excess calories
E66.01 [2000501501]
1.2e+00
1.9e+00
2.5e+00
—
2.1e+00
1.9e+00
1.6e+00
cases:2.55%
controls:0.75%
cases:2.45%
controls:0.37%
cases:0.87%
controls:0.07%
—
—
cases:0.85%
controls:0.10%
cases:2.70%
controls:0.42%
cases:5.49%
controls:1.18%
105
308
4016
40785
101
153
4025
40976
36
30
4090
41099
—
35
43
4086
41067
110
173
3967
40574
210
451
3618
37778
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.3e+00
1.8e+00
2.5e+00
—
2.4e+00
1.9e+00
1.3e+00
cases:4.68%
controls:1.28%
cases:4.05%
controls:0.71%
cases:2.11%
controls:0.18%
—
—
cases:1.89%
controls:0.17%
cases:5.18%
controls:0.84%
cases:8.86%
controls:2.61%
193
526
3928
40567
167
293
3959
40836
87
72
4039
41057
—
78
71
4043
41039
211
342
3866
40405
339
999
3489
37230
Mixed obsessional thoughts and acts
F42.2 [45542850]
1.1e+00
2.0e+00
1.7e+00
—
2.1e+00
2.3e+00
2.1e+00
cases:0.44%
controls:0.15%
cases:0.68%
controls:0.09%
cases:0.29%
controls:0.06%
—
—
cases:0.51%
controls:0.06%
cases:1.18%
controls:0.12%
cases:1.96%
controls:0.26%
18
60
4103
41033
28
39
4098
41090
12
23
4114
41106
—
21
26
4100
41084
48
50
4029
40697
75
98
3753
38131
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.3e-01
1.2e+00
1.7e+00
2.8e+00
2.2e+00
1.4e+00
1.2e+00
cases:4.90%
controls:2.93%
cases:5.11%
controls:1.53%
cases:1.65%
controls:0.30%
cases:0.27%
controls:0.02%
cases:2.57%
controls:0.30%
cases:6.16%
controls:1.55%
cases:13.30%
controls:4.21%
202
1205
3919
39888
211
628
3915
40501
68
125
4058
41004
11
7
4115
41122
106
122
4015
40988
251
632
3826
40115
509
1611
3319
36618
Recurrent depression, severe episode without somatic syndrome
F33.30 [2000501986]
1.7e+00
1.8e+00
2.1e+00
—
1.8e+00
2.9e+00
2.5e+00
cases:0.51%
controls:0.09%
cases:0.27%
controls:0.04%
cases:0.15%
controls:0.02%
—
—
cases:0.12%
controls:0.02%
cases:0.76%
controls:0.04%
cases:1.52%
controls:0.13%
21
37
4100
41056
11
18
4115
41111
6
7
4120
41122
—
5
8
4116
41102
31
17
4046
40730
58
49
3770
38180
Other specified anxiety disorders
F41.8 [45595908]
1.1e+00
1.7e+00
2.4e+00
—
2.5e+00
2.1e+00
1.2e+00
cases:0.97%
controls:0.33%
cases:0.85%
controls:0.15%
cases:0.39%
controls:0.03%
—
—
cases:0.41%
controls:0.03%
cases:1.30%
controls:0.16%
cases:2.01%
controls:0.61%
40
135
4081
40958
35
62
4091
41067
16
14
4110
41115
—
17
14
4104
41096
53
65
4024
40682
77
232
3751
37997
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.6e+00
1.6e+00
1.8e+00
—
1.5e+00
2.1e+00
2.4e+00
cases:1.80%
controls:0.36%
cases:1.02%
controls:0.20%
cases:0.36%
controls:0.06%
—
—
cases:0.36%
controls:0.08%
cases:1.77%
controls:0.23%
cases:4.62%
controls:0.45%
74
147
4047
40946
42
84
4084
41045
15
24
4111
41105
—
15
32
4106
41078
72
92
4005
40655
177
172
3651
38057
duloxetine; oral
N06AX21 [21604749]
1.5e+00
1.8e+00
1.9e+00
—
2.4e+00
1.9e+00
1.5e+00
cases:3.08%
controls:0.68%
cases:2.11%
controls:0.36%
cases:0.82%
controls:0.12%
—
—
cases:0.95%
controls:0.09%
cases:2.82%
controls:0.41%
cases:4.68%
controls:1.11%
127
279
3994
40814
87
148
4039
40981
34
51
4092
41078
—
39
35
4082
41075
115
168
3962
40579
179
424
3649
37805
Paranoid schizophrenia continuous
F20.00 [2000501920]
1.1e+00
1.6e+00
2.3e+00
—
2.2e+00
2.0e+00
1.9e+00
cases:0.32%
controls:0.11%
cases:0.36%
controls:0.08%
cases:0.24%
controls:0.02%
—
—
cases:0.24%
controls:0.03%
cases:0.49%
controls:0.07%
cases:0.97%
controls:0.15%
13
45
4108
41048
15
31
4111
41098
10
10
4116
41119
—
10
11
4111
41099
20
27
4057
40720
37
58
3791
38171
buspirone; oral
N05BE01 [21604601]
1.8e+00
1.9e+00
—
—
2.5e+00
2.4e+00
2.3e+00
cases:0.83%
controls:0.13%
cases:0.44%
controls:0.07%
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.76%
controls:0.07%
cases:1.70%
controls:0.18%
34
55
4087
41038
18
27
4108
41102
—
—
7
6
4114
41104
31
27
4046
40720
65
68
3763
38161
disulfiram; oral
N07BB01 [21604821]
2.0e+00
1.9e+00
—
—
2.3e+00
2.7e+00
2.0e+00
cases:1.07%
controls:0.14%
cases:0.44%
controls:0.06%
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.91%
controls:0.06%
cases:1.65%
controls:0.23%
44
59
4077
41034
18
26
4108
41103
—
—
6
6
4115
41104
37
26
4040
40721
63
88
3765
38141
Obesity
T82 [2002001125]
2.1e+00
2.4e+00
2.7e+00
—
—
1.6e+00
2.0e+00
cases:1.53%
controls:0.19%
cases:0.85%
controls:0.08%
cases:0.22%
controls:0.01%
—
—
—
—
cases:0.44%
controls:0.09%
cases:2.35%
controls:0.34%
63
79
4058
41014
35
31
4091
41098
9
6
4117
41123
—
—
18
35
4059
40712
90
129
3738
38100
Monitoring the use of the aid
R5140 [2001310249]
1.2e+00
1.3e+00
2.6e+00
—
2.3e+00
2.0e+00
1.5e+00
cases:0.80%
controls:0.24%
cases:0.46%
controls:0.13%
cases:0.22%
controls:0.02%
—
—
cases:0.15%
controls:0.01%
cases:0.76%
controls:0.11%
cases:1.72%
controls:0.38%
33
100
4088
40993
19
53
4107
41076
9
7
4117
41122
—
6
6
4115
41104
31
44
4046
40703
66
145
3762
38084
sertraline; oral
N06AB06 [21604714]
1.4e+00
1.8e+00
1.9e+00
—
2.0e+00
2.0e+00
1.7e+00
cases:5.82%
controls:1.45%
cases:5.02%
controls:0.90%
cases:1.67%
controls:0.26%
—
—
cases:1.80%
controls:0.25%
cases:7.28%
controls:1.01%
cases:11.78%
controls:2.45%
240
594
3881
40499
207
369
3919
40760
69
106
4057
41023
—
74
102
4047
41008
297
411
3780
40336
451
936
3377
37293
Psychological disorders other
P99 [2002000880]
1.3e+00
1.9e+00
2.0e+00
—
2.3e+00
1.7e+00
1.7e+00
cases:0.90%
controls:0.25%
cases:0.73%
controls:0.11%
cases:0.24%
controls:0.03%
—
—
cases:0.29%
controls:0.03%
cases:0.81%
controls:0.15%
cases:2.43%
controls:0.47%
37
101
4084
40992
30
47
4096
41082
10
14
4116
41115
—
12
12
4109
41098
33
61
4044
40686
93
179
3735
38050
Other function in accordance with nutritional therapy nomenclature
SPAT1298 [2001700399]
1.6e+00
3.5e+00
—
—
—
3.6e+00
2.0e+00
cases:0.36%
controls:0.07%
cases:0.46%
controls:0.01%
—
—
—
—
—
—
cases:0.54%
controls:0.01%
cases:0.68%
controls:0.09%
15
29
4106
41064
19
6
4107
41123
—
—
—
22
6
4055
40741
26
35
3802
38194
Anxious [avoidant] personality disorder
F60.6 [45557213]
2.4e+00
2.3e+00
—
1.0e+50
—
3.1e+00
2.8e+00
cases:0.36%
controls:0.03%
cases:0.24%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.42%
controls:0.02%
cases:0.91%
controls:0.05%
15
13
4106
41080
10
10
4116
41119
—
10
0
4116
41129
—
17
8
4060
40739
35
21
3793
38208
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
2.0e+00
2.2e+00
—
—
—
3.1e+00
3.2e+00
cases:0.61%
controls:0.08%
cases:0.32%
controls:0.03%
—
—
—
—
—
—
cases:0.61%
controls:0.03%
cases:1.41%
controls:0.06%
25
33
4096
41060
13
14
4113
41115
—
—
—
25
11
4052
40736
54
22
3774
38207
Other depressive episodes
F32.8 [45571759]
1.6e+00
1.9e+00
2.9e+00
—
—
2.5e+00
1.8e+00
cases:0.61%
controls:0.13%
cases:0.39%
controls:0.06%
cases:0.22%
controls:0.01%
—
—
—
—
cases:0.74%
controls:0.06%
cases:1.33%
controls:0.23%
25
53
4096
41040
16
25
4110
41104
9
5
4117
41124
—
—
30
24
4047
40723
51
89
3777
38140
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
9.0e-01
1.6e+00
2.7e+00
—
2.4e+00
1.4e+00
1.6e+00
cases:1.29%
controls:0.53%
cases:1.19%
controls:0.25%
cases:0.36%
controls:0.02%
—
—
cases:0.29%
controls:0.03%
cases:1.03%
controls:0.26%
cases:3.84%
controls:0.78%
53
216
4068
40877
49
104
4077
41025
15
10
4111
41119
—
12
11
4109
41099
42
104
4035
40643
147
299
3681
37930
Severe psychotic and other severe mental disorders
112 [2001600112]
2.0e+00
2.6e+00
—
—
—
3.4e+00
2.6e+00
cases:3.18%
controls:0.46%
cases:1.53%
controls:0.12%
—
—
—
—
—
—
cases:2.85%
controls:0.10%
cases:5.49%
controls:0.42%
131
189
3990
40904
63
48
4063
41081
—
—
—
116
40
3961
40707
210
159
3618
38070
Other psychiatric treatment contact
IGY99 [2001304323]
1.3e+00
1.4e+00
1.2e+00
—
2.9e+00
2.7e+00
2.2e+00
cases:1.19%
controls:0.31%
cases:0.78%
controls:0.19%
cases:0.19%
controls:0.06%
—
—
cases:0.75%
controls:0.04%
cases:3.46%
controls:0.23%
cases:3.79%
controls:0.43%
49
128
4072
40965
32
78
4094
41051
8
24
4118
41105
—
31
18
4090
41092
141
94
3936
40653
145
165
3683
38064
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
1.7e+00
1.4e+00
1.7e+00
—
3.0e+00
2.3e+00
2.1e+00
cases:0.92%
controls:0.16%
cases:0.58%
controls:0.14%
cases:0.12%
controls:0.02%
—
—
cases:0.24%
controls:0.01%
cases:1.20%
controls:0.12%
cases:2.09%
controls:0.27%
38
67
4083
41026
24
57
4102
41072
5
9
4121
41120
—
10
5
4111
41105
49
50
4028
40697
80
102
3748
38127
mianserin; oral
N06AX03 [21604732]
1.9e+00
2.1e+00
—
—
2.1e+00
2.1e+00
2.3e+00
cases:1.16%
controls:0.18%
cases:0.68%
controls:0.09%
—
—
—
—
cases:0.15%
controls:0.02%
cases:0.69%
controls:0.08%
cases:1.75%
controls:0.19%
48
75
4073
41018
28
35
4098
41094
—
—
6
7
4115
41103
28
33
4049
40714
67
71
3761
38158
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
9.7e-01
1.5e+00
2.1e+00
1.0e+50
3.3e+00
1.9e+00
7.6e-01
cases:1.04%
controls:0.40%
cases:0.82%
controls:0.19%
cases:0.36%
controls:0.04%
cases:0.56%
controls:0.00%
cases:0.63%
controls:0.02%
cases:1.15%
controls:0.18%
cases:1.62%
controls:0.76%
43
163
4078
40930
34
77
4092
41052
15
18
4111
41111
23
0
4103
41129
26
10
4095
41100
47
74
4030
40673
62
291
3766
37938
Psychiatric monitoring contact
IGY02 [2001304322]
1.3e+00
1.5e+00
1.9e+00
—
2.0e+00
2.1e+00
1.8e+00
cases:0.99%
controls:0.27%
cases:0.99%
controls:0.23%
cases:0.36%
controls:0.06%
—
—
cases:0.39%
controls:0.05%
cases:2.11%
controls:0.27%
cases:3.63%
controls:0.64%
41
113
4080
40980
41
95
4085
41034
15
23
4111
41106
—
16
22
4105
41088
86
110
3991
40637
139
245
3689
37984
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
1.3e+00
1.2e+00
1.8e+00
1.0e+50
2.7e+00
2.7e+00
2.6e+00
cases:0.92%
controls:0.27%
cases:0.36%
controls:0.11%
cases:0.15%
controls:0.02%
cases:0.34%
controls:0.00%
cases:0.22%
controls:0.01%
cases:1.30%
controls:0.09%
cases:1.91%
controls:0.15%
38
109
4083
40984
15
46
4111
41083
6
10
4120
41119
14
0
4112
41129
9
6
4112
41104
53
36
4024
40711
73
57
3755
38172
clonazepam; oral, parenteral
N03AE01 [21604415]
1.4e+00
1.6e+00
2.1e+00
—
1.9e+00
1.9e+00
1.5e+00
cases:1.46%
controls:0.35%
cases:1.19%
controls:0.24%
cases:0.58%
controls:0.07%
—
—
cases:0.41%
controls:0.06%
cases:1.47%
controls:0.22%
cases:2.04%
controls:0.48%
60
144
4061
40949
49
97
4077
41032
24
30
4102
41099
—
17
26
4104
41084
60
88
4017
40659
78
185
3750
38044
lamotrigine; oral
N03AX09 [21604431]
1.4e+00
1.5e+00
1.5e+00
—
1.8e+00
1.9e+00
2.1e+00
cases:3.25%
controls:0.79%
cases:2.28%
controls:0.50%
cases:0.70%
controls:0.15%
—
—
cases:0.90%
controls:0.15%
cases:3.41%
controls:0.51%
cases:7.13%
controls:0.93%
134
326
3987
40767
94
204
4032
40925
29
62
4097
41067
—
37
60
4084
41050
139
208
3938
40539
273
355
3555
37874
olanzapine; oral, parenteral
N05AH03 [21604543]
1.5e+00
1.4e+00
1.2e+00
—
1.7e+00
2.2e+00
2.3e+00
cases:2.69%
controls:0.64%
cases:1.91%
controls:0.49%
cases:0.56%
controls:0.17%
—
—
cases:0.80%
controls:0.14%
cases:4.15%
controls:0.48%
cases:7.68%
controls:0.82%
111
262
4010
40831
79
202
4047
40927
23
68
4103
41061
—
33
59
4088
41051
169
196
3908
40551
294
315
3534
37914
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
1.7e+00
1.5e+00
2.6e+00
1.0e+50
—
2.3e+00
2.1e+00
cases:0.99%
controls:0.18%
cases:0.65%
controls:0.14%
cases:0.19%
controls:0.01%
cases:0.19%
controls:0.00%
—
—
cases:1.67%
controls:0.16%
cases:2.77%
controls:0.35%
41
73
4080
41020
27
59
4099
41070
8
6
4118
41123
8
0
4118
41129
—
68
67
4009
40680
106
133
3722
38096
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
3.8e-01
9.5e-01
1.7e+00
3.7e+00
1.8e+00
1.0e+00
6.9e-01
cases:16.11%
controls:11.58%
cases:17.06%
controls:7.36%
cases:6.45%
controls:1.27%
cases:1.94%
controls:0.05%
cases:7.30%
controls:1.24%
cases:18.62%
controls:7.61%
cases:34.69%
controls:21.03%
664
4760
3457
36333
704
3029
3422
38100
266
522
3860
40607
80
20
4046
41109
301
508
3820
40602
759
3099
3318
37648
1328
8038
2500
30191
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
3.9e-01
9.5e-01
1.7e+00
3.7e+00
1.8e+00
1.0e+00
7.0e-01
cases:16.19%
controls:11.59%
cases:17.16%
controls:7.40%
cases:6.45%
controls:1.29%
cases:1.91%
controls:0.05%
cases:7.38%
controls:1.25%
cases:18.84%
controls:7.63%
cases:34.87%
controls:21.07%
667
4761
3454
36332
708
3042
3418
38087
266
529
3860
40600
79
20
4047
41109
304
514
3817
40596
768
3108
3309
37639
1335
8056
2493
30173
Psychiatric family contact
IGP01 [2001304317]
1.1e+00
1.1e+00
2.2e+00
—
2.5e+00
1.8e+00
1.6e+00
cases:0.63%
controls:0.21%
cases:0.39%
controls:0.13%
cases:0.19%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.83%
controls:0.14%
cases:0.99%
controls:0.20%
26
88
4095
41005
16
55
4110
41074
8
9
4118
41120
—
11
9
4110
41101
34
56
4043
40691
38
78
3790
38151
UNS Panic Syndrome
F41.09 [2000501997]
1.3e+00
1.8e+00
2.1e+00
1.0e+50
2.2e+00
1.8e+00
9.8e-01
cases:1.31%
controls:0.38%
cases:0.85%
controls:0.14%
cases:0.29%
controls:0.03%
cases:0.51%
controls:0.00%
cases:0.41%
controls:0.04%
cases:1.03%
controls:0.18%
cases:1.59%
controls:0.61%
54
155
4067
40938
35
57
4091
41072
12
14
4114
41115
21
0
4105
41129
17
18
4104
41092
42
72
4035
40675
61
232
3767
37997
Other healthcare associate professional
Z3229 [2001311561]
6.1e-02
1.0e+00
2.9e+00
1.0e+50
2.8e+00
1.9e+00
1.6e+00
cases:0.87%
controls:0.82%
cases:0.58%
controls:0.21%
cases:0.34%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.51%
controls:0.03%
cases:1.45%
controls:0.22%
cases:3.34%
controls:0.69%
36
338
4085
40755
24
86
4102
41043
14
8
4112
41121
10
0
4116
41129
21
13
4100
41097
59
88
4018
40659
128
263
3700
37966
Hypokalaemia
E87.6 [45537991]
1.6e+00
2.7e+00
1.0e+50
—
—
3.1e+00
2.8e+00
cases:0.36%
controls:0.07%
cases:0.36%
controls:0.02%
cases:0.22%
controls:0.00%
—
—
—
—
cases:0.37%
controls:0.02%
cases:1.12%
controls:0.07%
15
29
4106
41064
15
10
4111
41119
9
0
4117
41129
—
—
15
7
4062
40740
43
27
3785
38202
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
7.6e-01
1.1e+00
1.8e+00
1.0e+50
3.0e+00
1.9e+00
1.6e+00
cases:1.84%
controls:0.87%
cases:1.50%
controls:0.49%
cases:0.56%
controls:0.10%
cases:0.34%
controls:0.00%
cases:1.80%
controls:0.09%
cases:2.92%
controls:0.43%
cases:6.24%
controls:1.32%
76
357
4045
40736
62
202
4064
40927
23
40
4103
41089
14
0
4112
41129
74
37
4047
41073
119
176
3958
40571
239
504
3589
37725
Anxiety disorder/anxiety state
P74 [2002000868]
1.2e+00
2.0e+00
2.8e+00
—
2.0e+00
1.3e+00
8.9e-01
cases:1.70%
controls:0.54%
cases:1.58%
controls:0.21%
cases:0.44%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:1.03%
controls:0.27%
cases:2.72%
controls:1.14%
70
222
4051
40871
65
87
4061
41042
18
11
4108
41118
—
8
11
4113
41099
42
111
4035
40636
104
434
3724
37795
Anankastic personality disorder
F60.5 [45591150]
1.9e+00
2.5e+00
—
—
—
3.3e+00
2.4e+00
cases:0.44%
controls:0.07%
cases:0.44%
controls:0.04%
—
—
—
—
—
—
cases:1.03%
controls:0.04%
cases:1.20%
controls:0.11%
18
27
4103
41066
18
15
4108
41114
—
—
—
42
15
4035
40732
46
42
3782
38187
Bipolar affective disorder
F31 [45595902]
2.2e+00
2.5e+00
2.1e+00
—
—
2.7e+00
2.6e+00
cases:0.97%
controls:0.11%
cases:0.46%
controls:0.04%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.52%
controls:0.03%
cases:1.70%
controls:0.12%
40
45
4081
41048
19
15
4107
41114
5
6
4121
41123
—
—
21
14
4056
40733
65
47
3763
38182
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
8.2e-01
1.6e+00
2.4e+00
—
2.4e+00
1.5e+00
1.3e+00
cases:2.60%
controls:1.16%
cases:2.40%
controls:0.52%
cases:0.56%
controls:0.05%
—
—
cases:0.63%
controls:0.06%
cases:2.48%
controls:0.54%
cases:7.81%
controls:2.28%
107
478
4014
40615
99
212
4027
40917
23
21
4103
41108
—
26
23
4095
41087
101
220
3976
40527
299
870
3529
37359
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
5.0e-01
1.1e+00
2.0e+00
2.8e+00
1.9e+00
9.1e-01
7.2e-01
cases:13.69%
controls:8.77%
cases:12.34%
controls:4.31%
cases:3.49%
controls:0.48%
cases:0.29%
controls:0.02%
cases:3.45%
controls:0.53%
cases:10.89%
controls:4.71%
cases:28.13%
controls:16.00%
564
3603
3557
37490
509
1771
3617
39358
144
197
3982
40932
12
7
4114
41122
142
217
3979
40893
444
1918
3633
38829
1077
6118
2751
32111
Depressive disorder
P76 [2002000870]
1.2e+00
1.9e+00
2.2e+00
—
1.9e+00
1.5e+00
1.3e+00
cases:2.40%
controls:0.76%
cases:2.38%
controls:0.35%
cases:0.63%
controls:0.07%
—
—
cases:0.39%
controls:0.06%
cases:1.62%
controls:0.36%
cases:5.25%
controls:1.53%
99
313
4022
40780
98
143
4028
40986
26
28
4100
41101
—
16
25
4105
41085
66
146
4011
40601
201
586
3627
37643
paroxetine; oral
N06AB05 [21604713]
1.6e+00
1.7e+00
2.0e+00
—
1.5e+00
1.8e+00
1.5e+00
cases:2.50%
controls:0.51%
cases:1.50%
controls:0.28%
cases:0.44%
controls:0.06%
—
—
cases:0.41%
controls:0.09%
cases:1.94%
controls:0.34%
cases:3.08%
controls:0.74%
103
211
4018
40882
62
116
4064
41013
18
25
4108
41104
—
17
38
4104
41072
79
138
3998
40609
118
283
3710
37946
Pulmonary Disease
29 [38004472]
8.4e-01
9.6e-01
1.4e+00
3.0e+00
1.6e+00
1.1e+00
1.1e+00
cases:5.51%
controls:2.46%
cases:3.64%
controls:1.43%
cases:0.92%
controls:0.24%
cases:0.24%
controls:0.01%
cases:1.24%
controls:0.25%
cases:4.27%
controls:1.41%
cases:9.25%
controls:3.39%
227
1011
3894
40082
150
588
3976
40541
38
98
4088
41031
10
5
4116
41124
51
103
4070
41007
174
575
3903
40172
354
1295
3474
36934
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.4e+00
1.3e+00
—
—
2.8e+00
2.3e+00
2.2e+00
cases:0.63%
controls:0.15%
cases:0.36%
controls:0.10%
—
—
—
—
cases:0.19%
controls:0.01%
cases:1.03%
controls:0.11%
cases:2.14%
controls:0.25%
26
62
4095
41031
15
41
4111
41088
—
—
8
5
4113
41105
42
43
4035
40704
82
97
3746
38132
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.4e-01
9.3e-01
1.7e+00
3.4e+00
1.6e+00
9.7e-01
8.8e-01
cases:10.02%
controls:6.71%
cases:9.48%
controls:3.96%
cases:3.78%
controls:0.72%
cases:0.90%
controls:0.03%
cases:3.52%
controls:0.73%
cases:10.28%
controls:4.14%
cases:23.48%
controls:11.30%
413
2759
3708
38334
391
1629
3735
39500
156
298
3970
40831
37
12
4089
41117
145
301
3976
40809
419
1688
3658
39059
899
4320
2929
33909
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
5.8e-01
8.6e-01
1.5e+00
3.1e+00
1.8e+00
1.1e+00
9.6e-01
cases:4.95%
controls:2.84%
cases:3.44%
controls:1.48%
cases:0.90%
controls:0.21%
cases:0.27%
controls:0.01%
cases:1.38%
controls:0.23%
cases:4.56%
controls:1.50%
cases:12.15%
controls:5.03%
204
1169
3917
39924
142
610
3984
40519
37
86
4089
41043
11
5
4115
41124
57
94
4064
41016
186
613
3891
40134
465
1922
3363
36307
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
1.1e+00
1.4e+00
2.5e+00
—
2.2e+00
1.5e+00
1.2e+00
cases:2.16%
controls:0.76%
cases:1.89%
controls:0.48%
cases:0.70%
controls:0.06%
—
—
cases:0.75%
controls:0.09%
cases:2.55%
controls:0.59%
cases:7.11%
controls:2.24%
89
313
4032
40780
78
197
4048
40932
29
23
4097
41106
—
31
36
4090
41074
104
239
3973
40508
272
855
3556
37374
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.4e+00
1.7e+00
2.0e+00
—
1.9e+00
1.5e+00
1.4e+00
cases:0.99%
controls:0.24%
cases:0.63%
controls:0.12%
cases:0.29%
controls:0.04%
—
—
cases:0.32%
controls:0.05%
cases:0.69%
controls:0.15%
cases:1.49%
controls:0.38%
41
98
4080
40995
26
49
4100
41080
12
17
4114
41112
—
13
20
4108
41090
28
63
4049
40684
57
144
3771
38085
Gastroenterology
10 [38004455]
7.1e-01
1.1e+00
1.4e+00
3.2e+00
1.2e+00
1.2e+00
1.1e+00
cases:3.91%
controls:1.96%
cases:2.67%
controls:0.95%
cases:0.75%
controls:0.19%
cases:0.29%
controls:0.01%
cases:0.75%
controls:0.23%
cases:3.24%
controls:0.99%
cases:7.94%
controls:2.89%
161
807
3960
40286
110
390
4016
40739
31
80
4095
41049
12
5
4114
41124
31
93
4090
41017
132
403
3945
40344
304
1105
3524
37124
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
6.9e-01
1.9e+00
2.1e+00
—
2.2e+00
1.6e+00
1.4e+00
cases:1.67%
controls:0.85%
cases:1.87%
controls:0.29%
cases:0.36%
controls:0.05%
—
—
cases:0.53%
controls:0.06%
cases:1.40%
controls:0.30%
cases:4.99%
controls:1.28%
69
349
4052
40744
77
120
4049
41009
15
19
4111
41110
—
22
25
4099
41085
57
122
4020
40625
191
490
3637
37739
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.1e+00
1.5e+00
2.2e+00
—
1.7e+00
1.6e+00
1.5e+00
cases:4.27%
controls:1.39%
cases:2.57%
controls:0.58%
cases:0.99%
controls:0.11%
—
—
cases:0.61%
controls:0.11%
cases:3.19%
controls:0.66%
cases:6.87%
controls:1.55%
176
573
3945
40520
106
237
4020
40892
41
44
4085
41085
—
25
46
4096
41064
130
267
3947
40480
263
594
3565
37635
Other mixed anxiety disorders
F41.3 [45605492]
1.1e+00
1.2e+00
1.9e+00
1.0e+50
2.2e+00
1.9e+00
1.4e+00
cases:0.41%
controls:0.13%
cases:0.44%
controls:0.13%
cases:0.19%
controls:0.03%
cases:0.36%
controls:0.00%
cases:0.32%
controls:0.03%
cases:0.74%
controls:0.11%
cases:1.31%
controls:0.34%
17
55
4104
41038
18
53
4108
41076
8
12
4118
41117
15
0
4111
41129
13
14
4108
41096
30
45
4047
40702
50
129
3778
38100
Accelerated psychiatric treatment contact
IGY01 [2001304321]
1.4e+00
1.8e+00
2.5e+00
—
1.5e+00
2.0e+00
2.0e+00
cases:1.14%
controls:0.27%
cases:1.04%
controls:0.18%
cases:0.34%
controls:0.03%
—
—
cases:0.17%
controls:0.04%
cases:1.79%
controls:0.24%
cases:3.27%
controls:0.47%
47
112
4074
40981
43
75
4083
41054
14
11
4112
41118
—
7
15
4114
41095
73
98
4004
40649
125
180
3703
38049
clozapine; oral, parenteral
N05AH02 [21604542]
1.5e+00
1.5e+00
1.3e+00
—
1.3e+00
1.8e+00
2.3e+00
cases:0.99%
controls:0.22%
cases:0.90%
controls:0.21%
cases:0.73%
controls:0.19%
—
—
cases:0.61%
controls:0.16%
cases:1.37%
controls:0.24%
cases:2.61%
controls:0.27%
41
89
4080
41004
37
87
4089
41042
30
80
4096
41049
—
25
65
4096
41045
56
96
4021
40651
100
105
3728
38124
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
1.9e+00
2.2e+00
—
1.0e+50
—
3.2e+00
2.4e+00
cases:0.95%
controls:0.14%
cases:0.61%
controls:0.07%
—
—
cases:0.51%
controls:0.00%
—
—
cases:1.15%
controls:0.05%
cases:2.32%
controls:0.22%
39
58
4082
41035
25
28
4101
41101
—
21
0
4105
41129
—
47
19
4030
40728
89
84
3739
38145
mirtazapine; oral
N06AX11 [21604740]
1.1e+00
1.6e+00
1.9e+00
1.0e+50
2.0e+00
1.8e+00
1.2e+00
cases:7.74%
controls:2.60%
cases:5.74%
controls:1.25%
cases:1.50%
controls:0.23%
cases:0.51%
controls:0.00%
cases:1.87%
controls:0.25%
cases:8.05%
controls:1.40%
cases:13.82%
controls:4.50%
319
1067
3802
40026
237
514
3889
40615
62
95
4064
41034
21
0
4105
41129
77
102
4044
41008
328
570
3749
40177
529
1722
3299
36507
Electroconvulsive Therapy (ECT)
IFB01 [2001304301]
1.9e+00
2.4e+00
—
—
—
2.9e+00
2.4e+00
cases:0.22%
controls:0.03%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.44%
controls:0.02%
cases:0.78%
controls:0.07%
9
13
4112
41080
8
7
4118
41122
—
—
—
18
10
4059
40737
30
27
3798
38202
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
8.7e-01
1.1e+00
2.6e+00
—
2.7e+00
1.5e+00
9.7e-01
cases:2.50%
controls:1.06%
cases:1.33%
controls:0.47%
cases:0.53%
controls:0.04%
—
—
cases:0.61%
controls:0.04%
cases:2.11%
controls:0.48%
cases:5.28%
controls:2.06%
103
436
4018
40657
55
192
4071
40937
22
17
4104
41112
—
25
17
4096
41093
86
194
3991
40553
202
787
3626
37442
Obesity, unspecified
E66.9 [45576460]
1.5e+00
1.9e+00
2.3e+00
1.0e+50
1.5e+00
2.5e+00
1.4e+00
cases:1.14%
controls:0.25%
cases:0.80%
controls:0.12%
cases:0.24%
controls:0.02%
cases:0.39%
controls:0.00%
cases:0.15%
controls:0.03%
cases:1.01%
controls:0.08%
cases:1.41%
controls:0.37%
47
103
4074
40990
33
48
4093
41081
10
10
4116
41119
16
0
4110
41129
6
14
4115
41096
41
33
4036
40714
54
141
3774
38088
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
6.6e-01
1.3e+00
2.5e+00
—
2.9e+00
1.3e+00
1.0e+00
cases:0.80%
controls:0.41%
cases:0.61%
controls:0.17%
cases:0.32%
controls:0.03%
—
—
cases:0.39%
controls:0.02%
cases:0.71%
controls:0.19%
cases:1.72%
controls:0.63%
33
170
4088
40923
25
70
4101
41059
13
11
4113
41118
—
16
9
4105
41101
29
78
4048
40669
66
239
3762
37990
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.7e-01
9.8e-01
1.7e+00
3.1e+00
1.7e+00
8.8e-01
6.6e-01
cases:15.12%
controls:10.02%
cases:14.11%
controls:5.83%
cases:4.51%
controls:0.82%
cases:0.56%
controls:0.02%
cases:4.76%
controls:0.86%
cases:13.66%
controls:6.16%
cases:30.88%
controls:18.70%
623
4119
3498
36974
582
2396
3544
38733
186
336
3940
40793
23
10
4103
41119
196
355
3925
40755
557
2510
3520
38237
1182
7148
2646
31081
Other specific personality disorders
F60.8 [45600756]
1.9e+00
2.5e+00
—
1.0e+50
—
2.9e+00
2.3e+00
cases:0.36%
controls:0.06%
cases:0.24%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.54%
controls:0.03%
cases:0.91%
controls:0.09%
15
23
4106
41070
10
8
4116
41121
—
10
0
4116
41129
—
22
12
4055
40735
35
36
3793
38193
flupentixol; oral, parenteral
N05AF01 [21604531]
1.8e+00
2.9e+00
—
—
—
2.3e+00
2.6e+00
cases:0.44%
controls:0.07%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.78%
controls:0.06%
18
30
4103
41063
14
8
4112
41121
—
—
—
12
12
4065
40735
30
22
3798
38207
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
8.7e-01
1.1e+00
2.8e+00
—
2.4e+00
1.3e+00
1.1e+00
cases:1.53%
controls:0.64%
cases:1.19%
controls:0.38%
cases:0.39%
controls:0.02%
—
—
cases:0.34%
controls:0.03%
cases:1.37%
controls:0.39%
cases:4.36%
controls:1.46%
63
265
4058
40828
49
158
4077
40971
16
10
4110
41119
—
14
13
4107
41097
56
157
4021
40590
167
558
3661
37671
Recurrent depressive disorder, current episode moderate
F33.1 [45576543]
1.4e+00
2.2e+00
2.4e+00
—
1.6e+00
2.0e+00
1.6e+00
cases:0.92%
controls:0.23%
cases:0.99%
controls:0.11%
cases:0.32%
controls:0.03%
—
—
cases:0.15%
controls:0.03%
cases:1.01%
controls:0.14%
cases:2.32%
controls:0.46%
38
95
4083
40998
41
47
4085
41082
13
12
4113
41117
—
6
12
4115
41098
41
57
4036
40690
89
177
3739
38052
ziprasidone; oral, parenteral
N05AE04 [21604529]
2.2e+00
2.0e+00
—
—
—
2.0e+00
3.4e+00
cases:0.41%
controls:0.05%
cases:0.29%
controls:0.04%
—
—
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.89%
controls:0.03%
17
19
4104
41074
12
17
4114
41112
—
—
—
10
13
4067
40734
34
12
3794
38217
2-person team, doctor-nurse
ZXY51 [2001311525]
1.1e+00
1.6e+00
—
1.0e+50
1.9e+00
2.6e+00
2.3e+00
cases:0.58%
controls:0.19%
cases:0.32%
controls:0.07%
—
—
cases:0.46%
controls:0.00%
cases:0.17%
controls:0.02%
cases:1.01%
controls:0.08%
cases:1.31%
controls:0.14%
24
78
4097
41015
13
27
4113
41102
—
19
0
4107
41129
7
10
4114
41100
41
31
4036
40716
50
52
3778
38177
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.6e-01
1.2e+00
2.4e+00
—
2.7e+00
1.4e+00
1.0e+00
cases:4.00%
controls:2.10%
cases:3.13%
controls:0.93%
cases:1.19%
controls:0.11%
—
—
cases:1.77%
controls:0.12%
cases:3.75%
controls:0.92%
cases:9.90%
controls:3.79%
165
863
3956
40230
129
384
3997
40745
49
45
4077
41084
—
73
49
4048
41061
153
376
3924
40371
379
1450
3449
36779
Estradiol (E2) [Moles/volume] in Serum or Plasma
14715-7 [3026725]
5.9e-01
9.3e-01
2.9e+00
—
2.5e+00
1.8e+00
1.4e+00
cases:0.68%
controls:0.38%
cases:0.44%
controls:0.17%
cases:0.22%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.83%
controls:0.14%
cases:2.14%
controls:0.56%
28
156
4093
40937
18
71
4108
41058
9
5
4117
41124
—
7
6
4114
41104
34
58
4043
40689
82
214
3746
38015
vortioxetine; oral
N06AX26 [44819158]
1.4e+00
1.7e+00
1.7e+00
—
1.5e+00
1.6e+00
1.4e+00
cases:2.01%
controls:0.51%
cases:1.75%
controls:0.33%
cases:0.56%
controls:0.10%
—
—
cases:0.56%
controls:0.12%
cases:2.06%
controls:0.41%
cases:4.47%
controls:1.13%
83
208
4038
40885
72
134
4054
40995
23
41
4103
41088
—
23
49
4098
41061
84
168
3993
40579
171
431
3657
37798
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
F25.10 [2000501966]
2.1e+00
2.2e+00
—
—
—
2.5e+00
2.5e+00
cases:0.32%
controls:0.04%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
cases:0.37%
controls:0.03%
cases:0.86%
controls:0.07%
13
16
4108
41077
11
12
4115
41117
—
—
—
15
12
4062
40735
33
26
3795
38203
thioridazine; oral
N05AC02 [21604512]
1.6e+00
2.5e+00
—
—
—
2.9e+00
2.4e+00
cases:0.22%
controls:0.04%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.27%
controls:0.01%
cases:0.34%
controls:0.03%
9
18
4112
41075
7
6
4119
41123
—
—
—
11
6
4066
40741
13
12
3815
38217
Bipolar affective disorder, currently in remission
F31.7 [45581457]
1.9e+00
1.4e+00
—
1.0e+50
1.8e+00
1.9e+00
2.3e+00
cases:0.83%
controls:0.13%
cases:0.39%
controls:0.10%
—
—
cases:0.17%
controls:0.00%
cases:0.19%
controls:0.03%
cases:0.64%
controls:0.09%
cases:1.54%
controls:0.15%
34
53
4087
41040
16
41
4110
41088
—
7
0
4119
41129
8
13
4113
41097
26
38
4051
40709
59
58
3769
38171
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
4.2e-01
9.6e-01
1.6e+00
3.2e+00
1.7e+00
8.2e-01
6.1e-01
cases:17.18%
controls:12.03%
cases:17.01%
controls:7.28%
cases:4.92%
controls:1.00%
cases:0.68%
controls:0.03%
cases:5.34%
controls:1.06%
cases:16.34%
controls:7.89%
cases:34.95%
controls:22.58%
708
4943
3413
36150
702
2995
3424
38134
203
413
3923
40716
28
12
4098
41117
220
434
3901
40676
666
3216
3411
37531
1338
8632
2490
29597
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.5e+00
1.9e+00
—
1.6e+00
1.6e+00
1.4e+00
cases:3.69%
controls:1.19%
cases:2.79%
controls:0.63%
cases:1.28%
controls:0.19%
—
—
cases:0.95%
controls:0.19%
cases:3.07%
controls:0.61%
cases:6.87%
controls:1.72%
152
491
3969
40602
115
259
4011
40870
53
78
4073
41051
—
39
80
4082
41030
125
248
3952
40499
263
656
3565
37573
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
8.6e-01
1.5e+00
2.3e+00
—
1.9e+00
1.4e+00
1.2e+00
cases:4.78%
controls:2.08%
cases:4.39%
controls:0.97%
cases:1.09%
controls:0.11%
—
—
cases:0.95%
controls:0.14%
cases:4.12%
controls:1.08%
cases:12.77%
controls:4.11%
197
853
3924
40240
181
397
3945
40732
45
45
4081
41084
—
39
57
4082
41053
168
440
3909
40307
489
1571
3339
36658
Psychoeducation, group
IER01 [2001304205]
2.4e+00
—
—
—
1.0e+50
4.1e+00
2.7e+00
cases:0.36%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.00%
cases:2.28%
controls:0.04%
cases:1.46%
controls:0.10%
15
13
4106
41080
—
—
—
12
0
4109
41110
93
16
3984
40731
56
38
3772
38191
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
6.7e-01
1.5e+00
2.0e+00
1.0e+50
2.5e+00
1.2e+00
1.2e+00
cases:3.37%
controls:1.75%
cases:2.06%
controls:0.45%
cases:0.29%
controls:0.04%
cases:0.12%
controls:0.00%
cases:0.49%
controls:0.04%
cases:1.69%
controls:0.50%
cases:6.11%
controls:1.87%
139
721
3982
40372
85
187
4041
40942
12
16
4114
41113
5
0
4121
41129
20
16
4101
41094
69
202
4008
40545
234
715
3594
37514
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
8.4e-01
1.5e+00
2.0e+00
—
2.1e+00
1.6e+00
1.2e+00
cases:2.01%
controls:0.88%
cases:1.55%
controls:0.35%
cases:0.39%
controls:0.05%
—
—
cases:0.39%
controls:0.05%
cases:1.47%
controls:0.31%
cases:4.34%
controls:1.29%
83
363
4038
40730
64
145
4062
40984
16
22
4110
41107
—
16
20
4105
41090
60
127
4017
40620
166
492
3662
37737
Nausea and vomiting
R11 [45539317]
7.7e-01
1.5e+00
3.0e+00
—
2.1e+00
1.1e+00
8.7e-01
cases:1.60%
controls:0.74%
cases:0.99%
controls:0.23%
cases:0.51%
controls:0.03%
—
—
cases:0.39%
controls:0.05%
cases:0.83%
controls:0.29%
cases:2.69%
controls:1.15%
66
306
4055
40787
41
96
4085
41033
21
11
4105
41118
—
16
20
4105
41090
34
119
4043
40628
103
439
3725
37790
doxepin; oral, parenteral
N06AA12 [21604699]
1.4e+00
1.9e+00
—
—
2.5e+00
1.5e+00
2.0e+00
cases:1.16%
controls:0.28%
cases:0.61%
controls:0.09%
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.52%
controls:0.12%
cases:1.70%
controls:0.24%
48
117
4073
40976
25
39
4101
41090
—
—
7
6
4114
41104
21
48
4056
40699
65
92
3763
38137
agomelatine; oral
N06AX22 [21604750]
1.5e+00
1.8e+00
1.7e+00
—
1.9e+00
2.1e+00
1.9e+00
cases:0.85%
controls:0.19%
cases:0.68%
controls:0.11%
cases:0.15%
controls:0.03%
—
—
cases:0.19%
controls:0.03%
cases:1.05%
controls:0.13%
cases:2.09%
controls:0.33%
35
77
4086
41016
28
46
4098
41083
6
11
4120
41118
—
8
12
4113
41098
43
55
4034
40692
80
126
3748
38103
Bipolar affective disorder, current episode mild or moderate depression
F31.3 [45571755]
1.6e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.8e+00
cases:0.29%
controls:0.06%
cases:0.36%
controls:0.04%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.42%
controls:0.03%
cases:1.07%
controls:0.07%
12
25
4109
41068
15
15
4111
41114
—
5
0
4121
41129
—
17
14
4060
40733
41
26
3787
38203
Metabolic syndrome
E66.00 [2000501500]
1.8e+00
2.9e+00
—
—
—
2.6e+00
1.9e+00
cases:0.85%
controls:0.15%
cases:0.68%
controls:0.04%
—
—
—
—
—
—
cases:1.01%
controls:0.08%
cases:1.70%
controls:0.26%
35
60
4086
41033
28
15
4098
41114
—
—
—
41
32
4036
40715
65
101
3763
38128
Fibromyalgia
M79.7 [45553272]
1.3e+00
1.7e+00
2.5e+00
—
—
2.0e+00
1.6e+00
cases:0.68%
controls:0.18%
cases:0.48%
controls:0.09%
cases:0.17%
controls:0.01%
—
—
—
—
cases:0.66%
controls:0.09%
cases:1.18%
controls:0.25%
28
73
4093
41020
20
36
4106
41093
7
6
4119
41123
—
—
27
35
4050
40712
45
96
3783
38133
trimipramine; oral, parenteral
N06AA06 [21604693]
2.1e+00
2.4e+00
—
—
—
2.3e+00
2.3e+00
cases:0.58%
controls:0.07%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.76%
controls:0.08%
24
30
4097
41063
10
9
4116
41120
—
—
—
11
11
4066
40736
29
30
3799
38199
Alcohol dependence currently independent
F10.20 [2000501677]
1.6e+00
2.2e+00
—
1.0e+50
—
2.8e+00
2.4e+00
cases:0.29%
controls:0.06%
cases:0.22%
controls:0.02%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.49%
controls:0.03%
cases:0.86%
controls:0.08%
12
24
4109
41069
9
10
4117
41119
—
10
0
4116
41129
—
20
12
4057
40735
33
29
3795
38200
Psychiatric evaluation of working capacity and rehabilitation
IBB02 [2001304049]
1.7e+00
2.2e+00
—
1.0e+50
1.0e+50
3.4e+00
1.8e+00
cases:0.22%
controls:0.04%
cases:0.29%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
cases:0.15%
controls:0.00%
cases:0.56%
controls:0.02%
cases:0.63%
controls:0.11%
9
17
4112
41076
12
13
4114
41116
—
7
0
4119
41129
6
0
4115
41110
23
8
4054
40739
24
41
3804
38188
Emergency Medicine
93 [38004510]
3.8e-01
6.7e-01
1.2e+00
4.3e+00
1.1e+00
8.0e-01
4.9e-01
cases:9.59%
controls:6.73%
cases:7.17%
controls:3.80%
cases:1.87%
controls:0.55%
cases:1.41%
controls:0.02%
cases:1.55%
controls:0.52%
cases:8.58%
controls:4.03%
cases:19.54%
controls:13.00%
395
2766
3726
38327
296
1562
3830
39567
77
228
4049
40901
58
8
4068
41121
64
214
4057
40896
350
1643
3727
39104
748
4971
3080
33258
zolpidem; oral
N05CF02 [21604655]
1.2e+00
1.5e+00
2.0e+00
—
1.6e+00
1.4e+00
1.3e+00
cases:4.00%
controls:1.23%
cases:2.71%
controls:0.61%
cases:0.80%
controls:0.11%
—
—
cases:0.53%
controls:0.11%
cases:2.65%
controls:0.65%
cases:6.37%
controls:1.88%
165
507
3956
40586
112
251
4014
40878
33
47
4093
41082
—
22
45
4099
41065
108
266
3969
40481
244
717
3584
37512
EKG study
11524-6 [3013512]
8.5e-01
1.1e+00
1.9e+00
—
2.5e+00
1.4e+00
9.3e-01
cases:2.91%
controls:1.26%
cases:1.87%
controls:0.61%
cases:0.58%
controls:0.09%
—
—
cases:0.99%
controls:0.08%
cases:2.70%
controls:0.65%
cases:5.96%
controls:2.44%
120
519
4001
40574
77
251
4049
40878
24
37
4102
41092
—
41
34
4080
41076
110
264
3967
40483
228
931
3600
37298
Osmolality of Serum or Plasma
2692-2 [3008295]
8.9e-01
2.2e+00
—
—
1.0e+50
3.7e+00
2.8e+00
cases:0.24%
controls:0.10%
cases:0.24%
controls:0.03%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.49%
controls:0.01%
cases:0.78%
controls:0.05%
10
41
4111
41052
10
11
4116
41118
—
—
16
0
4105
41110
20
5
4057
40742
30
18
3798
38211
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.4e-01
9.5e-01
1.5e+00
2.7e+00
1.5e+00
9.4e-01
7.6e-01
cases:9.05%
controls:6.05%
cases:7.34%
controls:2.98%
cases:1.82%
controls:0.43%
cases:0.32%
controls:0.02%
cases:1.87%
controls:0.43%
cases:7.65%
controls:3.14%
cases:20.66%
controls:10.87%
373
2485
3748
38608
303
1225
3823
39904
75
175
4051
40954
13
9
4113
41120
77
175
4044
40935
312
1281
3765
39466
791
4156
3037
34073
Dissociative [conversion] disorder, unspecified
F44.9 [45605495]
1.5e+00
1.8e+00
—
1.0e+50
—
2.7e+00
2.6e+00
cases:0.34%
controls:0.07%
cases:0.19%
controls:0.03%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.44%
controls:0.03%
cases:1.15%
controls:0.08%
14
30
4107
41063
8
13
4118
41116
—
6
0
4120
41129
—
18
12
4059
40735
44
32
3784
38197
biperiden; oral, parenteral
N04AA02 [21604447]
1.9e+00
2.2e+00
—
—
—
2.2e+00
2.4e+00
cases:0.46%
controls:0.07%
cases:0.34%
controls:0.04%
—
—
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.73%
controls:0.07%
19
28
4102
41065
14
16
4112
41113
—
—
—
10
11
4067
40736
28
26
3800
38203
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
5.8e-01
1.3e+00
2.3e+00
—
2.1e+00
1.4e+00
9.7e-01
cases:1.43%
controls:0.81%
cases:1.21%
controls:0.33%
cases:0.32%
controls:0.03%
—
—
cases:0.44%
controls:0.05%
cases:1.28%
controls:0.33%
cases:3.16%
controls:1.23%
59
333
4062
40760
50
135
4076
40994
13
13
4113
41116
—
18
21
4103
41089
52
136
4025
40611
121
469
3707
37760
Procedure duration 0 to 9 minutes
ZXE01 [2001311395]
1.3e+00
1.8e+00
—
—
—
3.0e+00
2.5e+00
cases:0.34%
controls:0.09%
cases:0.27%
controls:0.05%
—
—
—
—
—
—
cases:0.86%
controls:0.04%
cases:1.38%
controls:0.12%
14
37
4107
41056
11
19
4115
41110
—
—
—
35
17
4042
40730
53
44
3775
38185
Bipolar disorder depressive episode with somatic syndrome
F31.31 [2000501977]
1.8e+00
—
—
—
—
3.0e+00
3.7e+00
cases:0.17%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.01%
cases:0.55%
controls:0.01%
7
11
4114
41082
—
—
—
—
10
5
4067
40742
21
5
3807
38224
Disruption of family by separation and divorce
Z63.5 [45561643]
1.6e+00
1.8e+00
—
1.0e+50
—
3.0e+00
2.1e+00
cases:0.36%
controls:0.08%
cases:0.17%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.29%
controls:0.01%
cases:0.29%
controls:0.03%
15
31
4106
41062
7
11
4119
41118
—
7
0
4119
41129
—
12
6
4065
40741
11
13
3817
38216
pH of Serum or Plasma
2753-2 [3018418]
6.0e-01
1.2e+00
1.8e+00
—
2.3e+00
1.5e+00
1.1e+00
cases:3.30%
controls:1.84%
cases:3.03%
controls:0.92%
cases:0.85%
controls:0.14%
—
—
cases:1.26%
controls:0.12%
cases:3.70%
controls:0.88%
cases:8.41%
controls:2.95%
136
756
3985
40337
125
378
4001
40751
35
57
4091
41072
—
52
51
4069
41059
151
359
3926
40388
322
1128
3506
37101
Assessment of need for psychiatric treatment
IAA01 [2001304011]
1.3e+00
2.0e+00
1.8e+00
—
2.2e+00
1.7e+00
1.3e+00
cases:0.95%
controls:0.26%
cases:0.97%
controls:0.13%
cases:0.12%
controls:0.02%
—
—
cases:0.17%
controls:0.02%
cases:1.03%
controls:0.18%
cases:2.32%
controls:0.62%
39
107
4082
40986
40
55
4086
41074
5
8
4121
41121
—
7
8
4114
41102
42
74
4035
40673
89
238
3739
37991
zopiclone; oral
N05CF01 [21604654]
1.2e+00
1.4e+00
1.5e+00
—
1.7e+00
1.5e+00
1.3e+00
cases:6.31%
controls:2.05%
cases:4.19%
controls:1.03%
cases:0.95%
controls:0.22%
—
—
cases:1.26%
controls:0.24%
cases:4.93%
controls:1.16%
cases:10.37%
controls:3.01%
260
843
3861
40250
173
424
3953
40705
39
91
4087
41038
—
52
99
4069
41011
201
471
3876
40276
397
1152
3431
37077
hydroxyzine; oral, parenteral
N05BB01 [21604590]
9.8e-01
1.2e+00
1.6e+00
—
1.9e+00
1.6e+00
1.2e+00
cases:3.83%
controls:1.48%
cases:1.79%
controls:0.54%
cases:0.41%
controls:0.08%
—
—
cases:0.53%
controls:0.08%
cases:2.94%
controls:0.61%
cases:6.69%
controls:2.05%
158
607
3963
40486
74
223
4052
40906
17
34
4109
41095
—
22
33
4099
41077
120
249
3957
40498
256
783
3572
37446
Syncope and collapse
R55 [45568141]
7.7e-01
1.6e+00
1.8e+00
—
2.1e+00
1.2e+00
1.0e+00
cases:1.16%
controls:0.54%
cases:0.80%
controls:0.17%
cases:0.17%
controls:0.03%
—
—
cases:0.15%
controls:0.02%
cases:0.64%
controls:0.20%
cases:1.83%
controls:0.67%
48
223
4073
40870
33
70
4093
41059
7
11
4119
41118
—
6
7
4115
41103
26
81
4051
40666
70
255
3758
37974
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.0e-01
8.0e-01
1.4e+00
3.2e+00
1.4e+00
7.8e-01
5.6e-01
cases:17.18%
controls:13.28%
cases:18.44%
controls:9.21%
cases:6.88%
controls:1.75%
cases:1.75%
controls:0.07%
cases:6.75%
controls:1.68%
cases:19.11%
controls:9.75%
cases:36.44%
controls:24.72%
708
5456
3413
35637
761
3790
3365
37339
284
720
3842
40409
72
30
4054
41099
278
692
3843
40418
779
3971
3298
36776
1395
9452
2433
28777
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.5e-01
1.1e+00
1.8e+00
—
2.4e+00
1.5e+00
1.1e+00
cases:5.70%
controls:3.37%
cases:4.87%
controls:1.65%
cases:1.62%
controls:0.28%
—
—
cases:2.62%
controls:0.23%
cases:6.06%
controls:1.47%
cases:12.72%
controls:4.44%
235
1384
3886
39709
201
680
3925
40449
67
115
4059
41014
—
108
96
4013
41014
247
601
3830
40146
487
1698
3341
36531
Asperger syndrome
F84.5 [45576562]
1.3e+00
1.3e+00
—
1.0e+50
2.0e+00
2.2e+00
1.6e+00
cases:0.32%
controls:0.09%
cases:0.29%
controls:0.08%
—
—
cases:0.32%
controls:0.00%
cases:0.24%
controls:0.03%
cases:0.66%
controls:0.07%
cases:0.89%
controls:0.18%
13
37
4108
41056
12
33
4114
41096
—
13
0
4113
41129
10
13
4111
41097
27
29
4050
40718
34
67
3794
38162
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
4.4e-01
8.9e-01
2.5e+00
—
2.3e+00
1.5e+00
1.2e+00
cases:1.07%
controls:0.69%
cases:0.68%
controls:0.28%
cases:0.34%
controls:0.03%
—
—
cases:0.24%
controls:0.02%
cases:1.08%
controls:0.25%
cases:2.98%
controls:0.90%
44
283
4077
40810
28
115
4098
41014
14
11
4112
41118
—
10
10
4111
41100
44
102
4033
40645
114
343
3714
37886
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
7.0e-01
1.1e+00
2.2e+00
—
2.1e+00
1.3e+00
1.0e+00
cases:6.36%
controls:3.26%
cases:5.82%
controls:2.01%
cases:2.01%
controls:0.22%
—
—
cases:2.38%
controls:0.30%
cases:7.16%
controls:2.07%
cases:16.12%
controls:6.56%
262
1339
3859
39754
240
827
3886
40302
83
91
4043
41038
—
98
125
4023
40985
292
845
3785
39902
617
2509
3211
35720
Obsessive-compulsive disorder, unspecified
F42.9 [45600745]
1.6e+00
2.2e+00
—
1.0e+50
—
2.3e+00
2.2e+00
cases:0.36%
controls:0.07%
cases:0.39%
controls:0.04%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.64%
controls:0.06%
cases:1.12%
controls:0.12%
15
29
4106
41064
16
18
4110
41111
—
9
0
4117
41129
—
26
25
4051
40722
43
47
3785
38182
Other eating disorders
F50.8 [45581465]
2.7e+00
—
—
1.0e+50
1.0e+50
—
5.7e+00
cases:0.29%
controls:0.02%
—
—
—
—
cases:8.99%
controls:0.00%
cases:4.49%
controls:0.00%
—
—
cases:7.13%
controls:0.03%
12
8
4109
41085
—
—
371
0
3755
41129
185
0
3936
41110
—
273
10
3555
38219
Bipolar affective disorder, current episode severe depression with psychotic symptoms
F31.5 [45586236]
2.0e+00
2.9e+00
—
1.0e+50
—
3.5e+00
—
cases:0.29%
controls:0.04%
cases:0.22%
controls:0.01%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.42%
controls:0.01%
—
—
12
17
4109
41076
9
5
4117
41124
—
6
0
4120
41129
—
17
5
4060
40742
—
Psychosocial counselling and guidance
SPAT1307 [2001700408]
9.4e-01
1.5e+00
2.1e+00
—
1.9e+00
1.0e+00
8.5e-01
cases:3.83%
controls:1.54%
cases:2.62%
controls:0.57%
cases:0.82%
controls:0.10%
—
—
cases:0.49%
controls:0.07%
cases:1.35%
controls:0.48%
cases:4.55%
controls:1.99%
158
632
3963
40461
108
234
4018
40895
34
43
4092
41086
—
20
30
4101
41080
55
196
4022
40551
174
762
3654
37467
Psychological sympt/compl other
P29 [2002000823]
1.0e+00
1.7e+00
2.2e+00
—
1.4e+00
1.1e+00
1.0e+00
cases:2.45%
controls:0.92%
cases:2.21%
controls:0.42%
cases:0.75%
controls:0.09%
—
—
cases:0.44%
controls:0.11%
cases:1.50%
controls:0.50%
cases:5.15%
controls:1.89%
101
378
4020
40715
91
174
4035
40955
31
36
4095
41093
—
18
46
4103
41064
61
202
4016
40545
197
723
3631
37506
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F98.9 [45547725]
1.2e+00
2.1e+00
—
1.0e+50
2.3e+00
2.7e+00
2.3e+00
cases:0.36%
controls:0.11%
cases:0.34%
controls:0.04%
—
—
cases:0.12%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.37%
controls:0.02%
cases:0.68%
controls:0.07%
15
45
4106
41048
14
18
4112
41111
—
5
0
4121
41129
5
5
4116
41105
15
10
4062
40737
26
25
3802
38204
Other rehabilitation service
R5599 [2001310270]
7.8e-01
1.6e+00
—
1.0e+50
2.2e+00
2.5e+00
2.0e+00
cases:0.49%
controls:0.22%
cases:0.41%
controls:0.09%
—
—
cases:0.12%
controls:0.00%
cases:0.22%
controls:0.02%
cases:1.30%
controls:0.11%
cases:1.36%
controls:0.18%
20
92
4101
41001
17
35
4109
41094
—
5
0
4121
41129
9
10
4112
41100
53
44
4024
40703
52
70
3776
38159
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
5.5e-01
1.1e+00
1.7e+00
—
2.4e+00
1.5e+00
1.1e+00
cases:6.02%
controls:3.57%
cases:5.45%
controls:1.80%
cases:1.60%
controls:0.31%
—
—
cases:2.89%
controls:0.27%
cases:6.84%
controls:1.69%
cases:14.29%
controls:5.16%
248
1469
3873
39624
225
741
3901
40388
66
128
4060
41001
—
119
113
4002
40997
279
689
3798
40058
547
1972
3281
36257
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.1e+00
1.2e+00
1.4e+00
—
1.2e+00
1.6e+00
1.9e+00
cases:2.64%
controls:0.89%
cases:1.87%
controls:0.55%
cases:0.58%
controls:0.15%
—
—
cases:0.46%
controls:0.14%
cases:2.35%
controls:0.51%
cases:4.47%
controls:0.73%
109
365
4012
40728
77
228
4049
40901
24
62
4102
41067
—
19
58
4102
41052
96
206
3981
40541
171
278
3657
37951
Other recurrent depressive disorders
F33.8 [45600740]
1.3e+00
2.2e+00
—
1.0e+50
—
2.5e+00
2.3e+00
cases:0.41%
controls:0.11%
cases:0.39%
controls:0.04%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.49%
controls:0.04%
cases:1.10%
controls:0.11%
17
47
4104
41046
16
18
4110
41111
—
9
0
4117
41129
—
20
16
4057
40731
42
43
3786
38186
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
1.2e+00
2.1e+00
—
—
2.3e+00
1.3e+00
1.3e+00
cases:0.44%
controls:0.13%
cases:0.90%
controls:0.11%
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.59%
controls:0.16%
cases:2.35%
controls:0.63%
18
52
4103
41041
37
45
4089
41084
—
—
6
6
4115
41104
24
67
4053
40680
90
241
3738
37988
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
7.1e-01
1.1e+00
2.4e+00
—
1.8e+00
1.0e+00
1.1e+00
cases:1.58%
controls:0.78%
cases:1.21%
controls:0.40%
cases:0.36%
controls:0.03%
—
—
cases:0.29%
controls:0.05%
cases:1.18%
controls:0.42%
cases:4.70%
controls:1.62%
65
321
4056
40772
50
164
4076
40965
15
13
4111
41116
—
12
19
4109
41091
48
170
4029
40577
180
618
3648
37611
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
1.7e+00
2.1e+00
—
—
—
2.0e+00
2.4e+00
cases:0.34%
controls:0.06%
cases:0.24%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.04%
cases:0.68%
controls:0.06%
14
26
4107
41067
10
12
4116
41117
—
—
—
12
16
4065
40731
26
23
3802
38206
12 lead EKG panel
34534-8 [3044889]
5.0e-01
1.2e+00
2.2e+00
—
2.4e+00
1.1e+00
8.5e-01
cases:7.43%
controls:4.65%
cases:7.15%
controls:2.30%
cases:2.40%
controls:0.26%
—
—
cases:2.86%
controls:0.27%
cases:6.84%
controls:2.41%
cases:17.29%
controls:8.24%
306
1909
3815
39184
295
947
3831
40182
99
108
4027
41021
—
118
110
4003
41000
279
982
3798
39765
662
3150
3166
35079
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
8.8e-01
1.3e+00
2.0e+00
—
1.9e+00
1.2e+00
1.0e+00
cases:1.67%
controls:0.70%
cases:1.19%
controls:0.34%
cases:0.51%
controls:0.07%
—
—
cases:0.51%
controls:0.08%
cases:1.50%
controls:0.47%
cases:3.47%
controls:1.29%
69
289
4052
40804
49
139
4077
40990
21
28
4105
41101
—
21
31
4100
41079
61
192
4016
40555
133
495
3695
37734
Outpatient Hospital
22 [8756]
1.9e-01
3.9e-01
1.0e+00
3.9e+00
1.5e+00
7.2e-01
5.2e-01
cases:21.01%
controls:18.01%
cases:7.71%
controls:5.33%
cases:1.58%
controls:0.57%
cases:2.21%
controls:0.05%
cases:2.69%
controls:0.63%
cases:10.28%
controls:5.26%
cases:26.67%
controls:17.80%
866
7400
3255
33693
318
2193
3808
38936
65
234
4061
40895
91
19
4035
41110
111
258
4010
40852
419
2142
3658
38605
1021
6805
2807
31424
Agoraphobia without concomitant panic disorder
F40.00 [2000501992]
1.8e+00
2.0e+00
—
—
—
2.3e+00
2.1e+00
cases:0.17%
controls:0.03%
cases:0.15%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.03%
cases:0.37%
controls:0.05%
7
11
4114
41082
6
8
4120
41121
—
—
—
11
11
4066
40736
14
18
3814
38211
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.3e-01
8.6e-01
1.4e+00
2.8e+00
1.5e+00
7.9e-01
5.9e-01
cases:17.01%
controls:12.85%
cases:18.20%
controls:8.59%
cases:6.20%
controls:1.63%
cases:1.09%
controls:0.07%
cases:6.50%
controls:1.59%
cases:18.05%
controls:9.12%
cases:36.00%
controls:23.79%
701
5280
3420
35813
751
3532
3375
37597
256
669
3870
40460
45
28
4081
41101
268
655
3853
40455
736
3718
3341
37029
1378
9095
2450
29134
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.6e-01
9.3e-01
1.8e+00
—
2.6e+00
1.6e+00
1.3e+00
cases:0.83%
controls:0.47%
cases:0.73%
controls:0.29%
cases:0.32%
controls:0.05%
—
—
cases:0.39%
controls:0.03%
cases:1.32%
controls:0.27%
cases:2.85%
controls:0.83%
34
195
4087
40898
30
118
4096
41011
13
22
4113
41107
—
16
12
4105
41098
54
108
4023
40639
109
318
3719
37911
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
3.7e-01
1.0e+00
1.9e+00
1.0e+50
2.5e+00
1.3e+00
1.4e+00
cases:0.58%
controls:0.40%
cases:0.44%
controls:0.15%
cases:0.24%
controls:0.04%
cases:0.12%
controls:0.00%
cases:0.32%
controls:0.03%
cases:0.52%
controls:0.14%
cases:1.04%
controls:0.25%
24
165
4097
40928
18
63
4108
41066
10
15
4116
41114
5
0
4121
41129
13
11
4108
41099
21
57
4056
40690
40
97
3788
38132
Bipolar affective disorder, current episode manic without psychotic symptoms
F31.1 [45576537]
2.6e+00
3.0e+00
—
—
—
—
2.6e+00
cases:0.41%
controls:0.03%
cases:0.24%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.04%
17
13
4104
41080
10
5
4116
41124
—
—
—
—
21
16
3807
38213
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.7e-01
5.9e-01
1.1e+00
3.0e+00
1.4e+00
8.7e-01
7.9e-01
cases:5.12%
controls:3.59%
cases:3.81%
controls:2.15%
cases:1.36%
controls:0.46%
cases:0.44%
controls:0.02%
cases:1.72%
controls:0.45%
cases:5.18%
controls:2.24%
cases:10.53%
controls:5.05%
211
1477
3910
39616
157
884
3969
40245
56
188
4070
40941
18
9
4108
41120
71
184
4050
40926
211
911
3866
39836
403
1930
3425
36299
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.8e-01
7.5e-01
1.4e+00
2.9e+00
1.3e+00
7.4e-01
5.9e-01
cases:10.99%
controls:7.78%
cases:11.39%
controls:5.74%
cases:4.14%
controls:1.04%
cases:0.95%
controls:0.05%
cases:3.64%
controls:1.05%
cases:12.14%
controls:6.20%
cases:26.31%
controls:16.53%
453
3195
3668
37898
470
2359
3656
38770
171
429
3955
40700
39
21
4087
41108
150
433
3971
40677
495
2526
3582
38221
1007
6318
2821
31911
Medical doctor
Z2221 [2001311556]
7.0e-01
8.7e-01
1.2e+00
—
2.2e+00
1.8e+00
1.3e+00
cases:6.87%
controls:3.54%
cases:2.96%
controls:1.25%
cases:0.65%
controls:0.19%
—
—
cases:1.80%
controls:0.21%
cases:6.35%
controls:1.16%
cases:12.02%
controls:3.56%
283
1453
3838
39640
122
516
4004
40613
27
79
4099
41050
—
74
87
4047
41023
259
472
3818
40275
460
1362
3368
36867
pH of Capillary blood
2745-8 [3009343]
4.6e-01
7.5e-01
2.2e+00
—
2.7e+00
1.2e+00
1.2e+00
cases:1.24%
controls:0.79%
cases:0.63%
controls:0.30%
cases:0.36%
controls:0.04%
—
—
cases:0.66%
controls:0.05%
cases:0.91%
controls:0.27%
cases:1.85%
controls:0.57%
51
323
4070
40770
26
123
4100
41006
15
17
4111
41112
—
27
19
4094
41091
37
109
4040
40638
71
217
3757
38012
Cocaine [Presence] in Urine
3397-7 [3016879]
6.6e-01
1.1e+00
2.4e+00
—
1.8e+00
9.6e-01
1.0e+00
cases:1.65%
controls:0.86%
cases:1.33%
controls:0.46%
cases:0.39%
controls:0.03%
—
—
cases:0.32%
controls:0.05%
cases:1.25%
controls:0.48%
cases:4.86%
controls:1.80%
68
355
4053
40738
55
190
4071
40939
16
14
4110
41115
—
13
21
4108
41089
51
197
4026
40550
186
689
3642
37540
Obesity due to excess calories
E66.0 [45581372]
1.5e+00
2.9e+00
—
—
—
2.0e+00
1.6e+00
cases:0.27%
controls:0.06%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:0.20%
controls:0.03%
cases:0.47%
controls:0.10%
11
24
4110
41069
14
8
4112
41121
—
—
—
8
11
4069
40736
18
37
3810
38192
Nutritional guidance related to treatment and rehabilitation for medical condition
OAB74 [2001308652]
—
2.1e+00
—
1.0e+50
—
3.4e+00
2.5e+00
—
—
cases:0.29%
controls:0.04%
—
—
cases:0.19%
controls:0.00%
—
—
cases:0.64%
controls:0.02%
cases:0.76%
controls:0.06%
—
12
15
4114
41114
—
8
0
4118
41129
—
26
9
4051
40738
29
24
3799
38205
Recurrent depressive disorder, current episode severe with psychotic symptoms
F33.3 [45562042]
2.1e+00
2.3e+00
—
—
—
3.0e+00
2.8e+00
cases:0.41%
controls:0.05%
cases:0.12%
controls:0.01%
—
—
—
—
—
—
cases:0.29%
controls:0.01%
cases:0.94%
controls:0.05%
17
21
4104
41072
5
5
4121
41124
—
—
—
12
6
4065
40741
36
21
3792
38208
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.6e-01
7.9e-01
1.0e+00
3.1e+00
8.7e-01
7.5e-01
8.0e-01
cases:5.87%
controls:3.44%
cases:3.85%
controls:1.79%
cases:0.82%
controls:0.29%
cases:0.27%
controls:0.01%
cases:0.80%
controls:0.34%
cases:3.90%
controls:1.87%
cases:12.38%
controls:5.95%
242
1414
3879
39679
159
735
3967
40394
34
121
4092
41008
11
5
4115
41124
33
138
4088
40972
159
763
3918
39984
474
2276
3354
35953
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
1.5e+00
1.1e+00
—
—
1.7e+00
1.4e+00
2.2e+00
cases:0.46%
controls:0.10%
cases:0.34%
controls:0.12%
—
—
—
—
cases:0.19%
controls:0.03%
cases:0.56%
controls:0.14%
cases:1.75%
controls:0.20%
19
43
4102
41050
14
48
4112
41081
—
—
8
14
4113
41096
23
58
4054
40689
67
75
3761
38154
macrogol; oral
A06AD15 [21600575]
1.0e+00
1.7e+00
1.3e+00
—
1.8e+00
2.0e+00
1.4e+00
cases:1.19%
controls:0.43%
cases:0.92%
controls:0.18%
cases:0.12%
controls:0.03%
—
—
cases:0.29%
controls:0.05%
cases:1.08%
controls:0.15%
cases:2.48%
controls:0.63%
49
177
4072
40916
38
72
4088
41057
5
13
4121
41116
—
12
20
4109
41090
44
61
4033
40686
95
242
3733
37987
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
5.8e-01
9.0e-01
1.8e+00
1.0e+50
2.3e+00
1.2e+00
1.1e+00
cases:4.08%
controls:2.31%
cases:2.69%
controls:1.11%
cases:0.78%
controls:0.13%
cases:0.12%
controls:0.00%
cases:0.95%
controls:0.09%
cases:3.78%
controls:1.22%
cases:10.55%
controls:3.77%
168
951
3953
40142
111
456
4015
40673
32
53
4094
41076
5
0
4121
41129
39
39
4082
41071
154
499
3923
40248
404
1442
3424
36787
melatonin; oral
N05CH01 [21604659]
9.5e-01
1.3e+00
1.7e+00
—
1.4e+00
1.4e+00
1.1e+00
cases:3.18%
controls:1.25%
cases:2.59%
controls:0.69%
cases:0.85%
controls:0.16%
—
—
cases:0.68%
controls:0.17%
cases:3.29%
controls:0.87%
cases:7.55%
controls:2.65%
131
514
3990
40579
107
282
4019
40847
35
65
4091
41064
—
28
69
4093
41041
134
355
3943
40392
289
1014
3539
37215
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
6.0e-01
1.1e+00
2.4e+00
—
1.9e+00
9.2e-01
9.6e-01
cases:1.70%
controls:0.94%
cases:1.38%
controls:0.48%
cases:0.39%
controls:0.03%
—
—
cases:0.32%
controls:0.05%
cases:1.30%
controls:0.52%
cases:5.04%
controls:1.99%
70
387
4051
40706
57
199
4069
40930
16
14
4110
41115
—
13
20
4108
41090
53
213
4024
40534
193
762
3635
37467
Rehabilitative psychiatric group intervention, social skills
IER05 [2001304209]
2.4e+00
—
—
—
—
2.8e+00
2.6e+00
cases:0.22%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.01%
cases:0.42%
controls:0.03%
9
8
4112
41085
—
—
—
—
10
6
4067
40741
16
12
3812
38217
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.1e-01
4.9e-01
1.1e+00
2.9e+00
1.5e+00
8.3e-01
7.0e-01
cases:6.67%
controls:5.00%
cases:5.60%
controls:3.50%
cases:2.28%
controls:0.77%
cases:0.58%
controls:0.03%
cases:2.98%
controls:0.70%
cases:7.65%
controls:3.48%
cases:14.08%
controls:7.52%
275
2054
3846
39039
231
1438
3895
39691
94
316
4032
40813
24
13
4102
41116
123
288
3998
40822
312
1418
3765
39329
539
2873
3289
35356
Intentional self-harm by sharp object
X78 [45756450]
1.5e+00
1.6e+00
—
—
—
2.7e+00
2.1e+00
cases:0.51%
controls:0.12%
cases:0.19%
controls:0.04%
—
—
—
—
—
—
cases:0.76%
controls:0.05%
cases:1.28%
controls:0.16%
21
49
4100
41044
8
16
4118
41113
—
—
—
31
22
4046
40725
49
61
3779
38168
Basophils [#/volume] in Blood
26444-0 [3006315]
3.2e-01
5.8e-01
1.0e+00
2.8e+00
1.5e+00
9.1e-01
7.4e-01
cases:7.64%
controls:5.68%
cases:6.01%
controls:3.45%
cases:1.84%
controls:0.68%
cases:0.53%
controls:0.03%
cases:2.84%
controls:0.66%
cases:8.00%
controls:3.37%
cases:16.17%
controls:8.40%
315
2336
3806
38757
248
1420
3878
39709
76
281
4050
40848
22
14
4104
41115
117
271
4004
40839
326
1372
3751
39375
619
3210
3209
35019
pH of Specimen
17433-4 [3019225]
8.3e-01
1.3e+00
1.3e+00
—
2.3e+00
1.8e+00
1.6e+00
cases:0.99%
controls:0.44%
cases:0.73%
controls:0.21%
cases:0.12%
controls:0.03%
—
—
cases:0.46%
controls:0.05%
cases:1.15%
controls:0.19%
cases:2.64%
controls:0.54%
41
180
4080
40913
30
85
4096
41044
5
13
4121
41116
—
19
19
4102
41091
47
79
4030
40668
101
208
3727
38021
Cannabinoids [Presence] in Urine
3427-2 [3028300]
5.8e-01
1.0e+00
2.4e+00
—
1.8e+00
9.3e-01
9.5e-01
cases:1.70%
controls:0.95%
cases:1.38%
controls:0.49%
cases:0.39%
controls:0.03%
—
—
cases:0.32%
controls:0.05%
cases:1.35%
controls:0.54%
cases:5.02%
controls:2.00%
70
392
4051
40701
57
203
4069
40926
16
14
4110
41115
—
13
21
4108
41089
55
218
4022
40529
192
765
3636
37464
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.1e-01
5.8e-01
9.9e-01
2.8e+00
1.5e+00
9.1e-01
7.4e-01
cases:7.60%
controls:5.68%
cases:5.99%
controls:3.46%
cases:1.82%
controls:0.69%
cases:0.53%
controls:0.03%
cases:2.84%
controls:0.66%
cases:8.00%
controls:3.37%
cases:16.09%
controls:8.38%
313
2335
3808
38758
247
1422
3879
39707
75
282
4051
40847
22
14
4104
41115
117
271
4004
40839
326
1375
3751
39372
616
3203
3212
35026
alprazolam; oral
N05BA12 [21604577]
1.2e+00
1.5e+00
1.2e+00
—
1.4e+00
1.3e+00
1.1e+00
cases:2.31%
controls:0.69%
cases:1.48%
controls:0.34%
cases:0.34%
controls:0.10%
—
—
cases:0.36%
controls:0.09%
cases:1.35%
controls:0.36%
cases:3.16%
controls:1.03%
95
283
4026
40810
61
138
4065
40991
14
43
4112
41086
—
15
38
4106
41072
55
146
4022
40601
121
393
3707
37836
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.4e-01
5.8e-01
9.9e-01
2.9e+00
1.4e+00
8.6e-01
7.3e-01
cases:7.81%
controls:5.71%
cases:5.72%
controls:3.29%
cases:1.77%
controls:0.67%
cases:0.51%
controls:0.03%
cases:2.50%
controls:0.64%
cases:7.26%
controls:3.22%
cases:15.13%
controls:7.94%
322
2348
3799
38745
236
1352
3890
39777
73
274
4053
40855
21
12
4105
41117
103
265
4018
40845
296
1311
3781
39436
579
3037
3249
35192
Persistent somatoform pain disorder
F45.4 [45605498]
1.4e+00
2.4e+00
—
1.0e+50
—
2.2e+00
1.7e+00
cases:0.27%
controls:0.07%
cases:0.32%
controls:0.03%
—
—
cases:0.15%
controls:0.00%
—
—
cases:0.32%
controls:0.03%
cases:0.55%
controls:0.10%
11
28
4110
41065
13
12
4113
41117
—
6
0
4120
41129
—
13
14
4064
40733
21
37
3807
38192
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.4e-01
5.7e-01
1.0e+00
2.8e+00
1.4e+00
8.9e-01
7.2e-01
cases:8.27%
controls:6.05%
cases:6.11%
controls:3.56%
cases:1.89%
controls:0.70%
cases:0.53%
controls:0.03%
cases:2.84%
controls:0.69%
cases:8.12%
controls:3.50%
cases:16.67%
controls:8.87%
341
2486
3780
38607
252
1466
3874
39663
78
289
4048
40840
22
14
4104
41115
117
282
4004
40828
331
1428
3746
39319
638
3391
3190
34838
Opiates [Presence] in Urine
3879-4 [3027008]
5.8e-01
1.0e+00
2.4e+00
—
1.8e+00
9.0e-01
9.5e-01
cases:1.70%
controls:0.96%
cases:1.36%
controls:0.49%
cases:0.39%
controls:0.03%
—
—
cases:0.32%
controls:0.05%
cases:1.30%
controls:0.53%
cases:4.99%
controls:2.00%
70
393
4051
40700
56
203
4070
40926
16
14
4110
41115
—
13
21
4108
41089
53
217
4024
40530
191
763
3637
37466
Obesity
E66 [45547648]
1.7e+00
2.3e+00
—
—
—
1.8e+00
1.8e+00
cases:1.26%
controls:0.23%
cases:0.99%
controls:0.10%
—
—
—
—
—
—
cases:0.66%
controls:0.11%
cases:2.38%
controls:0.40%
52
95
4069
40998
41
40
4085
41089
—
—
—
27
43
4050
40704
91
152
3737
38077
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.3e-01
5.8e-01
9.7e-01
2.8e+00
1.4e+00
8.7e-01
7.3e-01
cases:7.50%
controls:5.49%
cases:5.65%
controls:3.23%
cases:1.72%
controls:0.66%
cases:0.53%
controls:0.03%
cases:2.57%
controls:0.63%
cases:7.26%
controls:3.17%
cases:14.79%
controls:7.72%
309
2254
3812
38839
233
1329
3893
39800
71
271
4055
40858
22
14
4104
41115
106
260
4015
40850
296
1292
3781
39455
566
2953
3262
35276
Other intensified psychiatric treatment
IEY21 [2001304240]
2.7e+00
—
—
—
—
2.8e+00
2.2e+00
cases:0.24%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.01%
cases:0.44%
controls:0.05%
10
7
4111
41086
—
—
—
—
10
6
4067
40741
17
19
3811
38210
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.4e-01
5.8e-01
9.7e-01
2.8e+00
1.4e+00
8.7e-01
7.3e-01
cases:7.50%
controls:5.46%
cases:5.62%
controls:3.22%
cases:1.72%
controls:0.66%
cases:0.53%
controls:0.03%
cases:2.57%
controls:0.63%
cases:7.24%
controls:3.16%
cases:14.73%
controls:7.71%
309
2245
3812
38848
232
1324
3894
39805
71
272
4055
40857
22
14
4104
41115
106
260
4015
40850
295
1287
3782
39460
564
2946
3264
35283
Psychiatric network contact
IGV01 [2001304319]
1.5e+00
2.0e+00
—
—
—
2.2e+00
2.0e+00
cases:0.44%
controls:0.10%
cases:0.46%
controls:0.06%
—
—
—
—
—
—
cases:0.61%
controls:0.07%
cases:1.33%
controls:0.18%
18
42
4103
41051
19
25
4107
41104
—
—
—
25
29
4052
40718
51
69
3777
38160
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.3e-01
5.8e-01
9.4e-01
2.8e+00
1.4e+00
8.7e-01
7.3e-01
cases:7.50%
controls:5.51%
cases:5.70%
controls:3.26%
cases:1.70%
controls:0.67%
cases:0.53%
controls:0.03%
cases:2.57%
controls:0.64%
cases:7.28%
controls:3.17%
cases:14.89%
controls:7.74%
309
2266
3812
38827
235
1339
3891
39790
70
275
4056
40854
22
14
4104
41115
106
262
4015
40848
297
1293
3780
39454
570
2960
3258
35269
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.3e-01
5.8e-01
9.7e-01
2.7e+00
1.4e+00
9.1e-01
7.2e-01
cases:8.03%
controls:5.91%
cases:6.25%
controls:3.59%
cases:1.91%
controls:0.73%
cases:0.53%
controls:0.04%
cases:2.94%
controls:0.71%
cases:8.24%
controls:3.50%
cases:16.64%
controls:8.89%
331
2430
3790
38663
258
1475
3868
39654
79
301
4047
40828
22
15
4104
41114
121
293
4000
40817
336
1426
3741
39321
637
3399
3191
34830
Remote monitoring CPAP
WX780 [2001310837]
1.6e+00
2.1e+00
—
—
—
2.7e+00
1.3e+00
cases:0.24%
controls:0.05%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.50%
controls:0.14%
10
21
4111
41072
8
10
4118
41119
—
—
—
12
8
4065
40739
19
54
3809
38175
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
ICC01 [2001304102]
1.2e+00
1.9e+00
—
1.0e+50
—
2.1e+00
2.4e+00
cases:0.32%
controls:0.09%
cases:0.22%
controls:0.03%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.27%
controls:0.03%
cases:0.60%
controls:0.05%
13
39
4108
41054
9
14
4117
41115
—
9
0
4117
41129
—
11
14
4066
40733
23
20
3805
38209
Other psychiatric pharmacotherapy service
IFA99 [2001304299]
1.7e+00
1.9e+00
—
—
2.3e+00
1.9e+00
2.0e+00
cases:0.29%
controls:0.05%
cases:0.19%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.27%
controls:0.04%
cases:0.60%
controls:0.08%
12
22
4109
41071
8
12
4118
41117
—
—
5
5
4116
41105
11
16
4066
40731
23
30
3805
38199
Neurology
13 [38004458]
7.1e-01
7.5e-01
1.0e+00
2.7e+00
8.1e-01
8.1e-01
8.0e-01
cases:8.95%
controls:4.63%
cases:5.02%
controls:2.44%
cases:1.55%
controls:0.57%
cases:0.39%
controls:0.03%
cases:1.16%
controls:0.52%
cases:5.62%
controls:2.58%
cases:14.11%
controls:6.87%
369
1902
3752
39191
207
1004
3919
40125
64
234
4062
40895
16
11
4110
41118
48
215
4073
40895
229
1053
3848
39694
540
2628
3288
35601
Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]
1.8e+00
1.6e+00
—
—
-1.0e+50
2.3e+00
1.9e+00
cases:0.58%
controls:0.10%
cases:0.32%
controls:0.06%
—
—
—
—
cases:0.00%
controls:0.01%
cases:0.56%
controls:0.06%
cases:1.33%
controls:0.20%
24
41
4097
41052
13
26
4113
41103
—
—
0
5
4121
41105
23
24
4054
40723
51
76
3777
38153
Adolescent behaviour sympt/compl
P23 [2002000818]
1.5e+00
2.7e+00
—
—
—
1.7e+00
1.6e+00
cases:0.51%
controls:0.11%
cases:0.41%
controls:0.03%
—
—
—
—
—
—
cases:0.20%
controls:0.04%
cases:0.42%
controls:0.08%
21
47
4100
41046
17
11
4109
41118
—
—
—
8
15
4069
40732
16
31
3812
38198
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.0e-01
6.9e-01
1.1e+00
2.6e+00
1.3e+00
7.2e-01
6.5e-01
cases:11.43%
controls:7.97%
cases:7.68%
controls:3.99%
cases:1.91%
controls:0.62%
cases:0.27%
controls:0.02%
cases:1.97%
controls:0.53%
cases:8.07%
controls:4.10%
cases:21.60%
controls:12.61%
471
3277
3650
37816
317
1641
3809
39488
79
254
4047
40875
11
8
4115
41121
81
217
4040
40893
329
1672
3748
39075
827
4821
3001
33408
reboxetine; oral
N06AX18 [21604747]
2.1e+00
—
—
—
—
2.5e+00
3.0e+00
cases:0.29%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.31%
controls:0.02%
12
15
4109
41078
—
—
—
—
7
6
4070
40741
12
6
3816
38223
Other nonorganic psychotic disorders
F28 [45605491]
2.0e+00
1.7e+00
—
—
—
2.7e+00
2.8e+00
cases:0.27%
controls:0.04%
cases:0.15%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.52%
controls:0.03%
11
15
4110
41078
6
11
4120
41118
—
—
—
12
8
4065
40739
20
12
3808
38217
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.4e-01
5.6e-01
9.5e-01
2.8e+00
1.4e+00
8.5e-01
7.0e-01
cases:8.03%
controls:5.88%
cases:5.82%
controls:3.39%
cases:1.75%
controls:0.68%
cases:0.53%
controls:0.03%
cases:2.55%
controls:0.67%
cases:7.46%
controls:3.34%
cases:15.52%
controls:8.35%
331
2415
3790
38678
240
1396
3886
39733
72
280
4054
40849
22
14
4104
41115
105
275
4016
40835
304
1359
3773
39388
594
3193
3234
35036
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
2.0e+00
1.3e+00
—
—
—
3.0e+00
2.6e+00
cases:0.36%
controls:0.05%
cases:0.19%
controls:0.05%
—
—
—
—
—
—
cases:1.13%
controls:0.06%
cases:1.59%
controls:0.13%
15
21
4106
41072
8
21
4118
41108
—
—
—
46
24
4031
40723
61
48
3767
38181
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.6e-01
1.2e+00
2.1e+00
—
2.0e+00
1.1e+00
6.7e-01
cases:5.31%
controls:3.76%
cases:4.41%
controls:1.37%
cases:1.31%
controls:0.16%
—
—
cases:1.31%
controls:0.18%
cases:3.78%
controls:1.32%
cases:10.97%
controls:5.95%
219
1547
3902
39546
182
565
3944
40564
54
65
4072
41064
—
54
74
4067
41036
154
538
3923
40209
420
2273
3408
35956
chlorpromazine; oral, parenteral, rectal
N05AA01 [21604492]
2.0e+00
1.6e+00
—
—
—
2.5e+00
2.9e+00
cases:0.22%
controls:0.03%
cases:0.12%
controls:0.02%
—
—
—
—
—
—
cases:0.27%
controls:0.02%
cases:0.52%
controls:0.03%
9
12
4112
41081
5
10
4121
41119
—
—
—
11
9
4066
40738
20
11
3808
38218
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
3.9e-01
7.5e-01
1.1e+00
2.6e+00
1.1e+00
7.0e-01
6.8e-01
cases:7.47%
controls:5.16%
cases:6.79%
controls:3.31%
cases:1.43%
controls:0.47%
cases:0.17%
controls:0.01%
cases:1.55%
controls:0.51%
cases:7.48%
controls:3.85%
cases:19.59%
controls:11.03%
308
2122
3813
38971
280
1361
3846
39768
59
192
4067
40937
7
5
4119
41124
64
209
4057
40901
305
1568
3772
39179
750
4215
3078
34014
Short blood count panel - Blood
55429-5 [40758558]
1.9e-01
4.5e-01
8.9e-01
2.7e+00
1.6e+00
1.0e+00
7.5e-01
cases:3.91%
controls:3.25%
cases:2.42%
controls:1.56%
cases:0.78%
controls:0.32%
cases:0.22%
controls:0.01%
cases:1.43%
controls:0.29%
cases:3.65%
controls:1.36%
cases:7.45%
controls:3.65%
161
1336
3960
39757
100
643
4026
40486
32
131
4094
40998
9
6
4117
41123
59
120
4062
40990
149
556
3928
40191
285
1395
3543
36834
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
4.6e-01
7.2e-01
2.2e+00
—
2.7e+00
1.2e+00
1.2e+00
cases:1.24%
controls:0.79%
cases:0.63%
controls:0.31%
cases:0.39%
controls:0.04%
—
—
cases:0.68%
controls:0.05%
cases:0.93%
controls:0.27%
cases:1.93%
controls:0.58%
51
323
4070
40770
26
126
4100
41003
16
17
4110
41112
—
28
19
4093
41091
38
110
4039
40637
74
222
3754
38007
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
2.3e+00
2.6e+00
—
—
—
—
2.4e+00
cases:0.29%
controls:0.03%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.24%
controls:0.02%
12
12
4109
41081
7
5
4119
41124
—
—
—
—
9
8
3819
38221
Psychologist in multidisciplinary team
ZXY81 [2001311550]
1.8e+00
—
—
—
—
2.7e+00
2.9e+00
cases:0.24%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.37%
controls:0.02%
10
17
4111
41076
—
—
—
—
12
8
4065
40739
14
8
3814
38221
Feeling depressed
P03 [2002000800]
9.3e-01
1.7e+00
1.9e+00
—
1.2e+00
8.9e-01
6.8e-01
cases:4.51%
controls:1.83%
cases:4.17%
controls:0.77%
cases:1.02%
controls:0.16%
—
—
cases:0.41%
controls:0.12%
cases:1.69%
controls:0.70%
cases:6.11%
controls:3.18%
186
754
3935
40339
172
317
3954
40812
42
65
4084
41064
—
17
49
4104
41061
69
285
4008
40462
234
1216
3594
37013
Mixed disorder of scholastic skills
F81.3 [45605515]
1.1e+00
1.9e+00
—
1.0e+50
2.5e+00
1.5e+00
1.4e+00
cases:0.29%
controls:0.09%
cases:0.32%
controls:0.05%
—
—
cases:0.17%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.27%
controls:0.06%
cases:0.42%
controls:0.10%
12
39
4109
41054
13
19
4113
41110
—
7
0
4119
41129
7
6
4114
41104
11
24
4066
40723
16
38
3812
38191
Planned therapy visit for psychiatric disease
W0A12 [2001310894]
8.3e-01
9.8e-01
2.1e+00
—
3.1e+00
2.3e+00
1.9e+00
cases:0.27%
controls:0.12%
cases:0.19%
controls:0.07%
cases:0.12%
controls:0.01%
—
—
cases:0.27%
controls:0.01%
cases:0.47%
controls:0.05%
cases:0.65%
controls:0.10%
11
48
4110
41045
8
30
4118
41099
5
6
4121
41123
—
11
5
4110
41105
19
19
4058
40728
25
37
3803
38192
liraglutide; parenteral
A10BJ02 [1123630]
1.8e+00
1.6e+00
—
—
—
1.9e+00
2.0e+00
cases:0.46%
controls:0.08%
cases:0.32%
controls:0.06%
—
—
—
—
—
—
cases:0.49%
controls:0.07%
cases:1.62%
controls:0.23%
19
33
4102
41060
13
25
4113
41104
—
—
—
20
29
4057
40718
62
87
3766
38142
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
3.7e-01
1.2e+00
2.2e+00
—
1.9e+00
1.1e+00
6.2e-01
cases:4.49%
controls:3.14%
cases:3.54%
controls:1.13%
cases:1.09%
controls:0.12%
—
—
cases:0.90%
controls:0.14%
cases:2.72%
controls:0.97%
cases:8.23%
controls:4.60%
185
1289
3936
39804
146
466
3980
40663
45
48
4081
41081
—
37
58
4084
41052
111
395
3966
40352
315
1760
3513
36469
Endocrinology
46 [38004485]
1.7e-01
3.1e-01
7.4e-01
4.2e+00
1.0e+00
7.0e-01
3.1e-01
cases:4.10%
controls:3.48%
cases:4.12%
controls:3.05%
cases:1.53%
controls:0.74%
cases:1.65%
controls:0.02%
cases:2.21%
controls:0.82%
cases:6.92%
controls:3.55%
cases:10.82%
controls:8.18%
169
1428
3952
39665
170
1256
3956
39873
63
303
4063
40826
68
10
4058
41119
91
337
4030
40773
282
1447
3795
39300
414
3129
3414
35100
Supplier / Service Provider
OMOP5117446 [33004]
-9.3e-01
-9.6e-01
-1.1e+00
—
3.7e+00
2.9e+00
3.6e+00
cases:9.17%
controls:20.31%
cases:3.13%
controls:7.80%
cases:0.34%
controls:0.97%
—
—
cases:0.66%
controls:0.02%
cases:3.88%
controls:0.21%
cases:15.65%
controls:0.49%
378
8346
3743
32747
129
3210
3997
37919
14
398
4112
40731
—
27
7
4094
41103
158
86
3919
40661
599
187
3229
38042
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
2.9e-01
5.8e-01
8.7e-01
2.7e+00
1.3e+00
8.9e-01
7.4e-01
cases:8.59%
controls:6.55%
cases:6.86%
controls:3.94%
cases:2.18%
controls:0.93%
cases:0.56%
controls:0.04%
cases:3.08%
controls:0.90%
cases:8.93%
controls:3.88%
cases:18.10%
controls:9.55%
354
2693
3767
38400
283
1622
3843
39507
90
382
4036
40747
23
16
4103
41113
127
371
3994
40739
364
1580
3713
39167
693
3650
3135
34579
Counselling and guidance related to growth and development
SPAT1303 [2001700404]
1.7e-01
9.8e-01
2.4e+00
—
2.3e+00
1.6e+00
9.2e-01
cases:0.63%
controls:0.53%
cases:0.29%
controls:0.11%
cases:0.24%
controls:0.02%
—
—
cases:0.15%
controls:0.01%
cases:0.37%
controls:0.07%
cases:0.52%
controls:0.21%
26
219
4095
40874
12
45
4114
41084
10
9
4116
41120
—
6
6
4115
41104
15
29
4062
40718
20
80
3808
38149
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
3.8e-01
8.4e-01
1.7e+00
—
2.6e+00
9.9e-01
1.1e+00
cases:0.61%
controls:0.41%
cases:0.48%
controls:0.21%
cases:0.22%
controls:0.04%
—
—
cases:0.22%
controls:0.02%
cases:0.54%
controls:0.20%
cases:2.01%
controls:0.65%
25
170
4096
40923
20
86
4106
41043
9
16
4117
41113
—
9
7
4112
41103
22
82
4055
40665
77
247
3751
37982
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
2.6e-01
3.8e-02
—
—
2.8e+00
2.5e+00
2.0e+00
cases:0.44%
controls:0.34%
cases:0.12%
controls:0.12%
—
—
—
—
cases:0.27%
controls:0.02%
cases:1.23%
controls:0.11%
cases:2.32%
controls:0.32%
18
138
4103
40955
5
48
4121
41081
—
—
11
7
4110
41103
50
43
4027
40704
89
121
3739
38108
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
4.2e-01
7.2e-01
2.2e+00
—
2.6e+00
1.2e+00
1.3e+00
cases:1.19%
controls:0.78%
cases:0.61%
controls:0.30%
cases:0.34%
controls:0.04%
—
—
cases:0.61%
controls:0.05%
cases:0.83%
controls:0.25%
cases:1.78%
controls:0.51%
49
321
4072
40772
25
122
4101
41007
14
16
4112
41113
—
25
19
4096
41091
34
102
4043
40645
68
195
3760
38034
Fever, unspecified
R50.9 [45582716]
4.4e-01
8.2e-01
1.8e+00
1.0e+50
2.7e+00
8.4e-01
5.6e-01
cases:1.89%
controls:1.23%
cases:0.87%
controls:0.39%
cases:0.29%
controls:0.05%
cases:0.32%
controls:0.00%
cases:0.36%
controls:0.02%
cases:0.91%
controls:0.40%
cases:2.72%
controls:1.56%
78
504
4043
40589
36
159
4090
40970
12
19
4114
41110
13
0
4113
41129
15
10
4106
41100
37
161
4040
40586
104
598
3724
37631
Pediatric Medicine
37 [38004477]
-3.9e-01
-3.5e-01
3.0e-01
4.9e+00
1.6e+00
8.7e-01
5.4e-01
cases:12.47%
controls:17.39%
cases:6.06%
controls:8.36%
cases:2.81%
controls:2.10%
cases:10.32%
controls:0.08%
cases:9.32%
controls:2.04%
cases:14.64%
controls:6.72%
cases:10.29%
controls:6.26%
514
7148
3607
33945
250
3439
3876
37690
116
862
4010
40267
426
34
3700
41095
384
837
3737
40273
597
2739
3480
38008
394
2393
3434
35836
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
1.6e+00
1.4e+00
1.0e+50
—
—
3.0e+00
2.7e+00
cases:0.46%
controls:0.10%
cases:0.15%
controls:0.04%
cases:0.12%
controls:0.00%
—
—
—
—
cases:0.52%
controls:0.03%
cases:1.33%
controls:0.09%
19
40
4102
41053
6
15
4120
41114
5
0
4121
41129
—
—
21
11
4056
40736
51
35
3777
38194
Amphetamines [Presence] in Urine
3349-8 [3027944]
5.9e-01
1.0e+00
2.3e+00
—
1.6e+00
7.7e-01
8.7e-01
cases:1.67%
controls:0.93%
cases:1.36%
controls:0.48%
cases:0.34%
controls:0.03%
—
—
cases:0.24%
controls:0.05%
cases:1.13%
controls:0.53%
cases:4.60%
controls:1.99%
69
383
4052
40710
56
199
4070
40930
14
14
4112
41115
—
10
20
4111
41090
46
214
4031
40533
176
760
3652
37469
Hospital inpatient
ZY000 [2001311598]
1.5e+00
1.4e+00
—
1.0e+50
—
3.1e+00
2.5e+00
cases:0.46%
controls:0.10%
cases:0.19%
controls:0.05%
—
—
cases:0.29%
controls:0.00%
—
—
cases:0.78%
controls:0.04%
cases:1.41%
controls:0.11%
19
43
4102
41050
8
19
4118
41110
—
12
0
4114
41129
—
32
15
4045
40732
54
43
3774
38186
Delusional disorder
F22.0 [45581451]
1.3e+00
2.5e+00
—
—
—
2.3e+00
2.3e+00
cases:0.17%
controls:0.05%
cases:0.15%
controls:0.01%
—
—
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.34%
controls:0.03%
7
20
4114
41073
6
5
4120
41124
—
—
—
8
8
4069
40739
13
13
3815
38216

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1156
3128
4.68
307.65
6.4
6.1
1.12
1.08
mmol/l
5.88
1077
2918
942
2239
5.10
307.65
3.2
2.6
0.23
0.23
g/l
0.68
868
2110
2023
9614
3.08
279.01
3.0
2.8
2.35
2.34
mmol/l
1.34
1867
8980
2331
12325
2.94
259.15
2.4
1.7
97.19
98.07
pmol/l
0.40
1367
7080
2400
13233
2.84
240.63
8.0
5.8
1.22
1.21
mmol/l
0.40
2144
11556
1107
4029
3.35
235.46
4.1
3.8
0.84
0.83
mmol/l
0.97
1049
3833
2186
11584
2.80
235.06
7.5
5.5
1.22
1.22
mmol/l
2.26
2060
10808
1004
3485
3.45
229.99
1.9
1.6
1144.69
1156.62
nmol/l
0.15
808
2735
2220
12039
2.74
225.25
5.1
4.5
37.91
37.45
g/l
3.91
2087
11364
2721
16394
2.79
223.12
3.3
2.4
70.67
70.81
nmol/l
0.10
2574
15562
1621
7622
2.80
215.64
2.0
1.5
21.11
19.89
nmol/l
3.07
1485
6869
1576
7584
2.70
196.86
4.2
3.4
7.39
7.39
ph
1.67
1092
5145
660
1931
3.85
193.72
3.1
2.5
—
—
—
0
0
1784
9918
2.36
155.13
2.8
2.2
2.52
2.50
mg/l
0.23
1558
8665
1043
4680
2.62
143.26
2.3
2.1
2.40
2.40
mmol/l
0.22
912
4147
2005
11998
2.25
143.19
3.8
3.0
28.30
27.83
u/l
0.15
1903
11479
837
3376
2.83
141.68
3.4
2.5
—
—
—
0
0
3236
24057
2.39
129.84
8.0
6.5
72.32
72.40
u/l
0.04
3088
22857
569
1993
3.13
123.09
1.6
1.6
0.22
0.23
mg/l
0.16
213
787
2062
13075
2.10
120.50
1.7
1.4
1.18
1.54
u/ml
1.18
571
3779
218
386
5.88
117.61
14.4
12.9
0.61
0.59
mmol/l
0.53
205
358
866
3910
2.52
114.73
2.1
2.1
395.83
387.77
nmol/l
0.53
794
3636
1658
9885
2.10
112.04
3.4
2.5
60.54
56.13
u/l
0.87
1510
9235
1510
8841
2.09
105.75
3.9
3.5
7.54
8.29
mmol/l
5.08
1329
7963
1002
5110
2.25
99.00
2.6
2.3
13.98
14.82
umol/l
2.88
940
4783
1754
11059
1.99
98.14
1.6
1.4
1.94
2.00
g/l
1.22
1040
7273
2834
21077
2.01
97.17
12.5
8.1
3.78
4.01
e9/l
6.95
2457
18456
3830
32098
2.77
96.83
6.7
4.6
13.84
14.24
pmol/l
25.28
3642
30052
2235
15383
1.94
95.76
5.3
5.1
9.35
9.66
umol/l
0.81
2073
14430
2612
18968
1.96
95.00
7.9
6.2
0.04
0.04
e9/l
2.77
2270
16738
2611
18962
1.96
94.90
7.9
6.2
0.50
0.52
e9/l
7.01
2270
16749
2605
18928
1.95
94.24
6.2
4.3
6.01
6.08
mmol/l
0.84
2431
16735
2674
19646
1.95
93.04
7.9
6.1
1.96
2.03
e9/l
4.92
2382
17789
865
4256
2.29
92.48
3.0
2.0
—
—
—
0
0
2670
19643
1.94
92.08
8.7
6.4
0.17
0.18
e9/l
5.16
2364
17612
3242
25515
2.10
92.05
4.5
3.4
53.13
57.55
ug/l
1.75
3092
24435
916
4626
2.24
91.90
2.5
2.3
2.53
2.53
g/l
0.06
830
4275
142
212
6.88
90.53
5.2
4.1
192.38
178.96
umol/l
0.16
76
119
903
4594
2.22
88.63
3.0
1.9
—
—
—
0
0
2428
17453
1.89
88.21
8.0
6.2
8.05
8.05
%
0.02
2288
16517
2417
17365
1.89
87.77
8.0
6.2
0.68
0.66
%
1.16
2266
16360
2420
17404
1.89
87.49
7.9
6.1
2.57
2.70
%
2.39
2273
16441
1043
5673
2.10
85.93
1.9
1.6
433.34
38977734.93
pmol/l
5.35
918
5026
900
4631
2.19
85.54
3.0
1.9
—
—
—
0
0
897
4613
2.19
85.36
2.9
1.9
—
—
—
0
0
195
419
4.82
84.51
6.4
5.9
377.81
373.65
umol/l
0.11
163
366
818
4083
2.23
83.66
2.7
2.4
22.08
23.88
%
3.34
762
3803
2497
18312
1.86
82.99
7.8
6.0
30.86
30.42
%
1.41
2373
17504
2464
18022
1.86
82.29
7.7
5.9
55.27
55.91
%
2.17
2354
17353
3962
34414
2.94
81.43
18.6
9.6
3.87
3.88
mmol/l
0.71
3888
33420
3957
34400
2.90
80.17
18.5
9.6
139.34
139.42
mmol/l
1.37
3892
33504
553
2374
2.52
79.49
6.5
4.7
6.01
5.76
kpa
7.94
542
2299
545
2359
2.50
76.84
6.5
4.7
7.37
7.37
ph
0.76
316
1377
533
2292
2.51
76.18
6.5
4.7
1.42
1.34
mmol/l
0.19
467
1937
148
280
5.43
74.20
3.4
1.8
284.76
287.35
mosm/kgh2o
0.87
117
223
860
4574
2.10
73.89
2.9
1.9
—
—
—
0
0
1212
7281
1.92
73.63
2.7
2.0
269.22
155.95
u/l
0.69
1163
6961
4029
35694
3.06
72.23
8.2
5.4
1.69
1.73
mu/l
1.58
3915
34318
3724
31827
2.27
72.19
5.1
3.3
5.55
5.47
mmol/l
2.88
3537
30207
1188
7285
1.87
66.59
2.5
2.7
78.04
97.67
ug/g
1.79
897
5721
1232
7651
1.85
66.28
4.8
3.7
96.00
96.32
%
0.19
1200
7441
473
2057
2.46
65.54
5.8
4.4
4.61
4.78
kpa
1.02
462
1991
403
1633
2.61
64.78
7.2
5.1
24.14
23.86
mmol/l
1.16
398
1619
458
2021
2.41
61.29
9.5
7.7
1.19
1.27
mmol/l
1.19
449
1979
762
4133
2.02
60.91
1.8
1.6
362.56
318.92
mu/l
1.59
665
3694
469
2108
2.37
60.17
11.5
8.9
—
—
—
0
0
522
2465
2.27
59.66
3.1
3.1
1.61
1.64
%
0.27
452
2223
3227
26888
1.80
57.76
4.3
2.9
29.24
29.35
u/l
0.05
3091
25922
1502
10219
1.72
57.41
6.9
5.4
—
—
—
0
0
606
3089
2.12
57.03
2.8
2.3
32.04
50.79
u/l
0.62
504
2584
2249
17055
1.66
56.64
12.2
9.0
0.00
0.00
e9/l
1.38
1796
14036
1142
7243
1.78
55.62
3.2
2.3
—
0.83
—
0
12
790
4478
1.93
55.06
1.3
1.2
—
—
—
0
0
390
1681
2.45
54.75
4.9
4.2
5.19
5.06
kpa
2.95
374
1617
380
1643
2.44
52.93
4.7
4.2
7.40
7.41
ph
3.43
310
1375
703
3878
1.97
52.90
1.2
1.2
—
—
—
0
0
394
1778
2.33
49.75
10.2
9.2
25.01
24.42
mmol/l
2.56
389
1772
519
2636
2.10
48.88
1.7
1.4
7.72
9.15
u/l
1.89
410
2143
223
766
3.01
48.78
1.4
1.3
304.23
322.50
ug/g
0.48
103
350
149
403
3.79
47.66
2.9
2.5
—
—
—
0
0
1472
10357
1.64
47.25
3.7
2.9
115.16
87.34
e6/l
0.18
1085
7562
1310
8963
1.66
46.90
3.6
2.8
0.24
0.25
e6/l
0.06
918
6278
374
1708
2.30
45.82
1.8
1.6
0.26
0.48
nmol/l
10.03
298
1437
950
6006
1.74
45.42
3.0
2.5
511.93
541.16
mosm/kgh2o
2.98
826
5243
589
3217
1.96
45.11
3.0
3.6
4.36
4.67
pmol/l
13.18
526
2948
1811
13530
1.58
44.55
4.6
3.5
72.65
70.58
e6/l
0.05
1161
8448
296
1254
2.46
42.92
5.8
3.9
129.00
131.60
g/l
1.35
288
1223
4102
38049
2.71
41.85
12.9
8.7
24.04
23.68
u/l
0.51
4030
37170
366
1720
2.23
41.76
4.1
3.8
74.86
68.24
ng/l
0.66
326
1583
500
2653
2.00
41.43
1.2
1.2
36.34
3.80
u/ml
—
9
23
416
2066
2.12
41.27
8.7
8.6
7.41
7.42
ph
1.25
207
1124
410
2034
2.12
40.77
8.7
8.6
0.71
0.31
mmol/l
0.94
339
1566
989
6497
1.67
40.41
4.6
3.6
—
—
—
0
0
387
1902
2.13
39.39
7.7
7.8
6.24
6.23
mmol/l
0.00
370
1840
408
2054
2.09
38.98
8.9
8.5
5.18
4.96
kpa
4.51
393
1970
408
2055
2.08
38.92
8.9
8.5
12.84
14.22
kpa
5.09
392
1974
1264
8902
1.59
38.71
3.2
2.5
22.85
41.20
ng/l
0.73
525
3220
796
4990
1.73
38.48
3.3
2.6
4.62
5.13
e6/l
0.50
334
2228
688
4143
1.78
38.28
3.1
2.9
943.76
527.04
ng/l
0.64
533
3241
363
1767
2.15
37.83
9.2
9.3
95.64
96.46
%
1.07
354
1701
736
4538
1.75
37.67
1.6
1.4
14.95
17.61
iu/l
2.06
598
3826
4072
37866
2.43
37.26
18.9
10.9
66.67
65.57
umol/l
1.65
4035
37402
1420
10360
1.55
36.87
8.1
5.9
1.08
1.07
inr
0.98
1182
8593
171
592
2.96
36.86
6.7
4.5
60.17
63.96
%
1.33
163
575
3367
29566
1.63
36.83
5.6
3.9
36.68
36.03
mmol/mol
3.22
3206
28357
660
3988
1.77
36.12
2.1
1.8
—
—
—
0
0
194
734
2.72
35.44
2.9
3.2
24.27
23.92
mmol/l
0.74
182
718
262
1149
2.36
35.09
5.1
4.8
—
—
—
0
0
246
1053
2.41
34.79
10.8
10.8
24.32
23.86
mmol/l
1.22
235
1035
119
344
3.52
34.53
1.8
1.5
1.04
1.28
promille
0.94
89
271
2131
17154
1.48
33.40
3.8
3.1
6.39
6.27
ph
4.78
1151
9613
342
1710
2.08
33.13
2.8
2.8
68.19
69.99
e9/l
0.33
216
1163
810
5305
1.65
32.62
3.1
2.5
0.96
1.19
e6/l
0.82
354
2557
409
2199
1.95
32.30
4.5
2.8
7.37
7.35
ph
1.65
328
1585
593
3604
1.74
31.50
2.7
2.7
5.91
6.03
umol/l
0.06
472
3003
664
4182
1.69
30.94
2.0
1.6
—
—
—
0
0
1005
7017
1.56
30.72
3.0
2.4
9.18
9.51
e6/l
0.22
903
6272
191
770
2.54
30.71
2.8
2.5
1.58
2.36
index
0.59
97
426
69
150
4.65
29.53
1.3
1.5
133.46
130.41
nmol/l
0.18
69
150
733
4795
1.63
29.35
2.2
2.0
—
—
—
0
0
3654
33307
1.64
28.28
4.6
3.6
2.66
2.77
mmol/l
15.24
3476
32004
4004
37467
1.99
28.17
16.5
10.7
18.22
19.25
mg/l
1.47
3184
29764
1585
12372
1.44
27.36
1.9
1.7
1.29
1.27
mmol/l
0.59
1383
11095
850
5866
1.56
26.90
4.9
4.4
9.74
12.34
mg/mmol
0.80
551
3964
1147
8440
1.49
26.80
2.3
1.9
0.83
0.97
mg/l
0.59
800
6180
126
443
2.89
26.46
2.7
2.8
29.43
31.44
umol/l
0.40
110
418
1472
11389
1.44
26.40
3.0
2.3
—
—
—
0
0
838
5801
1.55
26.06
4.1
3.8
51.40
75.07
mg/l
2.44
558
3956
52
101
5.19
25.40
2.3
2.1
—
—
—
0
0
613
3966
1.63
25.36
1.5
1.4
—
—
—
0
0
3011
26556
1.44
25.14
5.5
4.1
278.27
2036.66
e6/l
3.82
41
313
221
1038
2.19
25.10
5.9
4.7
24.25
24.28
mmol/l
0.06
214
997
344
1908
1.87
24.55
3.6
2.9
1.22
1.23
mmol/l
0.33
292
1608
862
6075
1.52
24.51
1.5
1.4
435.49
555.50
titre
1.26
133
1219
3620
33176
1.57
24.51
4.4
3.5
4.56
4.65
mmol/l
9.23
3473
32009
3396
30726
1.49
24.18
3.7
3.0
1.16
1.14
mmol/l
0.81
3204
29500
1280
9780
1.44
24.07
3.8
3.2
1.02
1.51
kg/l
1.08
803
6242
488
3020
1.69
23.91
1.2
1.2
18.33
164.51
titre
—
9
94
718
4906
1.55
23.42
1.3
1.3
101.22
149.44
u/ml
2.66
217
1917
3599
33042
1.54
23.07
4.3
3.4
1.52
1.50
mmol/l
1.78
3420
31774
192
896
2.19
22.17
6.2
5.2
9.25
9.36
kpa
0.41
184
870
521
3341
1.63
22.16
1.3
1.4
—
—
—
0
0
85
267
3.22
21.74
2.1
2.2
1.80
1.85
umol/l
0.23
79
247
3677
34015
1.55
21.72
22.8
12.9
13.28
13.20
%
4.57
3649
33567
587
3907
1.58
21.35
3.7
2.4
29.34
29.07
s
0.61
564
3785
632
4298
1.55
20.87
3.7
2.8
336.65
332.85
ng/l
0.01
285
1902
539
3537
1.60
20.79
1.5
1.4
—
—
—
0
0
434
2699
1.67
20.77
1.2
1.2
—
—
—
0
0
85
280
3.07
20.10
2.2
1.6
66.47
70.56
mmol/l
0.24
64
240
1074
8172
1.42
19.97
2.0
1.7
—
—
—
0
0
162
739
2.23
19.80
3.8
2.8
7.40
7.41
ph
2.00
157
734
134
563
2.42
19.80
3.4
2.9
—
—
—
0
0
226
1178
1.97
19.42
2.1
2.2
4.93
5.64
ug/l
0.23
192
1026
156
709
2.24
19.25
1.9
2.2
191.64
291.20
ug/l
0.63
132
623
208
1073
1.98
18.42
2.2
2.1
—
—
—
0
0
1215
9557
1.37
18.25
3.8
3.3
1.80
0.20
—
5
50
1024
7862
1.39
17.73
1.4
1.3
59.09
20.48
iu/ml
0.44
232
2055
65
198
3.31
17.53
2.3
2.5
28.85
26.68
umol/l
0.98
60
184
914
6900
1.41
17.43
2.8
2.4
6293.88
7005.39
u/l
0.27
324
2817
236
1294
1.87
17.42
1.7
1.6
369.19
378.31
mu/l
0.12
203
1072
310
1849
1.73
17.26
1.9
1.8
6.37
6.35
nmol/l
0.01
266
1667
209
1107
1.93
17.15
1.2
1.1
—
—
—
0
0
85
310
2.77
16.80
1.8
1.6
19.86
21.36
umol/l
0.20
76
289
941
7190
1.39
16.62
1.4
1.3
11.60
7.58
u/ml
0.31
328
3034
183
937
1.99
16.57
4.4
5.3
—
—
—
0
0
106
441
2.43
16.07
3.2
3.2
92.77
92.59
%
0.15
99
429
110
477
2.34
15.22
2.6
2.6
21.07
24.32
nmol/l
2.39
104
461
113
506
2.26
14.53
4.2
2.8
9.44
9.34
kpa
0.19
108
501
113
507
2.26
14.46
4.1
2.8
2.12
1.99
mmol/l
0.12
64
265
113
507
2.26
14.46
4.2
2.8
5.05
4.91
kpa
1.57
108
502
220
1252
1.79
14.43
1.5
1.4
13.64
16.18
u/l
0.95
192
1067
344
2219
1.59
14.11
1.7
1.8
1.19
1.37
g/l
2.89
323
2095
428
2901
1.52
14.09
2.3
2.8
9.89
10.53
g/l
4.31
395
2720
2405
21362
1.28
13.80
4.2
3.4
0.00
0.00
estimate
0.37
509
4775
2425
21563
1.28
13.79
4.2
3.4
5.54
3.24
estimate
0.25
506
4758
2432
21654
1.28
13.58
4.2
3.4
0.00
0.01
estimate
3.05
496
4682
234
1385
1.73
13.41
1.6
2.3
65.90
67.68
g/l
3.51
214
1317
1243
10193
1.31
13.21
5.1
4.0
—
—
—
0
0
119
567
2.13
13.16
1.7
1.7
3.42
3.66
g/l
1.32
113
542
173
942
1.87
13.11
2.2
2.3
1.27
1.21
g/l
0.32
153
828
119
568
2.12
13.10
1.8
1.7
7.14
7.26
g/l
0.33
113
543
119
568
2.12
13.10
1.8
1.7
4.23
4.34
g/l
0.69
113
542
116
549
2.14
13.05
1.4
1.7
2.79
2.89
g/l
0.63
110
524
257
1572
1.67
13.04
1.1
1.1
4.96
5.09
eliau/ml
0.03
36
241
869
6786
1.35
12.98
2.3
2.3
301.11
298.32
umol/l
0.39
769
6232
4073
39261
1.69
12.86
15.4
9.5
—
—
—
0
0
114
543
2.13
12.63
3.6
3.2
28.10
25.89
mu/l
0.20
105
512
377
2570
1.51
12.05
1.2
1.2
—
—
—
0
0
394
2732
1.48
11.59
4.8
4.7
0.06
0.13
%
0.79
93
583
391
5473
0.68
11.33
1.2
1.3
—
—
—
0
0
404
2831
1.47
11.26
4.7
4.6
0.57
0.85
%
1.07
102
678
254
1616
1.60
11.05
3.1
2.5
20.03
20.36
s
0.78
208
1375
103
498
2.09
11.03
1.8
1.7
9.21
10.38
g/l
2.82
96
472
275
1784
1.58
11.02
1.4
1.3
—
—
—
0
0
2159
19225
1.24
10.92
2.7
2.3
—
—
—
0
0
171
987
1.76
10.76
1.2
1.4
51.58
98.00
titre
3.18
19
115
389
2732
1.46
10.71
4.2
4.4
0.42
0.56
%
0.65
99
653
117
605
1.96
10.43
1.5
1.1
—
—
—
0
0
1451
12426
1.25
10.25
3.0
2.6
0.44
0.03
0.95
16
136
134
731
1.86
10.17
1.1
1.1
—
—
—
0
0
179
1071
1.70
9.93
2.4
3.1
58.50
99.75
ng/l
3.14
148
926
225
1429
1.60
9.88
2.0
2.2
1.13
1.16
g/l
0.84
218
1369
270
1792
1.54
9.79
1.2
1.3
0.19
1.07
u/ml
—
10
118
163
956
1.73
9.73
1.6
1.9
—
—
—
0
0
211
1326
1.62
9.68
1.2
1.2
—
—
—
0
0
261
1729
1.54
9.55
1.7
1.6
6.81
7.90
u/ml
0.33
55
506
218
1388
1.60
9.49
2.0
2.2
0.22
0.22
g/l
0.06
211
1325
169
1012
1.69
9.36
6.2
6.9
1.23
1.16
mg/l
0.60
153
953
392
2828
1.42
9.34
5.1
4.9
0.01
0.20
%
0.75
83
564
389
2814
1.42
9.13
2.4
2.3
19.27
18.61
au/ml
0.08
35
397
40
138
2.91
8.92
2.8
2.9
—
—
—
0
0
36
117
3.09
8.89
1.4
1.5
15.37
17.15
umol/l
1.10
30
97
66
292
2.28
8.88
1.1
1.2
125.83
119.78
pmol/l
0.45
66
292
77
367
2.11
8.64
1.3
1.2
—
—
—
0
0
1430
12413
1.22
8.52
2.4
2.0
—
—
—
0
0
412
3047
1.39
8.50
3.8
3.0
33.82
32.97
%
0.79
318
2377
1590
13972
1.22
8.33
2.0
1.9
—
—
—
0
0
90
462
1.96
8.27
1.4
2.0
—
—
—
0
0
812
9769
0.79
8.18
1.6
1.6
1105.93
997.89
mu/l
2.67
673
8508
50
205
2.45
8.01
2.2
1.9
-0.06
0.24
mmol/l
0.25
45
184
79
393
2.02
7.95
1.3
1.2
—
—
—
0
0
147
891
1.67
7.84
1.1
1.1
3.60
2.84
eliau/ml
0.35
65
434
77
382
2.03
7.81
1.8
2.0
—
—
—
0
0
120
691
1.75
7.71
1.1
1.1
—
—
—
0
0
360
2648
1.39
7.67
1.3
1.3
16.64
33.49
au/ml
2.65
13
129
79
402
1.98
7.48
1.2
1.4
76.27
73.24
%
1.91
70
384
304
2191
1.41
7.30
2.8
2.2
0.27
0.25
e6/l
0.07
288
2054
263
1852
1.44
7.18
2.0
2.3
7.45
7.17
iu/ml
0.04
46
477
260
1828
1.45
7.16
1.1
1.1
—
—
—
0
0
103
581
1.79
7.13
4.1
2.5
0.98
0.86
nmol/l
0.49
88
504
18
30
6.01
7.05
1.5
1.6
509.92
512.74
nmol/l
0.01
18
30
76
392
1.95
6.96
1.2
1.4
577.11
517.53
mu/l
0.25
67
374
184
1214
1.54
6.94
1.3
1.4
12.64
13.58
u/ml
0.05
14
186
47
203
2.33
6.77
1.4
1.4
5.57
5.68
u/l
0.06
38
172
184
1222
1.53
6.74
1.3
1.4
1.94
4.80
u/ml
—
7
124
494
6171
0.77
6.63
1.6
1.6
3.00
3.25
ratio
4.76
342
4294
276
3747
0.72
6.59
1.6
1.5
63.82
60.23
ug/l
0.59
276
3747
31
112
2.78
6.44
1.3
1.2
130.15
107.77
nmol/l
0.29
25
86
51
234
2.19
6.40
1.5
1.7
1.56
2.48
nmol/l
0.46
37
181
575
4643
1.27
6.39
3.5
2.6
5.18
4.55
e9/l
0.32
482
4199
124
761
1.64
6.38
1.3
1.5
—
5.93
—
0
15
142
902
1.59
6.35
1.2
1.6
—
—
—
0
0
156
1021
1.54
6.14
1.2
1.3
—
—
—
0
0
38
157
2.43
6.07
1.2
1.4
12.34
13.50
pmol/l
0.83
29
133
57
280
2.05
6.03
1.1
1.1
290.25
301.43
mg/l
0.46
52
264
32
122
2.63
6.02
5.3
3.9
62.26
75.85
mg/l
0.63
23
96
49
227
2.17
6.02
3.4
2.9
16.16
15.63
index
0.07
32
164
146
946
1.56
6.02
1.3
1.6
12.84
22.67
e6/l
0.77
113
695
66
342
1.94
6.01
1.3
1.5
4.75
5.60
ug/l
1.02
61
303
28
100
2.81
5.96
3.5
1.2
—
—
—
0
0
147
960
1.55
5.86
1.3
1.6
285.74
4751.05
e6/l
0.58
121
746
44
199
2.22
5.75
1.8
1.5
—
—
—
0
0
18
50
3.60
5.73
1.2
2.4
8.81
52.69
ng/l
—
8
22
30
115
2.61
5.61
1.2
1.2
—
—
—
0
0
76
423
1.81
5.59
2.3
1.7
67.36
88.03
mu/l
0.28
63
384
64
338
1.90
5.54
1.4
1.3
0.21
0.21
nmol/l
0.02
40
231
4205
41394
1.68
5.48
28.8
16.4
89.86
89.44
fl
8.42
4185
41133
17
47
3.62
5.46
8.6
3.8
—
—
—
0
0
4204
41385
1.67
5.43
29.0
16.5
269.05
268.28
e9/l
0.36
4159
40736
56
285
1.97
5.41
1.1
1.3
—
281.82
—
0
11
56
285
1.97
5.41
1.1
1.3
88.57
225.57
titre
—
7
61
3570
34368
1.22
5.40
23.2
13.1
331.93
332.78
g/l
7.56
3557
34148
4205
41400
1.67
5.39
28.8
16.4
29.91
29.86
pg
1.22
4185
41140
4205
41401
1.67
5.38
29.5
16.7
39.62
40.37
%
2.99
4186
41119
4205
41402
1.67
5.37
28.9
16.5
4.44
4.49
e12/l
14.01
4147
40713
24
84
2.86
5.32
2.5
3.4
1.33
1.68
mmol/l
0.25
18
63
145
966
1.52
5.31
1.2
1.5
3.57
3.52
mmol/l
0.25
135
919
99
604
1.65
5.28
2.2
1.9
2.55
2.06
ug/l
0.18
89
537
389
4865
0.78
5.23
1.5
1.4
3.13
3.30
mmol/l
2.56
252
3085
4205
41415
1.65
5.18
29.0
16.5
6.57
6.88
e9/l
17.19
4149
40696
71
399
1.79
5.09
1.5
1.3
0.47
4.88
nmol/l
0.50
66
386
4205
41422
1.65
5.08
29.2
16.6
131.75
133.36
g/l
18.00
4185
41162
22
76
2.90
5.00
2.2
2.6
0.61
0.61
mmol/l
0.04
22
76
58
308
1.89
4.98
3.3
2.9
1.30
1.49
ratio
0.38
31
174
156
1071
1.47
4.96
1.2
1.3
27.29
40.46
u/ml
—
8
89
157
1083
1.46
4.88
1.2
1.5
357.50
426.10
mg/l
2.11
149
1040
44
215
2.05
4.79
2.3
1.8
0.71
0.86
%
0.90
19
113
106
675
1.58
4.79
4.8
5.7
1.26
1.17
mmol/l
0.53
97
592
145
2079
0.69
4.78
1.0
1.1
0.64
0.58
ratio
—
10
169
78
461
1.70
4.72
2.1
2.0
5.26
5.09
mmol/24h
0.19
70
432
59
321
1.85
4.72
3.0
2.2
21.89
26.86
mg/l
0.53
34
219
47
237
1.99
4.71
1.1
1.1
0.08
4.64
nmol/l
—
7
35
88
538
1.65
4.70
3.0
2.9
6.51
6.53
pmol/l
0.01
88
538
207
1513
1.38
4.68
1.9
2.3
6.63
3.82
iu/l
0.27
87
700
183
1312
1.41
4.64
1.4
1.3
207.85
235.34
u/ml
0.92
113
799
25
97
2.58
4.61
1.6
3.3
8.02
7.62
mmol/l
0.15
25
97
374
2990
1.27
4.52
1.3
1.3
—
—
—
0
0
63
355
1.78
4.52
3.2
3.0
42.40
31.28
mg/l
0.94
55
316
112
734
1.54
4.49
1.2
1.2
—
—
—
0
0
62
355
1.75
4.24
3.3
3.0
93.17
26.75
mg/l
0.71
53
315
21
78
2.70
4.23
2.7
3.4
0.98
0.81
nmol/l
0.98
14
61
74
449
1.66
4.11
1.1
1.1
1.46
1.45
g/l
0.14
67
416
121
823
1.48
4.10
1.4
1.3
6.31
4.16
u/ml
0.87
59
386
62
360
1.73
4.05
3.4
2.9
1.20
1.27
%
0.09
55
329
97
635
1.54
3.95
2.8
2.2
133.36
131.67
g/l
0.41
84
546
18
64
2.81
3.93
1.2
1.3
62.06
60.53
ug/l
0.10
18
64
35
170
2.06
3.93
1.2
1.4
146.14
150.26
mmol/24h
0.13
35
170
58
334
1.74
3.91
2.7
4.9
6.74
6.37
mmol/l
0.30
49
267
29
131
2.22
3.90
2.4
2.3
1.34
1.50
nmol/l
0.29
23
103
197
1475
1.35
3.89
5.6
2.9
3.61
3.57
g/l
0.13
180
1401
35
171
2.05
3.87
3.6
2.9
58.49
50.16
umol/l
0.69
29
161
122
842
1.46
3.86
1.8
2.2
10.51
10.16
mg/l
0.26
114
809
185
1381
1.35
3.74
2.0
1.9
—
—
—
0
0
21
84
2.50
3.69
1.9
2.4
22.38
29.10
umol/l
0.99
13
61
12
29
4.14
3.69
2.9
2.7
—
—
—
0
0
10
20
5.00
3.68
2.2
1.8
369.98
280.40
ug/l
—
10
20
32
155
2.07
3.64
3.1
3.1
82.70
58.41
mg/l
0.19
20
114
1270
11551
1.14
3.60
4.4
3.4
0.00
0.00
estimate
3.38
497
4605
8
13
6.15
3.49
1.4
2.8
—
—
—
0
0
64
392
1.64
3.49
1.5
1.4
512.69
719.37
pmol/l
0.36
48
345
149
1093
1.37
3.39
2.8
3.8
222.78
389.60
mg/l
1.93
78
520
74
477
1.56
3.29
1.3
1.3
—
—
—
0
0
92
622
1.49
3.28
1.6
1.5
0.49
0.51
e9/l
0.31
92
622
45
255
1.77
3.26
1.0
1.1
—
—
—
0
0
100
691
1.45
3.21
1.5
1.6
0.60
0.63
g/l
0.14
78
550
107
749
1.44
3.21
1.1
1.1
113.55
115.84
%
0.39
95
672
12
34
3.53
3.18
1.8
2.0
—
—
—
0
0
19
416
0.45
3.12
1.2
1.3
64.74
67.05
ug/l
0.08
19
416
10
26
3.84
2.97
2.4
1.8
233.60
206.74
mmol/l
—
10
26
29
150
1.94
2.82
2.1
2.1
104.62
106.23
mmol/l
0.88
29
150
29
150
1.94
2.82
2.1
2.1
3.75
3.94
mmol/l
1.42
29
150
181
1409
1.29
2.81
1.2
1.1
—
—
—
0
0
425
3631
1.19
2.78
1.4
1.3
433.83
205.45
u/ml
0.60
398
3381
38
216
1.76
2.77
3.1
2.6
1.92
1.59
g/24h
0.34
17
142
15
59
2.54
2.77
2.1
1.2
0.53
0.46
iu/ml
—
10
31
44
262
1.68
2.74
1.4
1.2
—
—
—
0
0
153
1172
1.31
2.69
1.5
1.4
—
—
—
0
0
53
337
1.58
2.57
1.1
1.1
—
—
—
0
0
223
1806
1.24
2.53
2.3
1.8
0.05
0.03
estimate
0.27
93
738
41
246
1.67
2.51
3.0
2.5
58.76
53.27
%
1.37
35
219
145
1119
1.30
2.44
1.5
1.4
138.84
135.73
au/ml
0.11
39
286
8
22
3.63
2.35
9.3
5.9
3.70
6.14
mmol/l
—
8
22
27
146
1.85
2.35
1.1
1.2
6.70
5.86
mmol/l
0.52
22
137
67
460
1.46
2.31
3.2
4.4
29.31
109.39
u/ml
1.93
15
160
403
3486
1.17
2.31
2.3
1.9
0.03
0.04
estimate
0.14
100
874
18
85
2.12
2.27
1.1
1.0
—
—
—
0
0
16
72
2.22
2.26
1.7
1.2
1.89
1.66
iu/ml
—
10
35
2003
19045
1.09
2.23
3.0
2.7
—
—
estimate
—
0
0
21
107
1.96
2.19
1.1
1.1
—
—
—
0
0
65
450
1.45
2.17
3.5
3.0
—
—
—
0
0
19
94
2.02
2.14
1.8
2.1
164.25
92.48
ng/l
0.32
19
94
21
108
1.95
2.13
2.1
2.0
14.03
24.90
umol/l
—
6
13
64
905
0.70
2.13
1.5
1.6
6.60
6.53
mmol/l
0.06
59
835
65
453
1.44
2.11
1.1
1.0
—
—
—
0
0
12
49
2.45
2.09
1.2
1.1
0.80
0.63
umol/24h
—
6
28
26
145
1.79
2.09
2.2
2.1
1.19
1.20
mmol/l
0.18
26
145
59
405
1.46
2.07
2.2
2.6
64.14
95.30
ug/min
0.47
31
280
62
431
1.44
2.05
1.2
1.2
—
—
—
0
0
21
111
1.89
1.99
1.1
1.4
34.11
35.90
g/l
0.24
15
105
292
2494
1.18
1.98
1.4
1.3
3.59
3.67
ug/l
0.07
283
2372
1729
16405
1.09
1.94
3.9
3.1
0.02
0.15
estimate
0.53
408
4015
11
45
2.44
1.92
1.4
1.4
3.31
8.60
pmol/l
—
5
18
16
78
2.05
1.89
1.6
1.4
—
—
—
0
0
1363
12817
1.09
1.88
3.4
2.7
0.14
0.03
estimate
0.43
423
4007
253
2147
1.19
1.87
2.1
2.4
5.81
5.37
umol/l
0.11
181
1591
12
52
2.31
1.86
2.3
1.5
—
—
—
0
0
48
325
1.48
1.84
1.2
1.4
—
—
—
0
0
12
53
2.26
1.79
1.0
1.6
31.00
10.38
nmol/l
—
5
14
34
520
0.65
1.75
1.7
1.9
—
—
—
0
0
113
889
1.28
1.73
2.4
3.2
58.36
57.59
%
0.26
113
889
24
140
1.71
1.70
1.3
1.1
—
—
—
0
0
12
55
2.18
1.66
1.1
1.0
—
—
—
0
0
418
3722
1.13
1.65
4.1
3.2
—
—
—
0
0
17
90
1.89
1.64
1.1
1.1
—
—
—
0
0
5
14
3.57
1.61
3.4
1.6
1.59
1.63
g/l
—
5
14
106
838
1.27
1.59
1.2
1.1
—
—
—
0
0
1665
15871
1.08
1.59
2.1
1.9
—
—
—
0
0
56
404
1.39
1.57
2.0
2.9
1549.95
1356.81
e6/l
0.92
44
334
19
106
1.79
1.57
2.1
2.1
—
—
—
0
0
31
199
1.56
1.55
1.5
1.2
62.48
68.55
umol/l
0.92
31
199
20
114
1.75
1.55
1.3
1.4
1627.30
3251.58
e6/l
—
10
73
15
78
1.92
1.53
2.1
3.1
16.26
16.90
%
0.26
15
78
5
15
3.33
1.52
1.4
1.1
—
—
—
0
0
6
21
2.85
1.50
1.0
1.0
2.53
4.79
u/ml
—
6
21
47
332
1.42
1.50
1.9
2.9
606.15
507.76
e6/l
0.94
34
256
60
445
1.35
1.45
1.3
1.4
—
—
—
0
0
15
80
1.87
1.43
1.1
1.1
—
176.00
—
0
5
42
295
1.42
1.40
1.2
1.3
31.08
24.93
u/l
0.12
35
250
80
623
1.29
1.39
2.6
2.2
—
—
—
0
0
7
29
2.41
1.39
2.1
1.4
53.26
28.21
nmol/l
—
7
29
48
349
1.38
1.33
1.9
2.9
199.61
203.26
e6/l
0.05
36
280
10
47
2.13
1.33
6.0
7.3
1.58
3.09
mg/l
—
10
40
17
98
1.73
1.30
1.3
1.5
10234.17
45131.70
e6/l
—
6
50
102
827
1.24
1.29
1.3
1.2
—
—
—
0
0
17
99
1.72
1.26
1.2
1.4
—
—
—
0
0
35
493
0.71
1.26
3.5
3.3
—
—
—
0
0
29
194
1.50
1.25
1.1
1.3
0.03
2.09
u/ml
2.35
29
194
13
70
1.86
1.23
1.5
1.7
9.12
8.90
mmol/l
0.05
13
70
15
85
1.76
1.22
1.2
1.5
—
—
—
0
0
32
221
1.45
1.19
1.1
1.1
2.70
11.30
u/ml
0.85
20
145
39
280
1.39
1.19
1.6
1.7
29.55
22.48
mg/l
0.52
11
109
1577
15137
1.06
1.16
2.1
1.9
—
—
—
0
0
5
20
2.50
1.15
1.0
1.1
0.01
0.06
u/ml
—
5
15
18
110
1.64
1.14
1.3
1.5
—
—
—
0
0
272
2423
1.13
1.14
1.1
1.1
—
—
—
0
0
32
225
1.42
1.11
2.0
2.8
0.33
0.20
e9/l
0.74
19
118
83
673
1.24
1.09
2.7
3.5
4.20
3.98
e9/l
0.33
83
673
94
775
1.22
1.06
1.3
1.2
169.77
2327.00
iu/ml
0.88
22
208
9
45
2.00
1.04
1.6
1.7
—
—
—
0
0
58
455
1.28
1.02
1.3
1.4
6.04
6.43
g/l
0.63
38
338
10
53
1.88
1.00
1.2
1.1
1.66
3.28
u/ml
—
10
32
14
83
1.69
1.00
1.2
1.1
—
—
—
0
0
14
83
1.69
1.00
1.1
1.0
—
—
—
0
0
5
110
0.45
0.99
1.6
1.5
—
—
—
0
0
5
23
2.17
0.98
1.8
1.3
—
—
—
0
0
302
3313
0.90
0.97
1.5
1.6
—
—
—
0
0
0
31
0.00
0.96
0.0
1.2
—
57.90
—
0
5
103
871
1.18
0.92
9.0
7.1
—
—
—
0
0
9
52
1.73
0.92
2.1
2.0
—
—
—
0
0
10
55
1.82
0.91
1.3
3.2
—
9.87
—
0
15
57
454
1.26
0.91
1.3
1.4
2.70
2.94
g/l
0.62
40
334
57
454
1.26
0.91
1.3
1.4
0.30
0.39
g/l
2.06
39
334
498
5320
0.93
0.90
1.6
1.5
67.71
61.58
ug/l
1.83
403
4550
6
29
2.07
0.89
1.0
1.1
1.62
1.52
umol/24h
—
6
29
41
314
1.31
0.88
1.1
1.1
—
—
—
0
0
57
456
1.25
0.88
1.3
1.2
—
—
—
0
0
10
56
1.78
0.87
1.2
1.1
0.03
0.03
u/ml
—
10
56
6
30
2.00
0.86
1.7
1.1
—
—
—
0
0
46
360
1.28
0.85
1.7
1.5
—
—
—
0
0
25
178
1.40
0.85
1.1
1.1
—
—
—
0
0
19
128
1.48
0.85
1.0
1.1
4.12
3.19
u/ml
0.08
14
96
17
250
0.68
0.84
1.5
1.2
—
—
—
0
0
8
47
1.70
0.80
1.1
1.9
38.25
43.74
g/l
—
8
47
63
760
0.82
0.79
1.3
1.3
259.19
1720.64
pmol/l
—
10
74
21
147
1.43
0.79
60.5
43.1
7.44
7.06
ug/l
0.42
21
135
49
392
1.25
0.78
1.1
1.2
1.06
1.05
ratio
0.53
41
330
29
216
1.34
0.77
2.3
2.9
9.36
9.66
mg/l
0.10
24
185
14
90
1.55
0.77
6.4
3.9
—
—
—
0
0
258
2356
1.10
0.76
1.8
2.3
21.10
36.41
u/ml
2.17
249
2275
0
28
0.00
0.76
0.0
3.8
—
1.97
—
0
18
15
99
1.51
0.75
1.3
1.4
—
—
—
0
0
470
4988
0.93
0.74
1.5
1.5
1.19
1.14
ratio
0.42
271
3018
78
660
1.18
0.73
3.7
3.1
18.62
23.90
mg/l
0.81
40
438
165
1478
1.12
0.71
3.1
2.5
1.02
1.02
ratio
0.03
137
1263
28
211
1.33
0.71
2.5
3.6
—
—
—
0
0
5
26
1.92
0.70
1.0
1.3
—
—
—
0
0
49
399
1.23
0.69
1.3
1.2
0.67
0.67
ratio
0.01
30
225
57
472
1.21
0.69
1.1
1.1
5.33
5.67
iu/ml
0.04
15
120
7
42
1.66
0.68
1.1
1.1
109.71
89.14
titre
—
7
42
58
483
1.20
0.66
1.9
1.8
19626.76
8096.21
e6/l
0.78
41
355
380
3553
1.07
0.66
1.4
1.3
217.97
235.82
miu/ml
0.42
163
1846
34
267
1.27
0.65
1.1
1.1
196.41
11.96
u/ml
0.46
28
175
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
11
70
1.57
0.64
1.2
1.2
—
—
—
0
0
148
1328
1.12
0.64
1.1
1.1
6.69
7.56
u/ml
0.16
72
645
452
4259
1.07
0.64
1.2
1.2
—
—
—
0
0
17
120
1.42
0.64
1.9
1.7
—
—
—
0
0
121
1074
1.13
0.63
1.2
1.1
18.38
14.53
au/ml
0.21
25
299
132
1178
1.12
0.63
1.1
1.1
0.21
0.53
u/ml
0.68
52
362
183
1664
1.10
0.62
1.1
1.1
2.20
2.42
u/ml
0.13
106
917
186
1696
1.10
0.60
1.1
1.1
5.19
6.70
u/ml
0.63
112
1014
19
139
1.37
0.59
1.3
1.2
29.11
27.88
s
0.51
19
139
177
1612
1.10
0.59
1.1
1.1
0.86
1.25
u/ml
0.78
97
770
23
299
0.77
0.59
1.2
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
20.86
—
0
18
23
297
0.77
0.57
1.3
1.2
8.78
8.22
mm/h
0.16
23
297
25
193
1.29
0.56
1.4
1.4
88.40
81.08
nmol/24h
0.25
25
193
31
385
0.80
0.56
1.0
1.1
1833.13
1459.08
miu/ml
1.06
31
385
28
220
1.27
0.56
1.3
1.5
—
—
—
0
0
6
37
1.62
0.55
27.5
6.2
5.53
5.52
kpa
—
6
37
209
1927
1.09
0.55
1.1
1.1
2.09
2.80
u/ml
0.65
119
1069
157
1433
1.10
0.52
1.1
1.1
4.83
5.44
u/ml
0.16
86
773
18
134
1.34
0.52
1.0
1.3
—
—
—
0
0
58
497
1.17
0.52
1.2
1.1
33.19
35.81
mg/l
0.13
47
409
6
96
0.62
0.52
1.0
1.4
5.07
5.39
mmol/l
—
6
96
9
65
1.38
0.50
1.3
1.6
—
—
—
0
0
183
1689
1.08
0.49
1.8
1.7
—
—
—
0
0
17
127
1.34
0.49
1.1
1.0
0.15
0.12
u/ml
—
8
58
351
3318
1.06
0.48
2.2
2.2
6.31
6.27
ph
0.25
204
2056
55
474
1.16
0.47
1.3
1.3
644.44
1035.37
titre
—
9
82
1641
16701
0.97
0.47
1.9
1.9
—
—
—
0
0
61
531
1.15
0.46
1.3
1.3
—
—
—
0
0
47
544
0.86
0.44
1.0
1.1
35.96
2.81
u/ml
0.44
21
176
37
312
1.19
0.42
1.0
1.0
10.94
14.32
u/ml
0.38
22
217
0
17
0.00
0.40
0.0
1.4
—
30.97
—
0
17
0
17
0.00
0.40
0.0
3.3
—
6.07
—
0
17
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
20
246
0.81
0.37
1.5
4.0
47.29
228.12
u/ml
0.91
15
227
88
964
0.91
0.37
1.2
1.3
—
—
—
0
0
61
544
1.12
0.35
1.0
1.1
0.94
2.67
u/ml
1.19
30
224
16
126
1.27
0.34
1.0
1.0
0.41
0.05
u/ml
—
7
56
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
12
91
1.32
0.33
1.1
1.2
—
—
—
0
0
11
143
0.77
0.32
1.1
1.0
—
—
—
0
0
11
143
0.77
0.32
1.1
1.0
—
—
—
0
0
11
143
0.77
0.32
1.1
1.0
—
—
—
0
0
54
482
1.12
0.32
1.1
1.1
195.17
200.02
mg/l
0.07
47
422
7
52
1.34
0.31
1.0
1.2
—
19.70
—
0
10
119
1108
1.07
0.30
1.2
1.2
—
—
—
0
0
23
194
1.18
0.29
1.1
1.4
—
—
—
0
0
14
112
1.25
0.28
1.1
1.0
—
—
—
0
0
22
187
1.17
0.26
2.0
3.0
43.44
46.10
%
0.38
11
108
5
72
0.69
0.26
6.2
4.2
0.12
0.20
%
—
5
72
46
508
0.90
0.25
1.0
1.1
0.79
1.15
u/ml
0.23
19
153
36
403
0.89
0.25
2.6
3.8
17.09
22.71
u/ml
0.83
36
390
37
329
1.12
0.25
1.8
1.6
5.28
5.68
mmol/l
1.02
30
282
87
810
1.07
0.24
1.3
1.3
—
—
—
0
0
15
124
1.21
0.23
2.2
2.4
28.67
27.27
%
0.18
15
124
12
97
1.24
0.22
1.0
1.1
0.18
0.82
u/ml
—
7
52
5
40
1.25
0.22
1.2
4.7
47.80
44.97
umol/l
—
5
34
0
10
0.00
0.21
0.0
1.7
—
2.44
—
0
10
0
11
0.00
0.21
0.0
1.5
—
48.55
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
59
545
1.08
0.21
3.1
3.4
41.57
493.41
u/ml
1.04
54
463
5
43
1.16
0.21
1.4
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
51
1.17
0.19
1.3
1.4
—
99.48
—
0
5
644
6546
0.98
0.19
2.2
2.2
—
—
—
0
0
26
231
1.12
0.19
1.4
1.2
—
—
—
0
0
11
90
1.22
0.19
1.5
2.3
—
—
—
0
0
16
137
1.17
0.18
26.8
29.7
156.25
125.11
ug/l
0.46
16
113
135
1291
1.04
0.18
1.2
1.1
—
—
—
0
0
14
119
1.17
0.17
1.5
1.3
189.66
110.08
pmol/l
1.14
14
119
135
1293
1.04
0.17
1.2
1.1
—
—
—
0
0
20
176
1.13
0.17
1.6
1.5
5720.80
66190.38
e6/l
0.84
15
109
13
110
1.18
0.16
1.0
1.0
0.03
0.69
u/ml
—
5
53
18
158
1.14
0.16
1.2
1.1
22.74
33.41
iu/ml
0.39
18
158
44
408
1.08
0.15
1.1
1.3
3.60
2.54
u/ml
0.26
32
207
18
159
1.13
0.14
1.9
2.8
—
—
—
0
0
148
1427
1.04
0.14
3.9
3.8
1.30
1.79
ug/l
1.13
127
1288
94
898
1.05
0.14
2.7
2.7
9.03
27.97
iu/ml
—
6
37
52
488
1.06
0.14
1.1
1.1
12.62
13.64
u/ml
0.17
23
216
24
218
1.10
0.13
2.3
2.1
—
—
—
0
0
24
260
0.92
0.11
2.6
1.7
59.53
45.51
%
0.90
19
165
29
269
1.08
0.11
4.2
4.0
7.15
8.69
mg/l
0.72
22
226
15
135
1.11
0.09
1.5
1.9
1815.00
1962.49
ml
—
10
127
81
835
0.97
0.08
2.4
2.5
0.47
0.67
ug/l
3.02
43
424
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
23
214
1.07
0.08
1.7
2.7
20.06
150.33
ug/l
0.74
23
198
7
67
1.04
0.08
1.6
1.8
—
—
—
0
0
41
391
1.05
0.07
1.0
1.0
—
—
—
0
0
9
85
1.06
0.07
1.2
1.1
—
—
—
0
0
102
994
1.02
0.07
1.4
1.5
33.69
37.22
nmol/l
0.44
93
919
196
1932
1.01
0.05
1.4
1.4
—
—
—
0
0
404
4058
0.99
0.04
1.5
1.5
—
—
—
0
0
38
391
0.97
0.03
2.4
1.9
4.02
2.12
u/ml
0.45
11
122
46
448
1.02
0.03
1.3
1.5
—
—
—
0
0
46
448
1.02
0.03
1.3
1.5
—
—
—
0
0
46
448
1.02
0.03
1.3
1.5
—
—
—
0
0
46
448
1.02
0.03
1.3
1.5
—
—
—
0
0
142
1432
0.99
0.03
2.5
3.9
42.88
39.95
ug/l
0.03
100
983
11
102
1.08
0.02
1.0
1.0
10.25
6.04
u/ml
0.24
11
102
19
182
1.04
0.02
1.5
1.5
0.00
0.00
estimate
-0.00
19
182
415
4130
1.00
0.01
1.6
1.6
—
—
—
0
0
20
206
0.97
0.01
7.6
7.9
5.13
91.14
ug/l
0.62
15
147
24
240
1.00
0.00
1.1
1.1
—
—
—
0
0
20
198
1.01
0.00
2.4
2.1
—
—
—
0
0
396
3956
1.00
0.00
1.5
1.5
1.26
1.26
mm
0.04
277
2970
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
0.03
—
0
7
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.36
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
55.80
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
32.80
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
154.00
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
80
1.00
-0.00
1.1
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
0.06
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_EATING – Eating disorder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).